
<html lang="en"     class="pb-page"  data-request-id="d773c61f-d0ef-44c4-8e9e-db672022317e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2021.64.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01715;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors" /></meta><meta name="dc.Creator" content="Chihoko  Yoshimura" /></meta><meta name="dc.Creator" content="Satoru  Nagatoishi" /></meta><meta name="dc.Creator" content="Daisuke  Kuroda" /></meta><meta name="dc.Creator" content="Yasuo  Kodama" /></meta><meta name="dc.Creator" content="Takao  Uno" /></meta><meta name="dc.Creator" content="Makoto  Kitade" /></meta><meta name="dc.Creator" content="Khoontee  Chong-Takata" /></meta><meta name="dc.Creator" content="Hiromi  Oshiumi" /></meta><meta name="dc.Creator" content="Hiromi  Muraoka" /></meta><meta name="dc.Creator" content="Satoshi  Yamashita" /></meta><meta name="dc.Creator" content="Yuichi  Kawai" /></meta><meta name="dc.Creator" content="Shuichi  Ohkubo" /></meta><meta name="dc.Creator" content="Kouhei  Tsumoto" /></meta><meta name="dc.Description" content="The cytosolic Hsp90-selective inhibitor TAS-116 has an acceptable safety profile and promising antitumor activity in clinical trials. We examined the binding characteristics of TAS-116 and its anal..." /></meta><meta name="Description" content="The cytosolic Hsp90-selective inhibitor TAS-116 has an acceptable safety profile and promising antitumor activity in clinical trials. We examined the binding characteristics of TAS-116 and its anal..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 23, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01715" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01715" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01715" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01715" /></link>
        
    
    

<title>Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01715" /></meta><meta property="og:title" content="Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0006.jpeg" /></meta><meta property="og:description" content="The cytosolic Hsp90-selective inhibitor TAS-116 has an acceptable safety profile and promising antitumor activity in clinical trials. We examined the binding characteristics of TAS-116 and its analogs to determine the impact of the ligand binding mode on selectivity for cytosolic Hsp90. Analyses of the co-crystal structure of Hsp90 and inhibitor TAS-116 suggest that TAS-116 interacts with the ATP-binding pocket, the ATP lid region, and the hydrophobic pocket. A competitive isothermal titration calorimetry analysis confirmed that a small fragment of TAS-116 (THS-510) docks into the lid region and hydrophobic pockets without binding to the ATP-binding pocket. THS-510 exhibited enthalpy-driven binding to Hsp90α and selectively inhibited cytosolic Hsp90 activity. The heat capacity change of THS-510 binding was positive, likely due to the induced conformational rearrangement of Hsp90. Thus, we concluded that interactions with the hydrophobic pocket of Hsp90 determine potency and selectivity of TAS-116 and derivatives for the cytosolic Hsp90 isoform." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01715"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01715">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01715&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01715&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01715&amp;href=/doi/10.1021/acs.jmedchem.0c01715" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2669-2677</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01779" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01875" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Chihoko Yoshimura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chihoko Yoshimura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chihoko++Yoshimura">Chihoko Yoshimura</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Satoru Nagatoishi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Satoru Nagatoishi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Satoru++Nagatoishi">Satoru Nagatoishi</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0794-3963" title="Orcid link">http://orcid.org/0000-0002-0794-3963</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daisuke Kuroda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daisuke Kuroda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daisuke++Kuroda">Daisuke Kuroda</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2390-4785" title="Orcid link">http://orcid.org/0000-0003-2390-4785</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yasuo Kodama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yasuo Kodama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yasuo++Kodama">Yasuo Kodama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Takao Uno</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Takao Uno</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Takao++Uno">Takao Uno</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3259-4603" title="Orcid link">http://orcid.org/0000-0002-3259-4603</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Makoto Kitade</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Makoto Kitade</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Technology Laboratory, CMC Division, Taiho Pharmaceutical Co. Ltd., Kamikawamachi, Kodama-gun, Saitama 367-0241, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Makoto++Kitade">Makoto Kitade</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Khoontee Chong-Takata</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Khoontee Chong-Takata</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Khoontee++Chong-Takata">Khoontee Chong-Takata</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hiromi Oshiumi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiromi Oshiumi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Formulation Research, CMC Division, Taiho Pharmaceutical Co. Ltd., Kawauchi-cho, Tokushima 771-0194, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiromi++Oshiumi">Hiromi Oshiumi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hiromi Muraoka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hiromi Muraoka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hiromi++Muraoka">Hiromi Muraoka</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Satoshi Yamashita</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Satoshi Yamashita</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Satoshi++Yamashita">Satoshi Yamashita</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuichi Kawai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuichi Kawai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuichi++Kawai">Yuichi Kawai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuichi Ohkubo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuichi Ohkubo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuichi++Ohkubo">Shuichi Ohkubo</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kouhei Tsumoto</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kouhei Tsumoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan</div><div class="loa-info-affiliations-info">Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#2e5a5d5b43415a416e4c47414b4049005a005b035a41455741004f4d00445e"><span class="__cf_email__" data-cfemail="a9dddadcc4c6ddc6e9cbc0c6ccc7ce87dd87dc84ddc6c2d0c687c8ca87c3d9">[email protected]</span></a>. Phone: +81-3-5841-0399. Fax: +81-3-5841-0397.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kouhei++Tsumoto">Kouhei Tsumoto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7643-5164" title="Orcid link">http://orcid.org/0000-0001-7643-5164</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01715&amp;href=/doi/10.1021%2Facs.jmedchem.0c01715" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2669–2677</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 October 2020</li><li><span class="item_label"><b>Published</b> online</span>23 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01715" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01715</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by-nc"><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_nc-1612971093307.svg" alt="NC: Only noncommercial uses of the work are permitted" /></img><span><strong>NC: </strong>Only noncommercial uses of the work are permitted</span></a><a href="https://creativecommons.org/licenses/by-nc-nd/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_nd-1612971093637.svg" alt="ND: No derivatives or adaptations of the work are permitted" /></img><span><strong>ND: </strong>No derivatives or adaptations of the work are permitted</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01715"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1685</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01715" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Thermodynamic Dissection of Potency and Selectivity of Cytosolic Hsp90 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Chihoko&quot;,&quot;last_name&quot;:&quot;Yoshimura&quot;},{&quot;first_name&quot;:&quot;Satoru&quot;,&quot;last_name&quot;:&quot;Nagatoishi&quot;},{&quot;first_name&quot;:&quot;Daisuke&quot;,&quot;last_name&quot;:&quot;Kuroda&quot;},{&quot;first_name&quot;:&quot;Yasuo&quot;,&quot;last_name&quot;:&quot;Kodama&quot;},{&quot;first_name&quot;:&quot;Takao&quot;,&quot;last_name&quot;:&quot;Uno&quot;},{&quot;first_name&quot;:&quot;Makoto&quot;,&quot;last_name&quot;:&quot;Kitade&quot;},{&quot;first_name&quot;:&quot;Khoontee&quot;,&quot;last_name&quot;:&quot;Chong-Takata&quot;},{&quot;first_name&quot;:&quot;Hiromi&quot;,&quot;last_name&quot;:&quot;Oshiumi&quot;},{&quot;first_name&quot;:&quot;Hiromi&quot;,&quot;last_name&quot;:&quot;Muraoka&quot;},{&quot;first_name&quot;:&quot;Satoshi&quot;,&quot;last_name&quot;:&quot;Yamashita&quot;},{&quot;first_name&quot;:&quot;Yuichi&quot;,&quot;last_name&quot;:&quot;Kawai&quot;},{&quot;first_name&quot;:&quot;Shuichi&quot;,&quot;last_name&quot;:&quot;Ohkubo&quot;},{&quot;first_name&quot;:&quot;Kouhei&quot;,&quot;last_name&quot;:&quot;Tsumoto&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2669-2677&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01715&quot;},&quot;abstract&quot;:&quot;The cytosolic Hsp90-selective inhibitor TAS-116 has an acceptable safety profile and promising antitumor activity in clinical trials. We examined the binding characteristics of TAS-116 and its analogs to determine the impact of the ligand binding mode on selectivity for cytosolic Hsp90. Analyses of the co-crystal structure of Hsp90 and inhibitor TAS-116 suggest that TAS-116 interacts with the ATP-binding pocket, the ATP lid region, and the hydrophobic pocket. A competitive isothermal titration calorimetry analysis confirmed that a small fragment of TAS-116 (THS-510) docks into the lid region and hydrophobic pockets without binding to the ATP-binding pocket. THS-510 exhibited enthalpy-driven binding to Hsp90α and selectively inhibited cytosolic Hsp90 activity. The heat capacity change of THS-510 binding was positive, likely due to the induced conformational rearrangement of Hsp90. Thus, we concluded that interactions with the hydrophobic pocket of Hsp90 determine potency and selectivity of TAS-116 and derivati&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01715&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01715" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01715&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01715" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01715&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01715" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01715&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01715&amp;href=/doi/10.1021/acs.jmedchem.0c01715" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01715" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01715" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01715%26sid%3Dliteratum%253Aachs%26pmid%3D33621080%26genre%3Darticle%26aulast%3DYoshimura%26date%3D2021%26atitle%3DThermodynamic%2BDissection%2Bof%2BPotency%2Band%2BSelectivity%2Bof%2BCytosolic%2BHsp90%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D5%26spage%3D2669%26epage%3D2677%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291383" title="Thermodynamics">Thermodynamics</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/jmcmar.2021.64.issue-5/20210311/jmcmar.2021.64.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The cytosolic Hsp90-selective inhibitor TAS-116 has an acceptable safety profile and promising antitumor activity in clinical trials. We examined the binding characteristics of TAS-116 and its analogs to determine the impact of the ligand binding mode on selectivity for cytosolic Hsp90. Analyses of the co-crystal structure of Hsp90 and inhibitor TAS-116 suggest that TAS-116 interacts with the ATP-binding pocket, the ATP lid region, and the hydrophobic pocket. A competitive isothermal titration calorimetry analysis confirmed that a small fragment of TAS-116 (THS-510) docks into the lid region and hydrophobic pockets without binding to the ATP-binding pocket. THS-510 exhibited enthalpy-driven binding to Hsp90α and selectively inhibited cytosolic Hsp90 activity. The heat capacity change of THS-510 binding was positive, likely due to the induced conformational rearrangement of Hsp90. Thus, we concluded that interactions with the hydrophobic pocket of Hsp90 determine potency and selectivity of TAS-116 and derivatives for the cytosolic Hsp90 isoform.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heat shock protein 90 (Hsp90) is a molecular chaperone essential for the maintenance of three-dimensional (3D) structure and the localization of proteins.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> There are four isoforms of Hsp90: Hsp90α and Hsp90β, which localize to the cytoplasm and nucleus, TRAP1 in the mitochondria, and Grp94, also known as gp96, in the endoplasmic reticulum.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Cytosolic Hsp90 mediates the proper folding and functions of a diverse range of client proteins including the tyrosine kinases ALK, FLT3, and MET and the growth factor receptors EGFR and FGFR, which have all been implicated in oncogenesis.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> The inhibition of cytosolic Hsp90 impairs the correct folding and maturation of many oncoproteins required for cancer growth and survival. Therefore, Hsp90 is a promising target for drug development in cancer therapy, and Hsp90 inhibitors have been tested in clinical trials.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6−9)</a></div><div class="NLM_p">Hsp90 requires ATP to drive its chaperone activity.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> ATP hydrolysis causes large and dynamic conformational changes in full-length Hsp90 dimers, and conformational changes are also observed in an ATP lid region of the N-terminal domain (NTD) of Hsp90.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Several Hsp90 inhibitors bind to the ATP-binding site of Hsp90 NTD, as shown by co-crystal structural analysis.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> Due to the flexibility of the structure of Hsp90, the shape of the pockets is highly dynamic.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A recent paper has indicated the dynamics of conformational changes in the interaction between HSP90 and inhibitors using a principal component analysis of molecular dynamics simulations.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Thus, the structural classes of Hsp90 inhibitors are diverse. Hsp90 inhibitors that bind to the Hsp90 NTD are classified based on the binding mode of the compounds. Geldanamycin analogs, radicicol, AUY922, and other resorcinol-type Hsp90 inhibitors are classified as type 1 inhibitors, which occupy the ATP-binding pocket (the first pocket).<a onclick="showRef(event, 'ref12 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref17">(12,17)</a> Purine analogs, such as BIIB021, BIIB028, and SNX-2112, interact with the first pocket and also the second pocket, which is formed when the Hsp90 ATP lid region adopts a helical form.<a onclick="showRef(event, 'ref14 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref18 ref19">(14,18,19)</a> Compounds that bind to both the first pocket and the second pocket are classified as type 2 inhibitors. Hsp90 inhibitors in clinical development have a distinct pattern of isoform selectivity. 17-AAG and AUY922 have pan-Hsp90 inhibitory activity. BIIB021 and SNX-2112 inhibit not only Hsp90α and Hsp90β but also moderately inhibit Grp94 and TRAP-1. The functions of TRAP-1 and Grp94 are poorly understood. However, the gut-specific deletion of <i>Grp94</i> results in the loss of intestinal homeostasis, and the liver-specific <i>Grp94</i> knockout in <i>PTEN</i>-null mice accelerates liver tumorigenesis. TRAP-1 is reported to protect against mitochondrial apoptosis.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, the isoform specificity of Hsp90 inhibitors may impact both adverse effects and antitumor efficacy of these agents.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a></div><div class="NLM_p">The orally available Hsp90 inhibitor TAS-116 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a) is in clinical testing.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> In the preclinical antitumor efficacy studies, TAS-116 showed the potential to be the best-in-class Hsp90 inhibitor as an antitumor agent. In addition, TAS-116 prolonged survival in fourth-line treatment settings for patients with metastatic or unresectable gastrointestinal stromal tumors in a Phase III clinical trial, which is currently ongoing. TAS-116 is the most selective compound for the cytosolic Hsp90 forms among the known Hsp90 inhibitors.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> As noted by Ernst et al., the structure of Hsp90 must be considered in design of isoform-selective inhibitors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Recently, Uno et al. reported a structure–activity relationship analysis of TAS-116 analogs.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> However, a biophysical characterization of the isoform selectivity of TAS-116 analogs has not been performed. We previously reported use of biophysical methods, including calorimetric analyses, for small-molecule inhibitor identification.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28−31)</a> Biophysical information on specific inhibitors is helpful for the selection and design of new hit or lead compounds for other target proteins. In this study, we examined the characteristics of binding of TAS-116 and its analogs to Hsp90 using structural, biological, and biophysical analyses, with particular emphasis on calorimetric and competitive analyses.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Chemical structure of TAS-116 and 16d. (b) Co-crystal structures of Hsp90α NTD with 16d (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a>) and THS-828 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9">3WQ9</a>). (c–f) A model of the complex of Hsp90α and TAS-116 was created using the MOE software. Shown are (c) a cartoon model of (d) the ATP-binding pocket, (e) the second pocket, and (f) the third pocket. The Hsp90α is shown in brown. TAS-116 is shown in a ball-and-stick rendering in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Characterization of Binding Modes of TAS-116</h3><div class="NLM_p">A co-crystal structure of the very close analog of TAS-116, 16d (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), with the human Hsp90α NTD has been reported recently (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The structure of another TAS-116 analog, THS-828 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S1a</a>), in complex with human Hsp90α NTD has also been reported (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9">3WQ9</a>). Based on the binding modes of these inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b), TAS-116 is expected to bind to the first and second pockets and also to a hydrophobic pocket, which we refer to as the third pocket, of Hsp90 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b,c). When the amido group of TAS-116 was changed to carbonic acid (THS-2415, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S1b</a>), no binding to Hsp90 was observed (data not shown). This result indicates that similar to other Hsp90 inhibitors, the hydrogen-bonding network with D93, T184, N51, and water molecules in the ATP-binding pocket of the Hsp90 NTD are critical for binding of TAS-116 to Hsp90. TAS-116 docked model was constructed from a 16d co-crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a>) by modifying the methyl group to an ethyl group, and energy minimization was performed using the Molecular Operating Environment (MOE) software package. In the model, hydrogen-bonding network in ATP pocket and π–π interactions with F138 and a hydrogen bond with Y139 in the second pocket are retained (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>d,e). Water-mediated interaction with Gln23, which was reported in the literature about other types of third pocket inhibitor, was not observed in the co-crystal structures of TAS-116 analogs.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> After optimization, Gln23 directly interacts with the nitrogen atom of the imidazole-pyrazole group of TAS-116 unlike co-crystal structures (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>f). Gln23 seems flexible and might contribute to the transition state of the interaction between TAS-116 analogs and Hsp90 NTD.</div><div class="NLM_p">To investigate the contribution of the amino acids of Hsp90α to the interaction with TAS-116, a site-directed mutagenesis study was performed. Four sites (Q23, N105, F138, and Y139) were selected for mutation based on the interactions observed in the crystal structure of the THS-828 and Hsp90 complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9">3WQ9</a>) and 16d and Hsp90 complex (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a>). Q23, F138, and Y139 are expected to interact directly with TAS-116. From the literature about the third pocket inhibitor,<a onclick="showRef(event, 'ref16 ref32'); return false;" href="javascript:void(0);" class="ref ref16 ref32">(16,32)</a> F138 is expected to have hydrophobic interaction with TAS-116. N105 is one of the constituent residues of ATP-lid region, and the local structure is highly flexible and forms a helix when Hsp90 takes helical form.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> N105 faces the solvent front in the helical form and seems not to interact directly with ligand (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Therefore, N105 was selected as a residue which is expected not to interact with TAS-116. Although D93 also interacts with TAS-116, we could not prepare D93A mutant due to low expression level. We successfully prepared Q23A, N105A, F138L, and Y139F mutants of Hsp90 and performed a previously described competitive binding assay<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to evaluate interaction of Hsp90 inhibitors 17-AAG, AUY922, BIIB021, SNX-2112, and TAS-116 with wild-type and mutant proteins. AUY922 and 17-AAG are type 1 inhibitors, and BIIB021 and SNX-2112 are type 2 inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S1</a>). The relative IC<sub>50</sub> values are summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c, and plots are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S3</a>. The perturbation effect for helical form specific inhibitors (TAS-116, SNX-2112, and BIIB-021) by Q23A mutation is greater than that of type 1 inhibitors (17-AAG and AUY-922), even though SNX-2112 and BIIB-021 do not interact with Q23. These results indicate that Q23 affects formation of the helical form and is not crucial for the interaction with TAS-116. Unexpectedly, Y139F mutation does not weaken the inhibitory effects of SNX-2112 and TAS-116, both were considered to form hydrogen bonds with Y139. Although the binding of other inhibitors was reduced, TAS-116 bound to the F138L mutant with affinity similar to its binding to the wild-type Hsp90. F138 forms a hydrophobic interaction with type 1 inhibitors.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In contrast, the type 2 inhibitors, BIIB021 and SNX-2112, interact with F138 through π–π interaction (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD">3QDD</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R92">3R92</a>).<a onclick="showRef(event, 'ref19 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref19 ref34 ref35">(19,34,35)</a> From our modeling study, we expected that the interaction between TAS-116 and F138 would be critical; however, as shown in the mutational study, the binding of TAS-116 to human Hsp90α does not depend strongly on the interaction with F138 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). This low dependence of TAS-116 on F138 may be a property acquired by TAS-116 through the use of the third pocket. The shape of the third pocket is not constant in many crystal structures of the helical form Hsp90 NTD. Therefore, we hypothesized that the shape of TAS-116 is the key to bind and stabilize the helical form with the third pocket of Hsp90 NTD.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) SPR analysis of the interaction between Hsp90α and TAS-116. (b) Binding locations of various inhibitors to Hsp90α (gray). The proteins in complexes with AUY922 (magenta) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>) and BIIB021 (green) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD">3QDD</a>) were aligned. TAS-116 (orange) was docked into the Hsp90α structure. (c) Fold difference in <i>K</i><sub>i</sub> values of inhibitors for mutant relative to wild-type Hsp90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Kinetic analysis using surface plasmon resonance (SPR) demonstrated that TAS-116 has a slow off-rate from the human Hsp90α NTD (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). The off-rate of TAS-116 was slower than that of type 1 inhibitor 17-AAG and type 2 inhibitor BIIB-021 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S2</a>). Another type 2 inhibitor SNX-2112 showed a slower off-rate (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S2</a>), which has a similar structure and binding mode with TAS-116. From the literature, changes in conformations and internal dynamics of Hsp90 are reported to be induced by inhibitor bindings, and some residues are proposed as hot spots.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As TAS-116 is not the highest affinity binder among known Hsp90 inhibitors (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S3</a>), the slow-off rate is likely due to the unique binding mode of TAS-116.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Characterization of Isoform Selectivity and Thermodynamics of THS-510</h3><div class="NLM_p">The Hsp90 inhibitory activities of TAS-116 among Hsp90 isoforms have been reported previously. The <i>K</i><sub>i</sub> values of TAS-116 for Hsp90α, Hsp90β, Grp94, and TRAP-1 are 34.7 nM, 21.3 nM, >50,000 nM, and >50,000 nM, respectively, in a competitive binding assay using FITC-labeled geldanamycin.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> TAS-116 analog 16d is reported to bind preferentially to the cytosolic isoforms.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Like TAS-116 and 16d, THS-828 (Hsp90α, 13 μM; Hsp90β, 17 μM; Grp94, >300 μM; TRAP-1, >300 μM) also binds to the cytosolic isoforms. To further study the unique binding characteristics of TAS-116, we prepared a fragment of TAS-116 that includes only the moiety that binds to the third pocket; this analog was named THS-975 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). In addition to the THS-975, THS-510 was synthesized (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>d). The binding activity and isoform selectivity of THS-975 and THS-510 were analyzed using the competitive binding assay. The IC<sub>50</sub> values of THS-975 for Hsp90α, Hsp90β, Grp94, and TRAP-1 were around 300 μM (T/C (%) showed 51% at 300 μM), 218 μM, >300 μM, and >300 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b). The IC<sub>50</sub> values of THS-510 for Hsp90α, Hsp90β, Grp94, and TRAP-1 were 293 μM, 89 μM, >300 μM, and >300 μM, respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>e). Although both THS-975 and THS-510 are smaller and their activity were very weak compared to TAS-116, THS-975 and THS-510 clearly bound to the cytosolic isoforms Hsp90α and Hsp90β but not to TRAP-1 or Grp94.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Characteristics of the interaction of THS-975 and THS-510 with Hsp90. (a, d) Chemical structure of THS-975 and THS-510. (b, e) Isoform selectivity of THS-975 and THS-510. Plotted is the percent ratio of the intensity of the test and control lines versus concentration of inhibitor. The data are the means of two independent experiments. (c, f) Enthalpy change on the binding of THS-975 and THS-510 to the human Hsp90α NTD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The direct binding of THS-975 and THS-510 to the human Hsp90α NTD was investigated using isothermal titration calorimetry (ITC). The calorimetric data were analyzed using a single-site binding model to obtain the thermodynamic parameters of the interaction between the human Hsp90α NTD and these fragment compounds. In the case of THS-975, although we obtained the exothermic binding reaction, the binding stoichiometry was not 1:1, and the binding enthalpy change was small. In other words, the pyrazole compound is not suitable for more quantitative and precise evaluation such as temperature dependence and competitive assay, as shown in this study due to unexpected errors. On the other hand, we quantitatively analyzed the binding of THS-510 to HSP90 in ITC. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f, moderate binding of THS-510 was observed (<i>K</i><sub>D</sub> = 2.7 μM) at 25 °C. The stoichiometry of binding calculated for THS-510 from the ITC data was 0.72 ± 0.03; therefore, THS-510 likely binds human Hsp90α in a 1:1 molar ratio. The thermodynamic parameters of the interaction between THS-510 and human Hsp90α NTD were Δ<i>G</i> of −7.6 ± 0.1 kcal/mol, Δ<i>H</i> of −5.7 ± 0.2 kcal/mol, and – <i>T</i>Δ<i>S</i> of −1.9 ± 0.1 kcal/mol, indicating that complex formation was primarily enthalpy driven. This suggests that hydrogen bonds or van der Waals stabilize the interaction between the human Hsp90α NTD and THS-510. It is noteworthy that this interaction also involved a slight entropic gain.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Exploration of the Binding Mode of THS-510 Using Competitive Thermodynamic Profiling</h3><div class="NLM_p">To estimate the contact region of THS-510 on Hsp90, a competitive binding analysis with known Hsp90 inhibitors was performed using ITC. We hypothesized that if a highly potent inhibitor of Hsp90 occupies the same binding site as THS-510 on Hsp90, the titration of THS-510 into Hsp90 prebound to the potent inhibitor will not cause exothermic reactions. In contrast, if the binding pockets of the potent Hsp90 inhibitor and THS-510 are different, THS-510 will bind to Hsp90 in the presence of the other inhibitor. We selected Hsp90 inhibitors of different types for this analysis: The type 1 inhibitors AUY922 and 17-AAG are expected to occupy the ATP-binding pocket because geldanamycin binds the ATP-binding pocket (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YET">1YET</a>). BIIB021, a type 2 inhibitor, binds to the Hsp90 helical form and occupies the ATP-binding pocket and the second pocket (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD">3QDD</a>).<a onclick="showRef(event, 'ref17 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref19">(17,19)</a></div><div class="NLM_p">When THS-510 was titrated into Hsp90α prebound to AUY922, an exothermic reaction was observed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). However, 17-AAG, which binds to the same site as AUY922, did not cause an exothermic reaction (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S4</a>). These results indicate that THS-510 does not occupy the ATP-binding pocket of Hsp90α. In contrast, addition of THS-510 to Hsp90α prebound to BIIB021 did not result in an exothermic reaction (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b), suggesting that THS-510 and BIIB021 have overlapping binding sites. As BIIB021 interacts with both the ATP-binding pocket and the second pocket of Hsp90α, our data suggest that THS-510 binds to the second pocket of the helical form of Hsp90α NTD but does not bind to the ATP-binding pocket.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Schematic of complex of human Hsp90α NTD with AUY922 and the competitive binding titration of THS-510 (upper). The ITC profile of the titration of THS-510 into human Hsp90 NTD in the presence of AUY922 (lower). (b) Schematic of the complex of human Hsp90α NTD with BIIB021 and the competitive binding titration of THS-510 (upper). The ITC profile of the titration of THS-510 into human Hsp90 NTD in the presence of BIIB021 (lower).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We hypothesized that the helical conformation of Hsp90 results from a conformational rearrangement of some residues of the ATP lid region. THS-510 was manually placed on the second and third pockets, and the complex was minimized using MOE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S5A,B</a>). In the energy-minimized structure, the imidazole ring of THS-510 interacts with F138 in the second pocket. A hydrogen bond and van der Waals interactions were observed between the ligand and Hsp90 in the third pocket. These noncovalent interactions probably contribute to the binding enthalpy of THS-510. The structural alignments of the structure of the complex of THS-510 with Hsp90 with the structures of BIIB021 and AUY922 in complex with Hsp90 suggest that the binding site of THS-510 partially overlaps with that of BIIB021 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S5A</a>) but does not overlap with the binding site of AUY922 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S5B</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Thermodynamic Characterization of TAS-116 and Its Analogs</h3><div class="NLM_p">To characterize the biophysical properties of the binding of TAS-116 to Hsp90, we examined the thermodynamics of the interaction of Hsp90 with TAS-116 and its analog THS-510. Binding reactions of both ligands to human Hsp90α NTD were exothermic. The tight binding of TAS-116 to the human Hsp90α NTD (<i>K</i><sub>D</sub> = 0.17 μM) was enthalpy driven at 25 °C (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Thermodynamic parameters for the interactions of THS-510, THS-762, and TAS-116 with human Hsp90α NTD. (b) Temperature dependence of the binding enthalpy change for THS-510 and TAS-116 binding to the human Hsp90α NTD. (c) Chemical structure of THS-762 and predicted regions of Hsp90 bound by each part of the molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To characterize the molecular mechanisms of the binding of THS-510 and TAS-116 to Hsp90, we examined the heat capacity changes (Δ<i>C</i><sub>p</sub>) over the temperature range from 20 to 30 °C using ITC (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S6</a>). Unexpectedly, binding of THS-510 to the human Hsp90α NTD had a positive Δ<i>C</i><sub>p</sub> value (0.56 kcal/mol·K), whereas that of TAS-116 had a negative Δ<i>C</i><sub>p</sub> value (−0.29 kcal/mol·K). The negative value of Δ<i>C</i><sub>p</sub> is suggestive of binding to a hydrophobic buried region, as previously described for ligands with binding that involves driving solvent molecules out of a pocket.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> There are previous works that described positive Δ<i>C</i><sub>p</sub> thermodynamics for the protein–small ligand interactions; the positive heat capacity change is thought to result when the ligand binds to an exposed nonpolar surface.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> Based on the model structures, we calculated the solvent-accessible surface area (ASA) of Hsp90 in each complex. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the nonpolar and polar ASAs of Hsp90 in the THS-510 complex (5809.7 and 4979.4 Å<sup>2</sup>) were larger than those in the TAS-116 complex (5785.9 and 4900.9 Å<sup>2</sup>), respectively. This difference was derived from the empty ATP-binding pocket of Hsp90. We speculate that the hydrophobic surface of the ATP-binding pocket is exposed when the THS-510 binding induces α-helix formation of the ATP lid region.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Solvent Accessible Surface Areas of Hsp90 and Inhibitors TAS-116 and THS-510</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">nonpolar (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">polar (Å<sup>2</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">total (Å<sup>2</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hsp90</td><td class="colsep0 rowsep0" align="char" char=".">5785.9</td><td class="colsep0 rowsep0" align="char" char=".">4900.9</td><td class="colsep0 rowsep0" align="char" char=".">10686.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TAS-116</td><td class="colsep0 rowsep0" align="char" char=".">61.7</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">62.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total</td><td class="colsep0 rowsep0" align="char" char=".">5847.6</td><td class="colsep0 rowsep0" align="char" char=".">4901.9</td><td class="colsep0 rowsep0" align="char" char=".">10749.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Hsp90</td><td class="colsep0 rowsep0" align="char" char=".">5809.7</td><td class="colsep0 rowsep0" align="char" char=".">4979.4</td><td class="colsep0 rowsep0" align="char" char=".">10789.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">THS-510</td><td class="colsep0 rowsep0" align="char" char=".">12.8</td><td class="colsep0 rowsep0" align="char" char=".">9.1</td><td class="colsep0 rowsep0" align="char" char=".">21.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total</td><td class="colsep0 rowsep0" align="char" char=".">5822.5</td><td class="colsep0 rowsep0" align="char" char=".">4988.5</td><td class="colsep0 rowsep0" align="char" char=".">10811</td></tr></tbody></table></div></div><div class="NLM_p last">Based on the putative binding mode of THS-510, we proposed that there would be an affinity enhancement if THS-510 was linked to a compound that filled the ATP-binding pocket of Hsp90. Actually, THS-762 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c), a conjugate of THS-510 and THS-828, showed the affinity enhancement. ITC revealed that the reaction of THS-762 with human Hsp90α NTD was exothermic (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). We could not perform the ITC experiment with THS-828 due to its low solubility. In comparison with the thermodynamic parameters of THS-510, THS-762 had a higher binding affinity, with an entropic gain and an enthalpic loss (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). In THS-762, hydrogen-bond networks between the benzamide moiety, Asp93, and water molecules are expected to contribute to the enthalpic gain, such as the case of TAS 116 analog 16d,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and the cyclohexanol group at the solvent front may contribute to the entropy gain. The decrease in favorable binding enthalpy means that enthalpy–entropy compensation occurred in the binding. Thus, TAS-116 is a favorable inhibitor, possessing the enthalpic contribution based on THS-510.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cytosolic Hsp90-selective inhibitor TAS-116 has a best-in-class potential as an anticancer drug; clinical trials are ongoing.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> In this study, we investigated the modes of binding of TAS-116 and its analogs. Co-crystal structures of Hsp90α with the TAS-116 analogs THS-828 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9">3WQ9</a>) and 16d (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> showed that the compounds bind to the Hsp90α helical form and interact with the ATP-binding pocket. Unlike the other tested inhibitors, TAS-116 bound to the Hsp90α mutant F138L almost as well as it bound to the wild-type protein. By binding to the third, hydrophobic pocket on Hsp90, TAS-116 has a reduced dependency on F138 compared to the other inhibitors tested, although modeling suggests that TAS-116 forms π–π interactions with F138. We also analyzed a fragment of TAS-116, THS-510, which includes only the moiety that binds to the third pocket. ITC experiments showed that THS-510 binds Hsp90α in an enthalpy-driven manner. THS-828, 16d, TAS-116, and THS-510 all show cytosolic Hsp90 selectivity, implying that inhibitors that bind to the third pocket are highly selective for cytosolic Hsp90. Tricyclic compounds have also been reported to bind Hsp90 in the third pocket region.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">SPR analysis showed that TAS-116 has a very slow off rate, likely because it binds to Hsp90 in a conformation-specific manner. We hypothesize that TAS-116 functions as a conformation lock for cytosolic Hsp90. As conformational change in Hsp90 is needed for its ATPase activity, TAS-116 might block this conformational change. Paralog inhibitors such as the Grp94 inhibitor PU-H54 and the TRAP1 inhibitor BIIB021 bind mainly in the ATP-binding pocket (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">Figure S7</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In addition, it was reported that XL-888 occupies the ATP-binding pocket, the second pocket, and the extended space of the second pocket of Hsp90 in the co-crystal structure,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> but the helical structure of the ATP lid region was disordered. Therefore, the large conformational changes of the ATP lid in Hsp90 and the positions of some residues in the second pocket and the third pocket are crucial for the isoform selectivity of Hsp90 inhibitors. As the roles of Hsp90 isoforms TRAP-1 and Grp94 are not fully understood, whether or not cytosolic selectivity will reduce the risk of adverse effects or influence antitumor activity are not known. TAS-116 and analogs will provide the opportunity to study the significance of isoform selectivity. In situ analyses of the kinetics of isoform-specific inhibition at the cellular level using fluorescently labeled derivatives of TAS-116 that retain isoform selectivity may clarify the functions of Hsp90 isoforms in more detail.</div><div class="NLM_p last">In this study, we utilized a combination of biophysical methods to analyze the binding modes of the evaluated inhibitors. Although ITC is a powerful tool for investigation of label-free investigation of ligand interactions with proteins, issues with compound solubility or aggregation may limit its use. We were not able to detect the thermodynamic binding energy of THS-828 to Hsp90 because THS-828 was not soluble. This makes it difficult to compare thermodynamic binding parameters of a series of compounds. However, thermodynamic analysis does provide information that can guide drug design. For example, knowledge of whether binding was enthalpically or entropically driven was suggestive of modes of action. Moreover, competitive ITC analyses revealed that THS-510 did not interact with the ATP-binding pocket. Based on this observation, hybrid compounds of THS-510 and the ATP-binding pocket binders were synthesized, which were bound with higher affinity to Hsp90 than THS-510. From this result, it is expected that a hybrid design combining THS-510 and other Hsp90 inhibitors will provide a novel type of Hsp90 inhibitor. In the case of Hsp90, co-crystal structures helped shape the design of the hybrid compound. However, even in the absence of co-crystal structures, competitive ITC analysis can reveal binding locations of lead compounds.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In this study, the cytosolic Hsp90-selective inhibitor TAS-116 and analogs were analyzed using biophysical techniques including ITC. The combined use of competitive ITC analysis and molecular modeling enabled the prediction of binding modes and revealed that compounds that bind to the third binding pocket of Hsp90 interacted with an enthalpy gain and induced the rigid conformation of ATP lid region. The third binding pocket of the compound is thought to determine the cytosolic Hsp90 binding selectivity and activity. A deeper understanding of isoform selectivity of Hsp90 will facilitate the design of additional compounds and will lead to a greater understanding of the roles of Hsp90 paralogs in diseases.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Materials</h3><div class="NLM_p last">For the enzyme assay, human Hsp90α and human Hsp90β were purchased from Enzo Life Sciences International, Inc. GRP94 was purchased from ATGen Co., Ltd. TRAP-1 was purchased from Enzo Life Sciences International, Inc. For the mutagenesis analysis, the human <i>Hsp90α</i> gene was mutated by a polymerase chain reaction (PCR) using PrimeSTAR Mutagenesis Basal Kit (Takara Bio Company). For the ITC experiments and crystal structural analysis, the NTD of human Hsp90α (amino acids 1–236) fused to a 6 × His tag was expressed in <i>E. coli</i> BL21 and purified over a nickel-affinity column. For SPR, the full-length human <i>Hsp90α</i> gene was cloned into the pCR8/GW/TOPO cloning vector (Invitrogen). The gene was then Gateway cloned into the destination vector, pEU-GST-DEST containing a biotin ligation site at the 5′ end of the GST coding sequence. The biotinylated GST-Hsp90α protein was expressed in the wheat cell-free synthesis system.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chemicals</h3><div class="NLM_p last">TAS-116, THS-828, THS-510, THS-762, BIIB021, and AUY922 were synthesized at Taiho Pharmaceutical Co., Ltd. as previously described.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> 17-AAG was purchased from BIOTREND. FITC-labeled geldanamycin was purchased from Enzo Life Sciences International, Inc.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Surface Plasmon Resonance</h3><div class="NLM_p last">Biotin-GST-Hsp90αNTD was immobilized on a streptavidin sensor chip (SA-chip, GE Healthcare), and measurements were obtained using a Biacore T-100 system (GE Healthcare Life Sciences). For control experiments, the sensor chip surface was analyzed in the absence of the compound. All experiments were performed in a running buffer containing PBS and 1 mM DTT. After the measurement, the sensor chip was washed and regenerated with a regeneration buffer containing PBS, 1 mM DTT, and 5% DMSO. All measurements were performed at 25 °C.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Competitive Binding Assay</h3><div class="NLM_p last">The interaction of Hsp90 inhibitors with Hsp90 was evaluated using the fluorescence polarization competitive binding assay with geldanamycin-FITC.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> Each compound was incubated with recombinant HSP90α for 2 h. Geldanamycin-FITC was added, and the mixture was incubated for a further 5 h. The concentration of each compound required to reduce by 50% the amount of recombinant proteins bound to geldanamycin-FITC (IC<sub>50</sub>) was determined, and the <i>K</i><sub>i</sub> values were calculated from the IC<sub>50</sub> values with the Chen–Prusoff equation.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Thermodynamic Analysis of the Binding of THS-510 to Human Hsp90α NTD</h3><div class="NLM_p last">Thermodynamic parameters for the interaction of the ligand and human Hsp90α NTD were determined using a MicroCal iTC200 isothermal titration calorimetry instrument (Malvern Instruments). The compound solution (100 μM) was titrated into a sample cell containing a solution of human Hsp90α NTD (10 μM). These experiments were conducted in 150 mM NaCl, 20 mM Tris-HCl, 5% DMSO, pH 7.5 at a constant temperature over the range of 15–30 °C. The free energy of ligand binding is described by the following equation:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_m001.gif" alt="" id="_i17" /></img></span>The heat capacity upon binding was derived from ITC experiments at different temperatures:<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_m002.gif" alt="" id="_i18" /></img></span></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Competitive Isothermal Binding Analysis</h3><div class="NLM_p last">Competitive isothermal titration analysis was performed by titrating ligand (600 μM) into the sample cell containing human Hsp90α NTD (20 μM) and a known Hsp90 inhibitor (100 μM) at 25 °C.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Modeling Study</h3><div class="NLM_p last">Using the co-crystal structures of human Hsp90α NTD in complexes with 16d or THS-828 (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9">3WQ9</a>, respectively) as the templates, TAS-116 and THS-510 were manually put onto human Hsp90α NTD using MOE.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The protein was kept rigid, and the water molecules were mostly retained. Energy minimizations were performed to maximize favorable interactions between protein and ligand. The solvent-accessible surface area was computed based on the Lee and Richards method implemented in the NACCESS program.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e1026-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01715" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01715?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01715</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Scheme for the synthesis of compounds (TAS-116, THS-510, THS-975, and THS-762), the data of SPR, competitive binding assay, ITC, molecular model of complexes (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf">jm0c01715_si_001.pdf (850.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_002.csv">jm0c01715_si_002.csv (0.47 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01715" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kouhei Tsumoto</span> - <span class="hlFld-Affiliation affiliation">The
Institute of Medical Science, The University
of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7643-5164" title="Orcid link">http://orcid.org/0000-0001-7643-5164</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9befe8eef6f4eff4dbf9f2f4fef5fcb5efb5eeb6eff4f0e2f4b5faf8b5f1eb"><span class="__cf_email__" data-cfemail="403433352d2f342f0022292f252e276e346e356d342f2b392f6e21236e2a30">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chihoko Yoshimura</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoru Nagatoishi</span> - <span class="hlFld-Affiliation affiliation">The
Institute of Medical Science, The University
of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0794-3963" title="Orcid link">http://orcid.org/0000-0002-0794-3963</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daisuke Kuroda</span> - <span class="hlFld-Affiliation affiliation">Department
of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2390-4785" title="Orcid link">http://orcid.org/0000-0003-2390-4785</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yasuo Kodama</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takao Uno</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3259-4603" title="Orcid link">http://orcid.org/0000-0002-3259-4603</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Makoto Kitade</span> - <span class="hlFld-Affiliation affiliation">Chemical
Technology Laboratory, CMC Division, Taiho
Pharmaceutical Co. Ltd., Kamikawamachi, Kodama-gun, Saitama 367-0241, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khoontee Chong-Takata</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiromi Oshiumi</span> - <span class="hlFld-Affiliation affiliation">Formulation
Research, CMC Division, Taiho Pharmaceutical
Co. Ltd., Kawauchi-cho, Tokushima 771-0194, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiromi Muraoka</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satoshi Yamashita</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuichi Kawai</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuichi Ohkubo</span> - <span class="hlFld-Affiliation affiliation">Discovery
and Preclinical Research Division, Taiho
Pharmaceutical Co. Ltd., Tsukuba, Ibaraki 300-2611, Japan</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.Y. and K.T. conceived the study. All authors designed the experiments and analyzed data. C.Y., S.N., and K.T. wrote the manuscript. All authors approved the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This work was supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED of Japan under Grant Number JP19am0101094 (to K.T.) and by JSPS KAKENHI-A grant 16H02420 (to K.T.).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Ms. Chizuru Saruta for collecting ITC data.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat shock protein 90</p></td></tr><tr><td class="NLM_term">NTD</td><td class="NLM_def"><p class="first last">N-terminal domain</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">molecular operation environment</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">ASA</td><td class="NLM_def"><p class="first last">solvent-accessible surface area</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 46 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifshits, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">7535</span>– <span class="NLM_lpage">7340</span>, <span class="refDoi"> DOI: 10.1073/pnas.1019559108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1073%2Fpnas.1019559108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=21502504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7340&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebiauthor=V.+M.+Riveraauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+strategies+to+overcome+crizotinib+resistance+in+non-small+cell+lung+cancers+harboring+the+fusion+oncogene+EML4-ALK&doi=10.1073%2Fpnas.1019559108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span></div><div class="casAuthors">Katayama, Ryohei; Khan, Tahsin M.; Benes, Cyril; Lifshits, Eugene; Ebi, Hiromichi; Rivera, Victor M.; Shakespeare, William C.; Iafrate, A. John; Engelman, Jeffrey A.; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7535-7540, S7535/1-S7535/17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The echinoderm microtubule-assocd. protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion oncogene represents a mol. target in a small subset of non-small cell lung cancers (NSCLCs).  This fusion leads to constitutive ALK activation with potent transforming activity.  In a pivotal phase 1 clin. trial, the ALK tyrosine kinase inhibitor (TKI) crizotinib (PF-02341066) demonstrated impressive antitumor activity in the majority of patients with NSCLC harboring ALK fusions.  However, despite these remarkable initial responses, cancers eventually develop resistance to crizotinib, usually within 1 y, thereby limiting the potential clin. benefit.  To det. how cancers acquire resistance to ALK inhibitors, we established a model of acquired resistance to crizotinib by exposing a highly sensitive EML4-ALK-pos. NSCLC cell line to increasing doses of crizotinib until resistance emerged.  We found that cells resistant to intermediate doses of crizotinib developed amplification of the EML4-ALK gene.  Cells resistant to higher doses (1 μM) also developed a gatekeeper mutation, L1196M, within the kinase domain, rendering EML4-ALK insensitive to crizotinib.  This gatekeeper mutation was readily detected using a unique and highly sensitive allele-specific PCR assay.  Although crizotinib was ineffectual against EML4-ALK harboring the gatekeeper mutation, we obsd. that two structurally different ALK inhibitors, NVPTAE684 and AP26113, were highly active against the resistant cancer cells in vitro and in vivo.  Furthermore, these resistant cells remained highly sensitive to the Hsp90 inhibitor 17-AAG.  Thus, we have developed a model of acquired resistance to ALK inhibitors and have shown that second-generation ALK TKIs or Hsp90 inhibitors are effective in treating crizotinib-resistant tumors harboring secondary gatekeeper mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPbiLG5xpg0LVg90H21EOLACvtfcHk0lh7oiFcmx_fhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D&md5=82f47736429e6f71f9fd5852e4df64cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1019559108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1019559108%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEbi%26aufirst%3DH.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520strategies%2520to%2520overcome%2520crizotinib%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520the%2520fusion%2520oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7535%26epage%3D7340%26doi%3D10.1073%2Fpnas.1019559108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lh7oiFcmx_fhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreedhar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csermely, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. F.</span></span> <span> </span><span class="NLM_article-title">Hsp90 isoforms: functions, expression and clinical importance</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00229-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2FS0014-5793%2804%2900229-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=15069952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2004&pages=11-15&author=A.+S.+Sreedharauthor=E.+Kalmarauthor=P.+Csermelyauthor=Y.+F.+Shen&title=Hsp90+isoforms%3A+functions%2C+expression+and+clinical+importance&doi=10.1016%2FS0014-5793%2804%2900229-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 isoforms: functions, expression and clinical importance</span></div><div class="casAuthors">Sreedhar Amere Subbarao; Kalmar Eva; Csermely Peter; Shen Yu-Fei</div><div class="citationInfo"><span class="NLM_cas:title">FEBS letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">11-5</span>
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein, Hsp90, is a main functional component of an important cytoplasmic chaperone complex, and it is involved in various cellular processes, such as cell proliferation, differentiation and apoptosis.  Identification of Hsp90 as a molecular target of various anticancer drugs highlighted its importance from the clinical point of view.  Here we summarize the current knowledge of various Hsp90 isoforms regarding their genomic location, molecular evolution, functional differences, differential induction after various environmental stresses and in pathological conditions as well as the growing importance of discriminating between Hsp90 isoforms in clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPSA2r_aCgUoNpW7w2tapOfW6udTcc2ea7UHHdaxv9HLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D&md5=d5340d922f408298ba90a5cc906b60f2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900229-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900229-7%26sid%3Dliteratum%253Aachs%26aulast%3DSreedhar%26aufirst%3DA.%2BS.%26aulast%3DKalmar%26aufirst%3DE.%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DY.%2BF.%26atitle%3DHsp90%2520isoforms%253A%2520functions%252C%2520expression%2520and%2520clinical%2520importance%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D562%26spage%3D11%26epage%3D15%26doi%3D10.1016%2FS0014-5793%2804%2900229-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosz, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span> <span> </span><span class="NLM_article-title">HSP90 at the hub of protein homeostasis: emerging mechanistic insights</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">528</span>, <span class="refDoi"> DOI: 10.1038/nrm2918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fnrm2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=20531426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=515-528&author=M.+Taipaleauthor=D.+F.+Jaroszauthor=S.+Lindquist&title=HSP90+at+the+hub+of+protein+homeostasis%3A+emerging+mechanistic+insights&doi=10.1038%2Fnrm2918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 at the hub of protein homeostasis: emerging mechanistic insights</span></div><div class="casAuthors">Taipale, Mikko; Jarosz, Daniel F.; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">515-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (HSP90) is a highly conserved mol. chaperone that facilitates the maturation of a wide range of proteins (known as clients).  Clients are enriched in signal transducers, including kinases and transcription factors.  Therefore, HSP90 regulates diverse cellular functions and exerts marked effects on normal biol., disease, and evolutionary processes.  Recent structural and functional analyses have provided new insights on the transcriptional and biochem. regulation of HSP90 and the structural dynamics it uses to act on a diverse client repertoire.  A comprehensive understanding of how HSP90 functions promises not only to provide new avenues for therapeutic intervention, but to shed light on fundamental biol. questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuMRSaY8uzGbVg90H21EOLACvtfcHk0lgId0w0XcdOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D&md5=492dca92cea32384d2ab4145230f53dd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2918%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DJarosz%26aufirst%3DD.%2BF.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DHSP90%2520at%2520the%2520hub%2520of%2520protein%2520homeostasis%253A%2520emerging%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D515%26epage%3D528%26doi%3D10.1038%2Fnrm2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krykbaeva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayatekin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westover, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karras, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">1001</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.cell.2012.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22939624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSns7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=987-1001&author=M.+Taipaleauthor=I.+Krykbaevaauthor=M.+Koevaauthor=C.+Kayatekinauthor=K.+D.+Westoverauthor=G.+I.+Karrasauthor=S.+Lindquist&title=Quantitative+analysis+of+HSP90-client+interactions+reveals+principles+of+substrate+recognition&doi=10.1016%2Fj.cell.2012.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition</span></div><div class="casAuthors">Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Westover, Kenneth D.; Karras, Georgios I.; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">987-1001</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HSP90 is a mol. chaperone that assocs. with numerous substrate proteins called clients.  It plays many important roles in human biol. and medicine, but determinants of client recognition by HSP90 have remained frustratingly elusive.  We systematically and quant. surveyed most human kinases, transcription factors, and E3 ligases for interaction with HSP90 and its cochaperone CDC37.  Unexpectedly, many more kinases than transcription factors bound HSP90.  CDC37 interacted with kinases, but not with transcription factors or E3 ligases.  HSP90::kinase interactions varied continuously over a 100-fold range and provided a platform to study client protein recognition.  In wild-type clients, HSP90 did not bind particular sequence motifs, but rather assocd. with intrinsically unstable kinases.  Stabilization of the kinase in either its active or inactive conformation with diverse small mols. decreased HSP90 assocn.  Our results establish HSP90 client recognition as a combinatorial process: CDC37 provides recognition of the kinase family, whereas thermodn. parameters det. client binding within the family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHzMXLTn5hx7Vg90H21EOLACvtfcHk0lgId0w0XcdOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSns7bF&md5=2ebda06d0ce0b8f65edff9f08f10dd31</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DKrykbaeva%26aufirst%3DI.%26aulast%3DKoeva%26aufirst%3DM.%26aulast%3DKayatekin%26aufirst%3DC.%26aulast%3DWestover%26aufirst%3DK.%2BD.%26aulast%3DKarras%26aufirst%3DG.%2BI.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DQuantitative%2520analysis%2520of%2520HSP90-client%2520interactions%2520reveals%2520principles%2520of%2520substrate%2520recognition%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D987%26epage%3D1001%26doi%3D10.1016%2Fj.cell.2012.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span> <span> </span><span class="NLM_article-title">Stressing the development of small molecules targeting HSP90</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1078-0432.CCR-13-2571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=24166908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=275-277&author=L.+Neckersauthor=J.+B.+Trepel&title=Stressing+the+development+of+small+molecules+targeting+HSP90&doi=10.1158%2F1078-0432.CCR-13-2571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Stressing the Development of Small Molecules Targeting HSP90</span></div><div class="casAuthors">Neckers, Len; Trepel, Jane B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-277</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the mol. chaperone HSP90 have been in clin. development as anticancer agents since 1999.  Recent clin. studies, including the work of Saif and colleagues in this issue of Clin. Cancer Research, demonstrate that significant progress has been made in overcoming the obstacles preventing regulatory approval.  Clin Cancer Res; 20(2); 275-7. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokmt4J2prgYrVg90H21EOLACvtfcHk0lgId0w0XcdOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D&md5=a81694c35395f63f394263843ba5fe3d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2571%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26atitle%3DStressing%2520the%2520development%2520of%2520small%2520molecules%2520targeting%2520HSP90%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D275%26epage%3D277%26doi%3D10.1158%2F1078-0432.CCR-13-2571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lgId0w0XcdOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patki, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, S. S.</span></span> <span> </span><span class="NLM_article-title">HSP90: chaperone-me-not</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1007/s12253-013-9675-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1007%2Fs12253-013-9675-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=23900891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=631-640&author=J.+M.+Patkiauthor=S.+S.+Pawar&title=HSP90%3A+chaperone-me-not&doi=10.1007%2Fs12253-013-9675-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90: Chaperone-me-not</span></div><div class="casAuthors">Patki, J. M.; Pawar, S. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  With increasing understanding of the mol. basis of carcinogenesis, its progression and metastasis, the cancer therapy has shifted from empirical approaches to targeting specific mols. that regulate the complex network of signalling pathways for cell survival and proliferation.  These include key players in malignant transformation like protein kinases, transcription factors, steroid hormone receptors, cell cycle regulators, signal transduction proteins and regulators of apoptosis.  Almost all these proteins depend upon the mol. chaperone Hsp90 for their proper folding, stability and function and thus are a part of the Hsp90 clientele.  Dependence of these proteins on Hsp90 makes this chaperone an appealing target for cancer therapeutics.  Inhibition of Hsp90 can affect multiple oncogenic pathways simultaneously.  Moreover Hsp90 inhibitors selectively kill cancer cells compared to normal cells and cancer cells have greater dependence on Hsp90 for the maintenance of intracellular protein homeostasis.  All this has led to a rapid pace discovery of Hsp90 clients as well as chem. inhibitors of Hsp90.  The role of hsp90 in cancer, tumor selectivity of Hsp90 inhibitors and the current status of Hsp90 inhibitors are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-L7_keMms8rVg90H21EOLACvtfcHk0lgWEtxJqmLecA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM&md5=31ad299d632f57170a06a6d00dc79c4b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs12253-013-9675-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-013-9675-4%26sid%3Dliteratum%253Aachs%26aulast%3DPatki%26aufirst%3DJ.%2BM.%26aulast%3DPawar%26aufirst%3DS.%2BS.%26atitle%3DHSP90%253A%2520chaperone-me-not%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D631%26epage%3D640%26doi%3D10.1007%2Fs12253-013-9675-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, T. F.</span></span> <span> </span><span class="NLM_article-title">Targeting heat shock proteins in cancer: a promising therapeutic approach</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1978</span>, <span class="refDoi"> DOI: 10.3390/ijms18091978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.3390%2Fijms18091978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOlsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1978&author=S.+Chatterjeeauthor=T.+F.+Burns&title=Targeting+heat+shock+proteins+in+cancer%3A+a+promising+therapeutic+approach&doi=10.3390%2Fijms18091978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting heat shock proteins in cancer: a promising therapeutic approach</span></div><div class="casAuthors">Chatterjee, Suman; Burns, Timothy F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1978/1-1978/39</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Heat shock proteins (HSPs) are a large family of chaperones that are involved in protein folding and maturation of a variety of "client" proteins protecting them from degrdn., oxidative stress, hypoxia, and thermal stress.  Hence, they are significant regulators of cellular proliferation, differentiation and strongly implicated in the mol. orchestration of cancer development and progression as many of their clients are well established oncoproteins in multiple tumor types.  Interestingly, tumor cells are more HSP chaperonage-dependent than normal cells for proliferation and survival because the oncoproteins in cancer cells are often misfolded and require augmented chaperonage activity for correction.  This led to the development of several inhibitors of HSP90 and other HSPs that have shown promise both preclinically and clin. in the treatment of cancer.  In this article, we comprehensively review the roles of some of the important HSPs in cancer, and how targeting them could be efficacious, esp. when traditional cancer therapies fail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0ySBoTnoS7Vg90H21EOLACvtfcHk0lgWEtxJqmLecA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOlsrbM&md5=2822359c852259c99f266ab277e19eee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fijms18091978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18091978%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DBurns%26aufirst%3DT.%2BF.%26atitle%3DTargeting%2520heat%2520shock%2520proteins%2520in%2520cancer%253A%2520a%2520promising%2520therapeutic%2520approach%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1978%26doi%3D10.3390%2Fijms18091978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. E.</span></span> <span> </span><span class="NLM_article-title">Stimulation of the weak ATPase activity of human hsp90 by a client protein</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>315</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1006/jmbi.2001.5245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1006%2Fjmbi.2001.5245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=11812147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2002&pages=787-798&author=S.+H.+McLaughlinauthor=H.+W.+Smithauthor=S.+E.+Jackson&title=Stimulation+of+the+weak+ATPase+activity+of+human+hsp90+by+a+client+protein&doi=10.1006%2Fjmbi.2001.5245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of the Weak ATPase Activity of Human Hsp90 by a Client Protein</span></div><div class="casAuthors">McLaughlin, Stephen H.; Smith, Harvey W.; Jackson, Sophie E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-798</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone involved in the folding and assembly of a limited set of "client" proteins, many of which are involved in signal transduction pathways.  In vivo, it is found in complex with addnl. proteins, including the chaperones Hsp70, Hsp40, Hip and Hop (Hsp-interacting and Hsp-organizing proteins, resp.), as well as high mol. mass immunophilins, such as FKBP59, and the small acidic protein p23.  The role of these proteins in Hsp90-mediated assembly processes is poorly understood.  It is known that ATP binding and hydrolysis are essential for Hsp90 function in vivo and in vitro.  Here we show, for the first time, that human Hsp90 has ATPase activity in vitro.  The ATPase activity is characterized using a sensitive assay based on a chem. modified form of the phosphate-binding protein from Escherichia coli.  Human Hsp90 is a very weak ATPase, its activity is significantly lower than that of the yeast homolog, and it has a half-life of ATP hydrolysis of eight minutes at 37°. Using a physiol. substrate of Hsp90, the ligand-binding domain of the glucocorticoid receptor, we show that this "client" protein can stimulate the ATPase activity up to 200-fold.  This effect is highly specific and unfolded or partially folded proteins, which are known to bind to Hsp90, do not affect the ATPase activity.  In addn., the peroxisome proliferator-activated receptor, which is related in both sequence and structure to the glucocorticoid receptor but which does not bind Hsp90, has no observable effect on the ATPase activity.  We establish the effect of the co-chaperones Hop, FKBP59 and p23 on the basal ATPase activity as well as the client protein-stimulated ATPase activity of human Hsp90.  In contrast with the yeast system, human Hop has little effect on the basal rate of ATP hydrolysis but significantly inhibits the client-protein stimulated rate.  Similarly, FKBP59 has little effect on the basal rate but stimulates the client-protein stimulated rate further.  In contrast, p23 inhibits both the basal and stimulated rates of ATP hydrolysis.  Our results show that the ATPase activity of human Hsp90 is highly regulated by both client protein and co-chaperone binding.  We suggest that the rate of ATP hydrolysis is crit. to the mode of action of Hsp90, consistent with results that have shown that both over and under-active ATPase mutants of yeast Hsp90 have impaired function in vivo.  We suggest that the tight regulation of the ATPase activity of Hsp90 is important and allows the client protein to remain bound to Hsp90 for sufficient time for activation to occur.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24_NNwfowvLVg90H21EOLACvtfcHk0lgLWp4tj_mBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlKrtQ%253D%253D&md5=0a506378cd14dc241eb51c564c26ffb0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2001.5245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2001.5245%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaughlin%26aufirst%3DS.%2BH.%26aulast%3DSmith%26aufirst%3DH.%2BW.%26aulast%3DJackson%26aufirst%3DS.%2BE.%26atitle%3DStimulation%2520of%2520the%2520weak%2520ATPase%2520activity%2520of%2520human%2520hsp90%2520by%2520a%2520client%2520protein%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D315%26spage%3D787%26epage%3D798%26doi%3D10.1006%2Fjmbi.2001.5245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/jm9004708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.+C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials&doi=10.1021%2Fjm9004708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0lgLWp4tj_mBqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17%26doi%3D10.1021%2Fjm9004708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgognoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span> <span> </span><span class="NLM_article-title">4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1021/jm701018h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1021%2Fjm701018h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></div><div class="casAuthors">Brough, Paul A.; Aherne, Wynne; Barril, Xavier; Borgognoni, Jennifer; Boxall, Kathy; Cansfield, Julie E.; Cheung, Kwai-Ming J.; Collins, Ian; Davies, Nicholas G. M.; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Finch, Harry; Fink, Alexandra; Hayes, Angela; Howes, Robert; Hubbard, Roderick E.; James, Karen; Jordan, Allan M.; Lockie, Andrea; Martins, Vanessa; Massey, Andrew; Matthews, Thomas P.; McDonald, Edward; Northfield, Christopher J.; Pearl, Laurence H.; Prodromou, Chrisostomos; Ray, Stuart; Raynaud, Florence I.; Roughley, Stephen D.; Sharp, Swee Y.; Surgenor, Allan; Walmsley, D. Lee; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 [heat shock protein 90] mol. chaperone show considerable promise as potential chemotherapeutic agents for cancer.  The structure-based design, synthesis, structure-activity relationships, and pharmacokinetics of potent small-mol. inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold were studied.  Analogs from this series have high affinity for Hsp90, as measured in a fluorescence polarization competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  The [(morpholinomethyl)phenyl]isoxazolecarboxamide I (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM.  I is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice.  In a human colon cancer xenograft model, I inhibits tumor growth by ∼50%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNA9AoWb8gLVg90H21EOLACvtfcHk0ljZ8xw8Fze9Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK&md5=fdb98dec600987e862b9b05555427948</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218%26doi%3D10.1021%2Fjm701018h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angove, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trewartha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinkovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydrois oindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5969</span>, <span class="refDoi"> DOI: 10.1021/jm100060b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5956-5969&author=A.+J.+Woodheadauthor=H.+Angoveauthor=M.+G.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=J.+E.+Coyleauthor=J.+Cosmeauthor=B.+Grahamauthor=P.+J.+Dayauthor=R.+Downhamauthor=L.+Fazalauthor=R.+Feltellauthor=E.+Figueroaauthor=M.+Fredericksonauthor=J.+Lewisauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=M.+A.+O%E2%80%99Brienauthor=L.+Parraauthor=S.+Patelauthor=T.+Phillipsauthor=D.+C.+Reesauthor=S.+Richauthor=D.+M.+Smithauthor=G.+Trewarthaauthor=M.+Vinkovicauthor=B.+Williamsauthor=A.+J.+Woolford&title=Discovery+of+%282%2C4-dihydroxy-5-isopropylphenyl%29-%5B5-%284-methylpiperazin-1-ylmethyl%29-1%2C3-dihydrois+oindol-2-yl%5Dmethanone+%28AT13387%29%2C+a+novel+inhibitor+of+the+molecular+chaperone+Hsp90+by+fragment+based+drug+design&doi=10.1021%2Fjm100060b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design</span></div><div class="casAuthors">Woodhead, Andrew J.; Angove, Hayley; Carr, Maria G.; Chessari, Gianni; Congreve, Miles; Coyle, Joseph E.; Cosme, Jose; Graham, Brent; Day, Philip J.; Downham, Robert; Fazal, Lynsey; Feltell, Ruth; Figueroa, Eva; Frederickson, Martyn; Lewis, Jonathan; McMenamin, Rachel; Murray, Christopher W.; O'Brien, M. Alistair; Parra, Lina; Patel, Sahil; Phillips, Theresa; Rees, David C.; Rich, Sharna; Smith, Donna-Michelle; Trewartha, Gary; Vinkovic, Mladen; Williams, Brian; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5956-5969</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the mol. chaperone heat shock protein 90 (Hsp90) are currently generating significant interest in clin. development as potential treatments for cancer.  In a preceding publication (DOI: 10.1021/jm100059d) we describe Astex's approach to screening fragments against Hsp90 and the subsequent optimization of two hits into leads with inhibitory activities in the low nanomolar range.  This paper describes the structure guided optimization of the 2,4-dihydroxybenzamide lead mol. 1 and details some of the drug discovery strategies employed in the identification of AT13387 (35), which has progressed through preclin. development and is currently being tested in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEtcgAmkVk7Vg90H21EOLACvtfcHk0ljZ8xw8Fze9Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D&md5=a2d2ac6dd9e9ba4cb89f83c32727a1d8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100060b%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DAngove%26aufirst%3DH.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DFeltell%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DParra%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DVinkovic%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520%25282%252C4-dihydroxy-5-isopropylphenyl%2529-%255B5-%25284-methylpiperazin-1-ylmethyl%2529-1%252C3-dihydrois%2520oindol-2-yl%255Dmethanone%2520%2528AT13387%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520molecular%2520chaperone%2520Hsp90%2520by%2520fragment%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5956%26epage%3D5969%26doi%3D10.1021%2Fjm100060b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beswick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2004.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure-activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms&doi=10.1016%2Fj.chembiol.2004.03.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0lhUQ5Ottb3GsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure-activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785%26doi%3D10.1016%2Fj.chembiol.2004.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schopf, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biebl, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">The HSP90 chaperone machinery</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1038/nrm.2017.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fnrm.2017.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=28429788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsV2mtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=345-360&author=F.+H.+Schopfauthor=M.+M.+Bieblauthor=J.+Buchner&title=The+HSP90+chaperone+machinery&doi=10.1038%2Fnrm.2017.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 chaperone machinery</span></div><div class="casAuthors">Schopf, Florian H.; Biebl, Maximilian M.; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">345-360</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The heat shock protein 90 (HSP90) chaperone machinery is a key regulator of proteostasis under both physiol. and stress conditions in eukaryotic cells.  As HSP90 has several hundred protein substrates (or 'clients'), it is involved in many cellular processes beyond protein folding, which include DNA repair, development, the immune response and neurodegenerative disease.  A large no. of co-chaperones interact with HSP90 and regulate the ATPase-assocd. conformational changes of the HSP90 dimer that occur during the processing of clients.  Recent progress has allowed the interactions of clients with HSP90 and its co-chaperones to be defined.  Owing to the importance of HSP90 in the regulation of many cellular proteins, it has become a promising drug target for the treatment of several diseases, which include cancer and diseases assocd. with protein misfolding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQAAfluC3NbVg90H21EOLACvtfcHk0lj2h_Oqwb-9ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsV2mtbw%253D&md5=65931b74cf0a4fb5e60c936177829bd4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2017.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2017.20%26sid%3Dliteratum%253Aachs%26aulast%3DSchopf%26aufirst%3DF.%2BH.%26aulast%3DBiebl%26aufirst%3DM.%2BM.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520HSP90%2520chaperone%2520machinery%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D18%26spage%3D345%26epage%3D360%26doi%3D10.1038%2Fnrm.2017.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span> <span> </span><span class="NLM_article-title">Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">25456</span>– <span class="NLM_lpage">25467</span>, <span class="refDoi"> DOI: 10.1039/C8RA05042B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1039%2FC8RA05042B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlajtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=25456-25467&author=J.+Chenauthor=J.+Wangauthor=F.+Laiauthor=W.+Wangauthor=L.+Pangauthor=W.+Zhu&title=Dynamics+revelation+of+conformational+changes+and+binding+modes+of+heat+shock+protein+90+induced+by+inhibitor+associations&doi=10.1039%2FC8RA05042B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations</span></div><div class="casAuthors">Chen, Jianzhong; Wang, Jinan; Lai, Fengbo; Wang, Wei; Pang, Laixue; Zhu, Weiliang</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">25456-25467</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) has been an attractive target of potential drug design for antitumor treatment.  The current work integrates mol. dynamics (MD) simulations, calcns. of binding free energy, and principal component (PC) anal. with scanning of inhibitor-residue interaction to probe the binding modes of inhibitors YK9, YKJ and YKI to Hsp90 and identify the hot spot of the inhibitor-Hsp90 binding.  The results suggest that the introductions of two groups G1 and G2 into YKJ and YKI strengthen the binding ability of YKJ and YKI to Hsp90 compared to YK9.  PC anal. based MD trajectories prove that inhibitor bindings exert significant effects on the conformational changes, internal dynamics and motion modes of Hsp90, esp. for the helix α2 and the loops L1 and L2.  The calcns. of residue-based free energy decompn. and scanning of the inhibitor-Hsp90 interaction suggest that six residues L107, G108, F138, Y139, W162 and F170 construct the common hot spot of the inhibitor-residue interactions.  Moreover the substitutions of the groups G1 and G2 in YKJ and YKI lead to two addnl. hydrogen bonding interactions and multiple hydrophobic interactions for bindings of YKJ and YKI to Hsp90.  This work is also expected to contribute theor. hints for the design of potent inhibitors toward Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEKKf_Jbr9ELVg90H21EOLACvtfcHk0lj2h_Oqwb-9ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlajtrjM&md5=f4bde81526802596822e02d6370189d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC8RA05042B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8RA05042B%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DDynamics%2520revelation%2520of%2520conformational%2520changes%2520and%2520binding%2520modes%2520of%2520heat%2520shock%2520protein%252090%2520induced%2520by%2520inhibitor%2520associations%26jtitle%3DRSC%2520Adv.%26date%3D2018%26volume%3D8%26spage%3D25456%26epage%3D25467%26doi%3D10.1039%2FC8RA05042B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80203-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2FS0092-8674%2800%2980203-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=9108479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=239-250&author=C.+E.+Stebbinsauthor=A.+A.+Russoauthor=C.+Schneiderauthor=N.+Rosenauthor=F.+U.+Hartlauthor=N.+P.+Pavletich&title=Crystal+structure+of+an+Hsp90-geldanamycin+complex%3A+targeting+of+a+protein+chaperone+by+an+antitumor+agent&doi=10.1016%2FS0092-8674%2800%2980203-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span></div><div class="casAuthors">Stebbins, Charles E.; Russo, Alicia A.; Schneider, Christine; Rosen, Neal; Hartl, F. Ulrich; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hsp90 chaperone is required for the activation of several families of eukaryotic protein kinases and nuclear hormone receptors, many of which are proto-oncogenic and play a prominent role in cancer.  The geldanamycin antibiotic has antiproliferative and anti-tumor effects, as it binds to Hsp90, inhibits the Hsp90-mediated conformational maturation/refolding reaction, and results in the degrdn. of Hsp90 substrates.  The structure of the geldanamycin-binding domain of Hsp90 (residues 9-232) reveals a pronounced pocket, 15 Å deep. that is highly conserved across species.  Geldanamycin binds inside this pocket, adopting a compact structure similar to that of a polypeptide chain in a turn conformation.  This, and the pocket's similarity to substrate-binding sites, suggest that the pocket binds a portion of the polypeptide substrate and participates in the conformational maturation/refolding reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnmleAOFITbVg90H21EOLACvtfcHk0lj2h_Oqwb-9ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D&md5=54a56450c509727e070f4db20a9d7b1a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980203-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980203-2%26sid%3Dliteratum%253Aachs%26aulast%3DStebbins%26aufirst%3DC.%2BE.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DSchneider%26aufirst%3DC.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DCrystal%2520structure%2520of%2520an%2520Hsp90-geldanamycin%2520complex%253A%2520targeting%2520of%2520a%2520protein%2520chaperone%2520by%2520an%2520antitumor%2520agent%26jtitle%3DCell%26date%3D1997%26volume%3D89%26spage%3D239%26epage%3D250%26doi%3D10.1016%2FS0092-8674%2800%2980203-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haystead, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">686</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.chembiol.2010.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=20659681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptleitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=686-694&author=P.+Faddenauthor=K.+H.+Huangauthor=J.+M.+Vealauthor=P.+M.+Steedauthor=A.+F.+Barabaszauthor=B.+Foleyauthor=M.+Huauthor=J.+M.+Partridgeauthor=J.+Riceauthor=A.+Scottauthor=L.+G.+Duboisauthor=T.+A.+Freedauthor=M.+A.+Silinskiauthor=T.+E.+Bartaauthor=P.+F.+Hughesauthor=A.+Ommenauthor=W.+Maauthor=E.+D.+Smithauthor=A.+W.+Spangenbergauthor=J.+Eavesauthor=G.+J.+Hansonauthor=L.+Hinkleyauthor=M.+Jenksauthor=M.+Lewisauthor=J.+Ottoauthor=G.+J.+Pronkauthor=K.+Verleysenauthor=T.+A.+Haysteadauthor=S.+E.+Hall&title=Application+of+chemoproteomics+to+drug+discovery%3A+identification+of+a+clinical+candidate+targeting+hsp90&doi=10.1016%2Fj.chembiol.2010.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90</span></div><div class="casAuthors">Fadden, Patrick; Huang, Kenneth H.; Veal, James M.; Steed, Paul M.; Barabasz, Amy F.; Foley, Briana; Hu, Mei; Partridge, Jeffrey M.; Rice, John; Scott, Anisa; Dubois, Laura G.; Freed, Tiffany A.; Rehder Silinski, Melanie A.; Barta, Thomas E.; Hughes, Philip F.; Ommen, Andy; Ma, Wei; Smith, Emilie D.; Woodward Spangenberg, Angela; Eaves, Jeron; Hanson, Gunnar J.; Hinkley, Lindsay; Jenks, Matthew; Lewis, Meredith; Otto, James; Pronk, Gijsbertus J.; Verleysen, Katleen; Haystead, Timothy A.; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">686-694</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: A chemoproteomics-based drug discovery strategy is presented that utilizes a highly parallel screening platform, encompassing more than 1000 targets, with a focused chem. library prior to target selection.  This chemoproteomics-based process enables a data-driven selection of both the biol. target and chem. hit after the screen is complete.  The methodol. has been exemplified for the purine binding proteome (proteins utilizing ATP, NAD, FAD).  Screening of an 8000 member library yielded over 1500 unique protein-ligand interactions, which included novel hits for the oncol. target Hsp90.  The approach, which also provides broad target selectivity information, was used to drive the identification of a potent and orally active Hsp90 inhibitor, SNX-5422, which is currently in phase 1 clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfemxEaaJVH7Vg90H21EOLACvtfcHk0lj9RxEFXDhO5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptleitL4%253D&md5=68486178a6847516af3fb5417a9b1911</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%2BA.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DOmmen%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DSpangenberg%26aufirst%3DA.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DG.%2BJ.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHaystead%26aufirst%3DT.%2BA.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DApplication%2520of%2520chemoproteomics%2520to%2520drug%2520discovery%253A%2520identification%2520of%2520a%2520clinical%2520candidate%2520targeting%2520hsp90%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D686%26epage%3D694%26doi%3D10.1016%2Fj.chembiol.2010.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamer, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichert, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timple, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehry, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harning, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bixler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snodgrass-Belt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span> <span> </span><span class="NLM_article-title">EC144 is a potent inhibitor of the heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7786</span>– <span class="NLM_lpage">7795</span>, <span class="refDoi"> DOI: 10.1021/jm300810x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300810x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7786-7795&author=J.+Shiauthor=R.+Van+de+Waterauthor=K.+Hongauthor=R.+B.+Lamerauthor=K.+W.+Weichertauthor=C.+M.+Sandovalauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=J.+Chaoauthor=K.+Lundgrenauthor=N.+Timpleauthor=R.+Loughauthor=G.+Ibanezauthor=C.+Boykinauthor=F.+J.+Burrowsauthor=M.+R.+Kehryauthor=T.+J.+Yunauthor=E.+K.+Harningauthor=C.+Ambroseauthor=J.+Thompsonauthor=S.+A.+Bixlerauthor=A.+Dunahauthor=P.+Snodgrass-Beltauthor=J.+Arndtauthor=I.+J.+Enyedyauthor=P.+Liauthor=V.+S.+Hongauthor=A.+McKenzieauthor=M.+A.+Biamonte&title=EC144+is+a+potent+inhibitor+of+the+heat+shock+protein+90&doi=10.1021%2Fjm300810x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">EC144 Is a Potent Inhibitor of the Heat Shock Protein 90</span></div><div class="casAuthors">Shi, Jiandong; Van de Water, Ryan; Hong, Kevin; Lamer, Ryan B.; Weichert, Kenneth W.; Sandoval, Cristina M.; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Chao, Jianhua; Lundgren, Karen; Timple, Noelito; Lough, Rachel; Ibanez, Gerardo; Boykin, Christina; Burrows, Francis J.; Kehry, Marilyn R.; Yun, Theodore J.; Harning, Erin K.; Ambrose, Christine; Thompson, Jeffrey; Bixler, Sarah A.; Dunah, Anthone; Snodgrass-Belt, Pamela; Arndt, Joseph; Enyedy, Istvan J.; Li, Ping; Hong, Victor S.; McKenzie, Andres; Biamonte, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7786-7795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alkyne 5-(2-amino-4-chloro-7-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methylpent-4-yn-2-ol (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more potent in vitro and in vivo than the first generation inhibitor (BIIB021) that completed phase II clin. trials.  Alkyne (EC144) is more potent than (BIIB021) in an Hsp90α binding assay (IC50 = 1.1 vs. 5.1 nM) as well as in its ability to degrade Her-2 in MCF-7 cells (EC50 = 14 vs. 38 nM).  In a mouse model of gastric tumors (N87), (EC144) stops tumor growth at 5 mg/kg and causes partial tumor regressions at 10 mg/kg (po, qd×5).  Under the same conditions, (BIIB021) stops tumor growth only at 120 mg/kg, and does not induce partial regressions.  Thus, alkyne (EC144) is approx. 20-fold more efficacious than (BIIB021) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRtKyDCD2OLVg90H21EOLACvtfcHk0lgvPBLJu2AKlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE&md5=201153ad61f71af267f1e1ba2ca7c2e7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300810x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300810x%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLamer%26aufirst%3DR.%2BB.%26aulast%3DWeichert%26aufirst%3DK.%2BW.%26aulast%3DSandoval%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DLough%26aufirst%3DR.%26aulast%3DIbanez%26aufirst%3DG.%26aulast%3DBoykin%26aufirst%3DC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DKehry%26aufirst%3DM.%2BR.%26aulast%3DYun%26aufirst%3DT.%2BJ.%26aulast%3DHarning%26aufirst%3DE.%2BK.%26aulast%3DAmbrose%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DBixler%26aufirst%3DS.%2BA.%26aulast%3DDunah%26aufirst%3DA.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%26aulast%3DArndt%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26atitle%3DEC144%2520is%2520a%2520potent%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7786%26epage%3D7795%26doi%3D10.1021%2Fjm300810x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Languino, L. R.</span></span> <span> </span><span class="NLM_article-title">TRAP-1, the mitochondrial Hsp90</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bbamcr.2011.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2qs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=767-73&author=D.+C.+Altieriauthor=G.+S.+Steinauthor=J.+B.+Lianauthor=L.+R.+Languino&title=TRAP-1%2C+the+mitochondrial+Hsp90&doi=10.1016%2Fj.bbamcr.2011.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">TRAP-1, the mitochondrial Hsp90</span></div><div class="casAuthors">Altieri, Dario C.; Stein, Gary S.; Lian, Jane B.; Languino, Lucia R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">767-773</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein folding quality control does not occur randomly in cells, but requires the action of specialized mol. chaperones compartmentalized in subcellular microenvironments and organelles.  Fresh exptl. evidence has now linked a mitochondrial-sp. heat Shock Protein-90 (Hsp90) homolog, Tumor Necrosis Factor Receptor-Assocd. Protein-1 (TRAP-1) to pleiotropic signaling circuitries of organelle integrity and cellular homeostasis.  TRAP-1-directed compartmentalized protein folding is broadly exploited in cancer and neurodegenerative diseases, presenting new opportunities for therapeutic intervention in humans.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (Hsp90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN8nsThSefvLVg90H21EOLACvtfcHk0lgvPBLJu2AKlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2qs74%253D&md5=3b14ed8cb8c961b07f7513c225d725bf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DG.%2BS.%26aulast%3DLian%26aufirst%3DJ.%2BB.%26aulast%3DLanguino%26aufirst%3DL.%2BR.%26atitle%3DTRAP-1%252C%2520the%2520mitochondrial%2520Hsp90%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D767%26epage%3D73%26doi%3D10.1016%2Fj.bbamcr.2011.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span> <span> </span><span class="NLM_article-title">Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">957</span>, <span class="refDoi"> DOI: 10.1002/hep.26711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1002%2Fhep.26711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=24027047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVeltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=947-957&author=W.+T.+Chenauthor=C.+C.+Tsengauthor=K.+Pfaffenbachauthor=G.+Kanelauthor=B.+Luoauthor=B.+L.+Stilesauthor=A.+S.+Lee&title=Liver-specific+knockout+of+GRP94+in+mice+disrupts+cell+adhesion%2C+activates+liver+progenitor+cells%2C+and+accelerates+liver+tumorigenesis&doi=10.1002%2Fhep.26711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis</span></div><div class="casAuthors">Chen, Wan-Ting; Tseng, Chun-Chih; Pfaffenbach, Kyle; Kanel, Gary; Luo, Biquan; Stiles, Bangyan L.; Lee, Amy S.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">947-957</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Liver cancer is one of the most common solid tumors, with poor prognosis and high mortality.  Mutation or deletion of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is strongly correlated with human liver cancer.  Glucose-regulated protein 94 (GRP94) is a major endoplasmic reticulum (ER) chaperone protein, but its in vivo function is still emerging.  To study the role of GRP94 in maintaining liver homeostasis and tumor development, we created two liver-specific knockout mouse models with the deletion of Grp94 alone, or in combination with Pten, using the albumin-cre system.  We demonstrated that while deletion of GRP94 in the liver led to hyperproliferation of liver progenitor cells, deletion of both GRP94 and PTEN accelerated development of liver tumors, including both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), suggestive of progenitor cell origin.  Furthermore, at the premalignant stage we obsd. disturbance of cell adhesion proteins and minor liver injury.  When GRP94 was deleted in PTEN-null livers, ERK was selectively activated.  Conclusion: GRP94 is a novel regulator of cell adhesion, liver homeostasis, and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFKC3nNU6dabVg90H21EOLACvtfcHk0liSQkZNPEPi7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVeltrc%253D&md5=03684dbe377452c37b1206efb08df044</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fhep.26711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26711%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26aulast%3DTseng%26aufirst%3DC.%2BC.%26aulast%3DPfaffenbach%26aufirst%3DK.%26aulast%3DKanel%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DStiles%26aufirst%3DB.%2BL.%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DLiver-specific%2520knockout%2520of%2520GRP94%2520in%2520mice%2520disrupts%2520cell%2520adhesion%252C%2520activates%2520liver%2520progenitor%2520cells%252C%2520and%2520accelerates%2520liver%2520tumorigenesis%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26spage%3D947%26epage%3D957%26doi%3D10.1002%2Fhep.26711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6877</span>– <span class="NLM_lpage">6882</span>, <span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+grp94+in+gut+homeostasis+via+chaperoning+canonical+Wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0liSQkZNPEPi7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520Wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, T.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2019.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.ejca.2019.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=31536852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsleltrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2019&pages=29-39&author=T.+Doiauthor=Y.+Kurokawaauthor=A.+Sawakiauthor=Y.+Komatsuauthor=M.+Ozakaauthor=T.+Takahashiauthor=Y.+Naitoauthor=S.+Ohkuboauthor=T.+Nishida&title=Efficacy+and+safety+of+TAS-116%2C+an+oral+inhibitor+of+heat+shock+protein+90%2C+in+patients+with+metastatic+or+unresectable+gastrointestinal+stromal+tumour+refractory+to+imatinib%2C+sunitinib+and+regorafenib%3A+a+phase+II%2C+single-arm+trial&doi=10.1016%2Fj.ejca.2019.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial</span></div><div class="casAuthors">Doi, Toshihiko; Kurokawa, Yukinori; Sawaki, Akira; Komatsu, Yoshito; Ozaka, Masato; Takahashi, Tsuyoshi; Naito, Yoichi; Ohkubo, Shuichi; Nishida, Toshirou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the efficacy and safety of TAS-116, a novel class of an orally active selective inhibitor of heat shock protein 90, in patients with advanced gastrointestinal stromal tumor (GIST) after failure of three or more lines of std. treatment with imatinib, sunitinib and regorafenib.In this single-arm phase II study, patients received 160 mg/day oral TAS-116 for five consecutive days, followed by a 2-day rest.  The primary end-point was centrally assessed progression-free survival (PFS).  The secondary end-points were objective response rate, disease control rate, overall survival (OS), metabolic response rate, safety, pharmacokinetics and pharmacogenomics.Forty-one patients were enrolled in Japan, and 40 patients underwent efficacy and safety evaluation.  At the cut-off date, the median PFS was 4.4 mo (95% confidence interval [CI], 2.8-6.0) and 12-wk progression-free rate was 73.4% (95% CI, 58.1-88.7).  Thirty-four patients (85.0%) had stable disease for ≥ 6 wk.  The median OS was 11.5 mo (95% CI, 7.0-not reached).  All patients experienced at least one treatment-related adverse event (AE), including diarrhoea (80.0%), decreased appetite (45.0%) and increase in blood creatinine level (42.5%).  Grade ≥3 AEs and treatment-related grade ≥3 AEs occurred in 23 (57.5%) and 21 (52.5%) patients, resp.  All AEs resolved after dose modification, and no TAS-116-related AEs led to treatment discontinuation.TAS-116 showed significant activity in advanced GIST refractory to std. treatment.  Further development of TAS-116 is warranted.JapicCTI-163182.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5lbmkeSpxh7Vg90H21EOLACvtfcHk0liSQkZNPEPi7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsleltrbL&md5=1fdb2d9f27376bd4c5f27fb506a9bd7f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2019.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2019.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DY.%26aulast%3DSawaki%26aufirst%3DA.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DOzaka%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DNishida%26aufirst%3DT.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520TAS-116%252C%2520an%2520oral%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%252C%2520in%2520patients%2520with%2520metastatic%2520or%2520unresectable%2520gastrointestinal%2520stromal%2520tumour%2520refractory%2520to%2520imatinib%252C%2520sunitinib%2520and%2520regorafenib%253A%2520a%2520phase%2520II%252C%2520single-arm%2520trial%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2019%26volume%3D121%26spage%3D29%26epage%3D39%26doi%3D10.1016%2Fj.ejca.2019.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimomura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagitani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitazono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyanagi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuboki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawazoe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calleja, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishio, M.</span></span> <span> </span><span class="NLM_article-title">First-in-human phase I study of an oral HSP90 inhibitor, TAS-116, in patients with advanced solid tumors</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-18-0831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1535-7163.MCT-18-0831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=30679388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=531-540&author=A.+Shimomuraauthor=N.+Yamamotoauthor=S.+Kondoauthor=Y.+Fujiwaraauthor=S.+Suzukiauthor=N.+Yanagitaniauthor=A.+Horiikeauthor=S.+Kitazonoauthor=F.+Ohyanagiauthor=T.+Doiauthor=Y.+Kubokiauthor=A.+Kawazoeauthor=K.+Shitaraauthor=I.+Ohnoauthor=U.+Banerjiauthor=R.+Sundarauthor=S.+Ohkuboauthor=E.+M.+Callejaauthor=M.+Nishio&title=First-in-human+phase+I+study+of+an+oral+HSP90+inhibitor%2C+TAS-116%2C+in+patients+with+advanced+solid+tumors&doi=10.1158%2F1535-7163.MCT-18-0831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-human phase I study of an oral HSP90 inhibitor, TAS-116, in patients with advanced solid tumors</span></div><div class="casAuthors">Shimomura, Akihiko; Yamamoto, Noboru; Kondo, Shunsuke; Fujiwara, Yutaka; Suzuki, Shigenobu; Yanagitani, Noriko; Horiike, Atsushi; Kitazono, Satoru; Ohyanagi, Fumiyoshi; Doi, Toshihiko; Kuboki, Yasutoshi; Kawazoe, Akihito; Shitara, Kohei; Ohno, Izumi; Banerji, Udai; Sundar, Raghav; Ohkubo, Shuichi; Calleja, Elizabeth M.; Nishio, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-540</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HSP90 is involved in stability and function of cancer-related proteins.  This study was conducted to define the MTD, safety, pharmacokinetics, pharmacodynamics, and preliminary antitumor efficacy of TAS-116, a novel class, orally available, highly selective inhibitor of HSP90.  Patients with advanced solid tumors received TAS-116 orally once daily (QD, step 1) or every other day (QOD, step 2) in 21-day cycles.  Each step comprised a dose escalation phase to det. MTD and an expansion phase at the MTD.  In the dose escalation phase, an accelerated dose-titrn. design and a "3 + 3" design were used.  Sixty-one patients were enrolled in Japan and the United Kingdom.  MTD was detd. to be 107.5 mg/m2/day for QD, and 210.7 mg/m2/day for QOD.  Eye disorders have been reported with HSP90 inhibitors; however, those obsd. with TAS-116 in the expansion phases were limited to grade 1.  The systemic exposure of TAS-116 increased dose-proportionally with QD and QOD regimens.  Two patients with non-small cell lung cancer and one patient with gastrointestinal stromal tumor (GIST) achieved a confirmed partial response.  TAS-116 had an acceptable safety profile with some antitumor activity, supporting further development of this HSP90 inhibitor.  This is a result from a first-in-human study, in which the HSP90 inhibitor TAS-116 demonstrated preliminary antitumor efficacy in patients with advanced solid tumors, including those with heavily pretreated GIST.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHzu4ZpCONq7Vg90H21EOLACvtfcHk0ljFqXxGVMpSMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7vM&md5=79a9b187f299ee566a7291bf8e19d7ca</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0831%26sid%3Dliteratum%253Aachs%26aulast%3DShimomura%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DYanagitani%26aufirst%3DN.%26aulast%3DHoriike%26aufirst%3DA.%26aulast%3DKitazono%26aufirst%3DS.%26aulast%3DOhyanagi%26aufirst%3DF.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DKuboki%26aufirst%3DY.%26aulast%3DKawazoe%26aufirst%3DA.%26aulast%3DShitara%26aufirst%3DK.%26aulast%3DOhno%26aufirst%3DI.%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DSundar%26aufirst%3DR.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DCalleja%26aufirst%3DE.%2BM.%26aulast%3DNishio%26aufirst%3DM.%26atitle%3DFirst-in-human%2520phase%2520I%2520study%2520of%2520an%2520oral%2520HSP90%2520inhibitor%252C%2520TAS-116%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2019%26volume%3D18%26spage%3D531%26epage%3D540%26doi%3D10.1158%2F1535-7163.MCT-18-0831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsumachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanoh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonekura, K.</span></span> <span> </span><span class="NLM_article-title">TAS-116, a highly selective inhibitor of heat shock protein 90alpha and beta, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1535-7163.MCT-14-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=25416789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=14-22&author=S.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=H.+Hitotsumachiauthor=C.+Yoshimuraauthor=M.+Kitadeauthor=A.+Hashimotoauthor=K.+Itoauthor=A.+Gomoriauthor=K.+Takahashiauthor=Y.+Shibataauthor=A.+Kanohauthor=K.+Yonekura&title=TAS-116%2C+a+highly+selective+inhibitor+of+heat+shock+protein+90alpha+and+beta%2C+demonstrates+potent+antitumor+activity+and+minimal+ocular+toxicity+in+preclinical+models&doi=10.1158%2F1535-7163.MCT-14-0219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models</span></div><div class="casAuthors">Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins.  A no. of HSP90 inhibitors have been developed clin. for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic.  The 4-(1H-pyrazolo[3,4-b]pyridine-1-yl)benzamide TAS-116 is a selective inhibitor of cytosolic HSP90α and β that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1.  Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90α and β alone was sufficient to exert antitumor activity in certain tumor models.  One of the most notable HSP90-related adverse events universally obsd. to differing degrees in the clin. setting is visual disturbance.  A two-week administration of the isoxazole resorcinol NVP-AUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats.  In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue.  Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compd. in s.c. xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina.  Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors.  Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are obsd. with other compds. of this class.  Mol Cancer Ther; 14(1); 14-22. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB25Txc_IcKbVg90H21EOLACvtfcHk0lhKdvkAAYBXyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D&md5=3ffdc26a7f0178d4e44413e22c003f77</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0219%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DHitotsumachi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DKitade%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DGomori%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DKanoh%26aufirst%3DA.%26aulast%3DYonekura%26aufirst%3DK.%26atitle%3DTAS-116%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090alpha%2520and%2520beta%252C%2520demonstrates%2520potent%2520antitumor%2520activity%2520and%2520minimal%2520ocular%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D14%26epage%3D22%26doi%3D10.1158%2F1535-7163.MCT-14-0219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vought, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Correlation between chemotype-dependent binding conformations of HSP90alpha/beta and isoform selectivity-Implications for the structure-based design of HSP90alpha/beta selective inhibitors for treating neurodegenerative diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bmcl.2013.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=24332488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=204-208&author=J.+T.+Ernstauthor=M.+Liuauthor=H.+Zuccolaauthor=T.+Neubertauthor=K.+Beaumontauthor=A.+Turnbullauthor=A.+Kallelauthor=B.+Voughtauthor=D.+Stamos&title=Correlation+between+chemotype-dependent+binding+conformations+of+HSP90alpha%2Fbeta+and+isoform+selectivity-Implications+for+the+structure-based+design+of+HSP90alpha%2Fbeta+selective+inhibitors+for+treating+neurodegenerative+diseases&doi=10.1016%2Fj.bmcl.2013.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span></div><div class="casAuthors">Ernst, Justin T.; Liu, Michael; Zuccola, Harmon; Neubert, Timothy; Beaumont, Kevin; Turnbull, Amy; Kallel, Adam; Vought, Bryan; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-208</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HSP90 continues to be a target of interest for neurodegeneration indications.  Selective knockdown of the HSP90 cytosolic isoforms α and β is sufficient to reduce mutant huntingtin protein levels in vitro.  Chemotype-dependent binding conformations of HSP90α/β appear to strongly influence isoform selectivity.  The rational design of HSP90α/β inhibitors selective vs. the mitochondrial (TRAP1) and endoplasmic reticulum (GRP94) isoforms offers a potential mitigating strategy for mechanism-based toxicities.  Better tolerated HSP90 inhibitors would be attractive for targeting chronic neurodegenerative diseases such as Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64ZOr5JsRerVg90H21EOLACvtfcHk0lhKdvkAAYBXyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO&md5=6799a46090ee297d70700f7c42b79f80</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DKallel%26aufirst%3DA.%26aulast%3DVought%26aufirst%3DB.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DCorrelation%2520between%2520chemotype-dependent%2520binding%2520conformations%2520of%2520HSP90alpha%252Fbeta%2520and%2520isoform%2520selectivity-Implications%2520for%2520the%2520structure-based%2520design%2520of%2520HSP90alpha%252Fbeta%2520selective%2520inhibitors%2520for%2520treating%2520neurodegenerative%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D204%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2013.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshiumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funabashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGnsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=531-551&author=T.+Unoauthor=Y.+Kawaiauthor=S.+Yamashitaauthor=H.+Oshiumiauthor=C.+Yoshimuraauthor=T.+Mizutaniauthor=T.+Suzukiauthor=K.+T.+Chongauthor=K.+Shigenoauthor=M.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=K.+Funabashiauthor=K.+Takahashiauthor=S.+Ohkuboauthor=M.+Kitade&title=Discovery+of+3-Ethyl-4-%283-isopropyl-4-%284-%281-methyl-1+H-pyrazol-4-yl%29-1+H-imidazol-1-yl%29-1+H-pyrazolo%5B3%2C4-+b%5Dpyridin-1-yl%29benzamide+%28TAS-116%29+as+a+Potent%2C+Selective%2C+and+Orally+Available+HSP90+Inhibitor&doi=10.1021%2Facs.jmedchem.8b01085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-ethyl-4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)benzamide (TAS-116) as a potent, selective, and orally available HSP90 inhibitor</span></div><div class="casAuthors">Uno, Takao; Kawai, Yuichi; Yamashita, Satoshi; Oshiumi, Hiromi; Yoshimura, Chihoko; Mizutani, Takashi; Suzuki, Tatsuya; Chong, Khoon Tee; Shigeno, Kazuhiko; Ohkubo, Mitsuru; Kodama, Yasuo; Muraoka, Hiromi; Funabashi, Kaoru; Takahashi, Koichi; Ohkubo, Shuichi; Kitade, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">531-551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (HSP90) is a promising target for cancer therapy, as it assists in the stabilization of cancer-related proteins, promoting cancer cell growth, and survival.  A novel series of HSP90 inhibitors were discovered by structure-activity relationship (SAR)-based optimization of an initial hit compd. having a 4-(4-(quinolin-3-yl)-1H-indol-1-yl)benzamide structure.  The pyrazolo[3,4-b]pyridine deriv., I (TAS-116), is a selective inhibitor of HSP90α and HSP90β among the HSP90 family proteins and exhibits oral availability in mice.  The X-ray cocrystal structure of the I analog II demonstrated a unique binding mode at the N-terminal ATP binding site.  Oral administration of I demonstrated potent antitumor effects in an NCI-H1975 xenograft mouse model without significant body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBSBSC2j6FrVg90H21EOLACvtfcHk0lhJaaX0s35HNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGnsLjK&md5=0e7673a985350bd5cb52a1263449a9da</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01085%26sid%3Dliteratum%253Aachs%26aulast%3DUno%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DOshiumi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DMizutani%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DChong%26aufirst%3DK.%2BT.%26aulast%3DShigeno%26aufirst%3DK.%26aulast%3DOhkubo%26aufirst%3DM.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DFunabashi%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKitade%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25203-Ethyl-4-%25283-isopropyl-4-%25284-%25281-methyl-1%2520H-pyrazol-4-yl%2529-1%2520H-imidazol-1-yl%2529-1%2520H-pyrazolo%255B3%252C4-%2520b%255Dpyridin-1-yl%2529benzamide%2520%2528TAS-116%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520HSP90%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D531%26epage%3D551%26doi%3D10.1021%2Facs.jmedchem.8b01085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caaveiro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajihara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Incorporation of rapid thermodynamic data in fragment-based drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2155</span>– <span class="NLM_lpage">2159</span>, <span class="refDoi"> DOI: 10.1021/jm301603n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301603n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislOnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2155-2159&author=A.+Kobeauthor=J.+M.+Caaveiroauthor=S.+Tashiroauthor=D.+Kajiharaauthor=M.+Kikkawaauthor=T.+Mitaniauthor=K.+Tsumoto&title=Incorporation+of+rapid+thermodynamic+data+in+fragment-based+drug+discovery&doi=10.1021%2Fjm301603n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Incorporation of Rapid Thermodynamic Data in Fragment-Based Drug Discovery</span></div><div class="casAuthors">Kobe, Akihiro; Caaveiro, Jose M. M.; Tashiro, Shinya; Kajihara, Daisuke; Kikkawa, Masato; Mitani, Tomoya; Tsumoto, Kouhei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2155-2159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has enjoyed increasing popularity in recent years.  We introduce SITE (single-injection thermal extinction), a novel thermodn. methodol. that selects high-quality hits early in FBDD.  SITE is a fast calorimetric competitive assay suitable for automation that captures the essence of isothermal titrn. calorimetry but using significantly fewer resources.  We describe the principles of SITE and identify a novel family of fragment inhibitors of the enzyme ketosteroid isomerase displaying high values of enthalpic efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq38swGDujGtrVg90H21EOLACvtfcHk0lhJaaX0s35HNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislOnsb8%253D&md5=c87d21b6629d0f1b482f0e79d54ab2fc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm301603n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301603n%26sid%3Dliteratum%253Aachs%26aulast%3DKobe%26aufirst%3DA.%26aulast%3DCaaveiro%26aufirst%3DJ.%2BM.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DKajihara%26aufirst%3DD.%26aulast%3DKikkawa%26aufirst%3DM.%26aulast%3DMitani%26aufirst%3DT.%26aulast%3DTsumoto%26aufirst%3DK.%26atitle%3DIncorporation%2520of%2520rapid%2520thermodynamic%2520data%2520in%2520fragment-based%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2155%26epage%3D2159%26doi%3D10.1021%2Fjm301603n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chigira, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyafusa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caaveiro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">15337</span>, <span class="refDoi"> DOI: 10.1038/srep15337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fsrep15337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=26471247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ylurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=15337&author=K.+Nakanoauthor=T.+Chigiraauthor=T.+Miyafusaauthor=S.+Nagatoishiauthor=J.+M.+Caaveiroauthor=K.+Tsumoto&title=Discovery+and+characterization+of+natural+tropolones+as+inhibitors+of+the+antibacterial+target+CapF+from+Staphylococcus+aureus&doi=10.1038%2Fsrep15337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus</span></div><div class="casAuthors">Nakano, Koichiro; Chigira, Takeru; Miyafusa, Takamitsu; Nagatoishi, Satoru; Caaveiro, Jose M. M.; Tsumoto, Kouhei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15337</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The rapid spread of antibiotic-resistance among pathogenic bacteria poses a serious risk for public health.  The search for novel therapeutic strategies and antimicrobial compds. is needed to ameliorate this menace.  The bifunctional metalloenzyme CapF is an antibacterial target produced by certain pathogenic bacteria essential in the biosynthetic route of capsular polysaccharide, a mucous layer on the surface of bacterium that facilitates immune evasion and infection.  The authors report the first inhibitor of CapF from Staphylococcus aureus that was identified by employing fragment-based methodologies.  The hit compd. 3-isopropenyl-tropolone inhibits the first reaction catalyzed by CapF, disrupting the synthesis of a key precursor of capsular polysaccharide.  Isothermal titrn. calorimetry demonstrates that 3-isopropenyl-tropolone binds tightly (KD = 27 ± 7 μM) to the cupin domain of CapF.  In addn., the crystal structure of the enzyme-inhibitor complex shows that the compd. engages the essential Zn2+ ion necessary for the first reaction catalyzed by the enzyme, explaining its inhibitory effect.  Moreover, the tropolone compd. alters the coordination sphere of the metal, leading to the overall destabilization of the enzyme.  The authors propose 3-isopropenyl-tropolone as a precursor to develop stronger inhibitors for this family of enzymes to impair the synthesis of capsular polysaccharide in Staphylococcus aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNaUw71IAPvbVg90H21EOLACvtfcHk0lhN8FjEOeGm0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ylurzN&md5=fbbe52935544d25e73996945a78b8b6b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep15337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep15337%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DChigira%26aufirst%3DT.%26aulast%3DMiyafusa%26aufirst%3DT.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DCaaveiro%26aufirst%3DJ.%2BM.%26aulast%3DTsumoto%26aufirst%3DK.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520natural%2520tropolones%2520as%2520inhibitors%2520of%2520the%2520antibacterial%2520target%2520CapF%2520from%2520Staphylococcus%2520aureus%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D15337%26doi%3D10.1038%2Fsrep15337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochidome, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sando, S.</span></span> <span> </span><span class="NLM_article-title">Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">876</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-08833-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fs41467-019-08833-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=30787298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A280%3ADC%252BB3cflslOkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=876&author=H.+Nonakaauthor=Y.+Nakanishiauthor=S.+Kunoauthor=T.+Otaauthor=K.+Mochidomeauthor=Y.+Saitoauthor=F.+Sugiharaauthor=Y.+Takakusagiauthor=I.+Aokiauthor=S.+Nagatoishiauthor=K.+Tsumotoauthor=S.+Sando&title=Design+strategy+for+serine+hydroxymethyltransferase+probes+based+on+retro-aldol-type+reaction&doi=10.1038%2Fs41467-019-08833-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction</span></div><div class="casAuthors">Nonaka Hiroshi; Nakanishi Yuki; Kuno Satoshi; Ota Tomoki; Mochidome Kentaro; Saito Yutaro; Sando Shinsuke; Sugihara Fuminori; Takakusagi Yoichi; Aoki Ichio; Takakusagi Yoichi; Aoki Ichio; Nagatoishi Satoru; Tsumoto Kouhei; Nagatoishi Satoru; Tsumoto Kouhei; Sando Shinsuke</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">876</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine.  It plays an important role in one-carbon metabolism.  Recently, SHMT has been shown to be associated with various diseases.  Therefore, SHMT has attracted attention as a biomarker and drug target.  However, the development of molecular probes responsive to SHMT has not yet been realized.  This is because SHMT catalyzes an essential yet simple reaction; thus, the substrates that can be accepted into the active site of SHMT are limited.  Here, we focus on the SHMT-catalyzed retro-aldol reaction rather than the canonical serine-glycine conversion and succeed in developing fluorescent and (19)F NMR molecular probes.  Taking advantage of the facile and direct detection of SHMT, the developed fluorescent probe is used in the high-throughput screening for human SHMT inhibitors, and two hit compounds are obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSF_WgJkdtmgzAEfvC7EH1LfW6udTcc2ea1HDCMSr21tLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cflslOkug%253D%253D&md5=06891eb7a710a3919a09c4757fea35a5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-08833-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-08833-7%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DS.%26aulast%3DOta%26aufirst%3DT.%26aulast%3DMochidome%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DSugihara%26aufirst%3DF.%26aulast%3DTakakusagi%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DTsumoto%26aufirst%3DK.%26aulast%3DSando%26aufirst%3DS.%26atitle%3DDesign%2520strategy%2520for%2520serine%2520hydroxymethyltransferase%2520probes%2520based%2520on%2520retro-aldol-type%2520reaction%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D876%26doi%3D10.1038%2Fs41467-019-08833-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caaveiro, J. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakakido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of inhibitors of the Parkinson’s disease associated protein DJ-1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2783</span>– <span class="NLM_lpage">2793</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00701</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00701" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWitbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2783-2793&author=S.+Tashiroauthor=J.+M.+M.+Caaveiroauthor=M.+Nakakidoauthor=A.+Tanabeauthor=S.+Nagatoishiauthor=Y.+Tamuraauthor=N.+Matsudaauthor=D.+Liuauthor=Q.+Q.+Hoangauthor=K.+Tsumoto&title=Discovery+and+optimization+of+inhibitors+of+the+Parkinson%E2%80%99s+disease+associated+protein+DJ-1&doi=10.1021%2Facschembio.8b00701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Inhibitors of the Parkinson's Disease Associated Protein DJ-1</span></div><div class="casAuthors">Tashiro, Shinya; Caaveiro, Jose M. M.; Nakakido, Makoto; Tanabe, Aki; Nagatoishi, Satoru; Tamura, Yasushi; Matsuda, Noriyuki; Liu, Dali; Hoang, Quyen Q.; Tsumoto, Kouhei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2783-2793</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DJ-1 is a Parkinson's disease assocd. protein endowed with enzymic, redox sensing, regulatory, chaperoning, and neuroprotective activities.  Although DJ-1 has been vigorously studied for the past decade and a half, its exact role in the progression of the disease remains uncertain.  In addn., little is known about the spatiotemporal regulation of DJ-1, or the biochem. basis explaining its numerous biol. functions.  Progress has been hampered by the lack of inhibitors with precisely known mechanisms of action.  Herein, we have employed biophys. methodologies and X-ray crystallog. to identify and to optimize a family of compds. inactivating the crit. Cys106 residue of human DJ-1.  We demonstrate these compds. are potent inhibitors of various activities of DJ-1 in vitro and in cell-based assays.  This study reports a new family of DJ-1 inhibitors with a defined mechanism of action, and contributes toward the understanding of the biol. function of DJ-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIpuF6tAj7_LVg90H21EOLACvtfcHk0lhn_1gNMhudxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWitbrL&md5=b7325ba7c546acd7ad8db1827228c82a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00701%26sid%3Dliteratum%253Aachs%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DCaaveiro%26aufirst%3DJ.%2BM.%2BM.%26aulast%3DNakakido%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DA.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHoang%26aufirst%3DQ.%2BQ.%26aulast%3DTsumoto%26aufirst%3DK.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520inhibitors%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520associated%2520protein%2520DJ-1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D2783%26epage%3D2793%26doi%3D10.1021%2Facschembio.8b00701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilorge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamberton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrebola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerif, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohaut, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Certal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruxer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouyon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grepin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combeau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulaouic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dereu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikol, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailliet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minoux, H.</span></span> <span> </span><span class="NLM_article-title">Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7219</span>, <span class="refDoi"> DOI: 10.1021/jm200784m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200784m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7206-7219&author=F.+Valleeauthor=C.+Carrezauthor=F.+Pilorgeauthor=A.+Dupuyauthor=A.+Parentauthor=L.+Bertinauthor=F.+Thompsonauthor=P.+Ferrariauthor=F.+Fassyauthor=A.+Lambertonauthor=A.+Thomasauthor=R.+Arrebolaauthor=S.+Guerifauthor=A.+Rohautauthor=V.+Certalauthor=J.+M.+Ruxerauthor=T.+Gouyonauthor=C.+Delormeauthor=A.+Jouanenauthor=J.+Dumasauthor=C.+Grepinauthor=C.+Combeauauthor=H.+Goulaouicauthor=N.+Dereuauthor=V.+Mikolauthor=P.+Maillietauthor=H.+Minoux&title=Tricyclic+series+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+part+I%3A+discovery+of+tricyclic+imidazo%5B4%2C5-c%5Dpyridines+as+potent+inhibitors+of+the+Hsp90+molecular+chaperone&doi=10.1021%2Fjm200784m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5-c]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Vallee, Francois; Carrez, Chantal; Pilorge, Fabienne; Dupuy, Alain; Parent, Annick; Bertin, Luc; Thompson, Fabienne; Ferrari, Paul; Fassy, Florence; Lamberton, Annabelle; Thomas, Anne; Arrebola, Rosalia; Guerif, Stephane; Rohaut, Alexandre; Certal, Victor; Ruxer, Jean-Marie; Gouyon, Thierry; Delorme, Cecile; Jouanen, Alain; Dumas, Jacques; Grepin, Claudine; Combeau, Cecile; Goulaouic, Helene; Dereu, Norbert; Mikol, Vincent; Mailliet, Patrick; Minoux, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7206-7219</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed after a low throughput screen (LTS) of a focused library contg. approx. 21K compds. selected by virtual screening.  The initial [1-{3-H-imidazo[4-5-c]pyridin-2-yl}-3,4-dihydro-2H-pyrido[2,1-a]isoindole-6-one] (1) compd. showed moderate activity (IC50 = 7.6 μM on Hsp82, the yeast homolog of Hsp90).  A high-resoln. X-ray structure shows that compd. 1 binds into an "induced" hydrophobic pocket, 10-15 Å away from the ATP/resorcinol binding site.  Iterative cycles of structure-based drug design (SBDD) and chem. synthesis led to the design and prepn. of analogs with improved affinity.  These optimized mols. make productive interactions within the ATP binding site as reported by other Hsp90 inhibitors.  This resulted in compd. 8 (I), which is a highly potent inhibitor in biochem. and cellular assays (Kd = 0.35 nM on Hsp90; IC50 = 30 nM on SKBr3 mammary carcinoma cells) and in an in vivo leukemia model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkJP_-jKMFXLVg90H21EOLACvtfcHk0lhn_1gNMhudxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbnE&md5=59dcceed7dc283fcc4c116c3616865f8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm200784m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200784m%26sid%3Dliteratum%253Aachs%26aulast%3DVallee%26aufirst%3DF.%26aulast%3DCarrez%26aufirst%3DC.%26aulast%3DPilorge%26aufirst%3DF.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DF.%26aulast%3DFerrari%26aufirst%3DP.%26aulast%3DFassy%26aufirst%3DF.%26aulast%3DLamberton%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DArrebola%26aufirst%3DR.%26aulast%3DGuerif%26aufirst%3DS.%26aulast%3DRohaut%26aufirst%3DA.%26aulast%3DCertal%26aufirst%3DV.%26aulast%3DRuxer%26aufirst%3DJ.%2BM.%26aulast%3DGouyon%26aufirst%3DT.%26aulast%3DDelorme%26aufirst%3DC.%26aulast%3DJouanen%26aufirst%3DA.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DGrepin%26aufirst%3DC.%26aulast%3DCombeau%26aufirst%3DC.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DDereu%26aufirst%3DN.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DMailliet%26aufirst%3DP.%26aulast%3DMinoux%26aufirst%3DH.%26atitle%3DTricyclic%2520series%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520part%2520I%253A%2520discovery%2520of%2520tricyclic%2520imidazo%255B4%252C5-c%255Dpyridines%2520as%2520potent%2520inhibitors%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7206%26epage%3D7219%26doi%3D10.1021%2Fjm200784m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokh, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggenweiler, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirrenberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frech, M.</span></span> <span> </span><span class="NLM_article-title">Protein conformational flexibility modulates kinetics and thermodynamics of drug binding</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2276</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02258-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fs41467-017-02258-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=29273709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A280%3ADC%252BC1Mzksleqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2276&author=M.+Amaralauthor=D.+B.+Kokhauthor=J.+Bomkeauthor=A.+Wegenerauthor=H.+P.+Buchstallerauthor=H.+M.+Eggenweilerauthor=P.+Matiasauthor=C.+Sirrenbergauthor=R.+C.+Wadeauthor=M.+Frech&title=Protein+conformational+flexibility+modulates+kinetics+and+thermodynamics+of+drug+binding&doi=10.1038%2Fs41467-017-02258-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Protein conformational flexibility modulates kinetics and thermodynamics of drug binding</span></div><div class="casAuthors">Amaral M; Matias P; Amaral M; Wegener A; Frech M; Amaral M; Kokh D B; Wade R C; Bomke J; Buchstaller H P; Eggenweiler H M; Matias P; Sirrenberg C; Wade R C; Wade R C</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2276</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based drug design has often been restricted by the rather static picture of protein-ligand complexes presented by crystal structures, despite the widely accepted importance of protein flexibility in biomolecular recognition.  Here we report a detailed experimental and computational study of the drug target, human heat shock protein 90, to explore the contribution of protein dynamics to the binding thermodynamics and kinetics of drug-like compounds.  We observe that their binding properties depend on whether the protein has a loop or a helical conformation in the binding site of the ligand-bound state.  Compounds bound to the helical conformation display slow association and dissociation rates, high-affinity and high cellular efficacy, and predominantly entropically driven binding.  An important entropic contribution comes from the greater flexibility of the helical relative to the loop conformation in the ligand-bound state.  This unusual mechanism suggests increasing target flexibility in the bound state by ligand design as a new strategy for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLPI8jjKBQEQvupmecNw_lfW6udTcc2eZkU6CddLi1kLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mzksleqsg%253D%253D&md5=2ccf76a6569363af27b6f27cb1be5b7a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02258-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02258-w%26sid%3Dliteratum%253Aachs%26aulast%3DAmaral%26aufirst%3DM.%26aulast%3DKokh%26aufirst%3DD.%2BB.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DWegener%26aufirst%3DA.%26aulast%3DBuchstaller%26aufirst%3DH.%2BP.%26aulast%3DEggenweiler%26aufirst%3DH.%2BM.%26aulast%3DMatias%26aufirst%3DP.%26aulast%3DSirrenberg%26aufirst%3DC.%26aulast%3DWade%26aufirst%3DR.%2BC.%26aulast%3DFrech%26aufirst%3DM.%26atitle%3DProtein%2520conformational%2520flexibility%2520modulates%2520kinetics%2520and%2520thermodynamics%2520of%2520drug%2520binding%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D2276%26doi%3D10.1038%2Fs41467-017-02258-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBean, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushin, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boschelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, J. I.</span></span> <span> </span><span class="NLM_article-title">Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3627</span>– <span class="NLM_lpage">3631</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bmcl.2011.04.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=21605975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3627-3631&author=C.+W.+Zapfauthor=J.+D.+Bloomauthor=J.+L.+McBeanauthor=R.+G.+Dushinauthor=J.+M.+Golasauthor=H.+Liuauthor=J.+Lucasauthor=F.+Boschelliauthor=E.+Voganauthor=J.+I.+Levin&title=Discovery+of+a+macrocyclic+o-aminobenzamide+Hsp90+inhibitor+with+heterocyclic+tether+that+shows+extended+biomarker+activity+and+in+vivo+efficacy+in+a+mouse+xenograft+model&doi=10.1016%2Fj.bmcl.2011.04.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model</span></div><div class="casAuthors">Zapf, Christoph W.; Bloom, Jonathan D.; McBean, Jamie L.; Dushin, Russell G.; Golas, Jennifer M.; Liu, Hao; Lucas, Judy; Boschelli, Frank; Vogan, Erik; Levin, Jeremy I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3627-3631</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of macrocyclic ortho-aminobenzamide Hsp90 inhibitors is reported.  In continuation of our research, heterocycle-contg. tethers were explored with the intent to further improve potency and minimize hERG liabilities.  This effort culminated in the discovery of compd. 10, which efficiently suppressed proliferation of HCT116 and U87 cells.  This compd. showed prolonged Hsp90-inhibitory activity at least 24 h post-administration consistent with elevated and prolonged exposure in the tumor.  When studied in a xenograft model, the compd. demonstrated significant suppression of tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRrrpG_p0G7Vg90H21EOLACvtfcHk0liykR_MfqGY1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhs70%253D&md5=4afc55549e0cd2aa83ce0a89af81fae5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.102%26sid%3Dliteratum%253Aachs%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DBloom%26aufirst%3DJ.%2BD.%26aulast%3DMcBean%26aufirst%3DJ.%2BL.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DGolas%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DBoschelli%26aufirst%3DF.%26aulast%3DVogan%26aufirst%3DE.%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26atitle%3DDiscovery%2520of%2520a%2520macrocyclic%2520o-aminobenzamide%2520Hsp90%2520inhibitor%2520with%2520heterocyclic%2520tether%2520that%2520shows%2520extended%2520biomarker%2520activity%2520and%2520in%2520vivo%2520efficacy%2520in%2520a%2520mouse%2520xenograft%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3627%26epage%3D3631%26doi%3D10.1016%2Fj.bmcl.2011.04.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.3892/or.2014.3552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.3892%2For.2014.3552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=25334086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVyisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=230-238&author=X.+Wangauthor=S.+Wangauthor=Y.+Liuauthor=D.+Huangauthor=K.+Zhengauthor=Y.+Zhangauthor=X.+Wangauthor=Q.+Liuauthor=D.+Yangauthor=Y.+Wang&title=Comparative+effects+of+SNX-7081+and+SNX-2112+on+cell+cycle%2C+apoptosis+and+Hsp90+client+proteins+in+human+cancer+cells&doi=10.3892%2For.2014.3552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells</span></div><div class="casAuthors">Wang, Xiao; Wang, Shaoxiang; Liu, Yuting; Huang, Dane; Zheng, Kai; Zhang, Yi; Wang, Xiaoyan; Liu, Qiuying; Yang, Depo; Wang, Yifei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-238</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">SNX-2112, a novel 2-aminobenzamide inhibitor of Hsp90, previously showed a broad spectrum of anticancer activity.  However, subsequent development has been discontinued due to ocular toxicity as identified in a phase I study.  SNX-7081, another closely related Hsp90 inhibitor with a side chain of indole instead of indazole, has recently attracted attention.  The aim of the present study was to investigate the anticancer effects of SNX-7081 in eleven cell lines, as well as the mechanisms involved, with SNX-2112 serving as a ref.  The cytotoxic effects were detd. using an MTT assay and apoptosis was measured using flow cytometry.  The results showed that SNX-7081 exerted better inhibitory effects than SNX-2112 in six eighths of the human cancer cell lines, with an av. IC50 of 1 μM.  The two inhibitors exerted low cytotoxicity in L-02, HDF and MRC5 normal human cells (IC50 >50 μM), and arrested cancer cells at the G2/M phase in a similar manner to normal cells.  Compared with SNX-2112, SNX-7081 exhibited more potent effects on cell apoptosis in four sixths of the human cancer cell lines, and was more active in the downregulation of Hsp90 client proteins.  In addn., SNX-7081 exhibited a stronger binding affinity to Hsp90 than SNX-2112 in mol. docking expts.  Considering the superior effects against Hsp90 affinity, cell growth, apoptosis, and Hsp90 client proteins in a majority of human cancer cells, the novel SNX-7081 may be a promising alternative to SNX-2112, which merits further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodmOB3wdORxbVg90H21EOLACvtfcHk0liPuMc2AnPNtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVyisr4%253D&md5=7b22276e7bea0d14e5afac658851e374</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3892%2For.2014.3552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2014.3552%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DComparative%2520effects%2520of%2520SNX-7081%2520and%2520SNX-2112%2520on%2520cell%2520cycle%252C%2520apoptosis%2520and%2520Hsp90%2520client%2520proteins%2520in%2520human%2520cancer%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2015%26volume%3D33%26spage%3D230%26epage%3D238%26doi%3D10.3892%2For.2014.3552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banipal, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banipal, P. K.</span></span> <span> </span><span class="NLM_article-title">Binding studies of caffeine and theophylline to bovine serum albumin: Calorimetric and spectroscopic approach</span>. <i>J. Mol. Liq.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">1048</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.1016/j.molliq.2016.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.molliq.2016.09.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFenu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2016&pages=1048-1055&author=T.+S.+Banipalauthor=N.+Kaurauthor=P.+K.+Banipal&title=Binding+studies+of+caffeine+and+theophylline+to+bovine+serum+albumin%3A+Calorimetric+and+spectroscopic+approach&doi=10.1016%2Fj.molliq.2016.09.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Binding studies of caffeine and theophylline to bovine serum albumin: Calorimetric and spectroscopic approach</span></div><div class="casAuthors">Banipal, Tarlok S.; Kaur, Navalpreet; Banipal, Parampaul K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Liquids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1048-1055</span>CODEN:
                <span class="NLM_cas:coden">JMLIDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-7322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Binding studies of pharmacol. active drugs-caffeine and theophylline to bovine serum albumin (BSA) in phosphate buffer soln., pH = 7.4 have been investigated using spectroscopic (UV-visible, fluorescence and NMR) and calorimetric (isothermal titrn. calorimetry) techniques.  The derived parameters obtained from all the techniques suggest that the magnitude of binding affinity of BSA-drug follows the order: theophylline > caffeine, which may be attributed to greater acidity of former at physiol. pH.  UV-visible and fluorescence spectroscopy suggests 1:1 stoichiometry of drug-protein interactions, while calorimetric results support two binding sites.  Apart from the tryptophan binding site, a low affinity site also exists which is assessed from the calorimetric measurements.  The neg. enthalpy and pos. entropy, both favors the binding process, and the feasibility of binding is also supported by neg. value of Gibbs free energy.  The pos. heat capacity, consistent with the pos. entropy, may be attributed to the exposure of hydrophobic protein surfaces.  The obsd. pos. changes in chem. shifts, Δ δ may be due to the deshielding of drug protons owing to hydrophilic-ionic/hydrogen bonding interactions with BSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFd7k6XHNNGLVg90H21EOLACvtfcHk0liPuMc2AnPNtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFenu73N&md5=afa5be62581ed77786799020786d09ee</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.molliq.2016.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molliq.2016.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DBanipal%26aufirst%3DT.%2BS.%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DBanipal%26aufirst%3DP.%2BK.%26atitle%3DBinding%2520studies%2520of%2520caffeine%2520and%2520theophylline%2520to%2520bovine%2520serum%2520albumin%253A%2520Calorimetric%2520and%2520spectroscopic%2520approach%26jtitle%3DJ.%2520Mol.%2520Liq.%26date%3D2016%26volume%3D223%26spage%3D1048%26epage%3D1055%26doi%3D10.1016%2Fj.molliq.2016.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandeel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh-Hashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase</span>. <i>J. Therm. Anal. Calorim.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2089</span>– <span class="NLM_lpage">2097</span>, <span class="refDoi"> DOI: 10.1007/s10973-013-3319-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1007%2Fs10973-013-3319-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyjtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2014&pages=2089-2097&author=M.+Kandeelauthor=Y.+Noguchiauthor=K.+Oh-Hashiauthor=H.-S.+Kimauthor=Y.+Kitade&title=Molecular+dynamics+and+energetic+perceptions+of+substrate+recognition+by+thymidylate+kinase&doi=10.1007%2Fs10973-013-3319-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase</span></div><div class="casAuthors">Kandeel, Mahmoud; Noguchi, Yoshihiro; Oh-Hashi, Kentaro; Kim, Hye-Sook; Kitade, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thermal Analysis and Calorimetry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2089-2097</span>CODEN:
                <span class="NLM_cas:coden">JTACF7</span>;
        ISSN:<span class="NLM_cas:issn">1388-6150</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Plasmodium deoxyguanylate pathways are an attractive area of investigation for future metabolic and drug discovery studies due to their unusual substrate specificities.  We investigated the energetic contribution to thymidylate kinase substrate binding, and the forces underlying ligand recognition.  The binding const. varied from 8 × 104 M-1 at 290 K to 6 × 104 M-1 at 310 K for dGMP, and from 16 × 104 M-1 at 290 K to 4 × 104 M-1 at 310 K for TMP.  ΔCp was estd. as -1.75 kJ mol-1 K-1 for TMP and +2 kJ mol-1 K-1 for dGMP.  In comparison with TMP, the binding of dGMP to PfTMK produced less favorable enthalpy change, pos. or favorable entropic contribution at lower temp., pos. heat capacity change, neg. ΔS°HE·, pos. ΔSother, higher total solvent-exposed surface area and more or less rigid body binding.  These changes indicate unfavorable conditions for proper binding and lower conformational changes, and suboptimal structural reordering during dGMP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG1u76B8BqnLVg90H21EOLACvtfcHk0lhVZKQYTV88rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyjtL%252FI&md5=eeb7c2d75d27b1c873f92819d92624b3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs10973-013-3319-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10973-013-3319-5%26sid%3Dliteratum%253Aachs%26aulast%3DKandeel%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DOh-Hashi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.-S.%26aulast%3DKitade%26aufirst%3DY.%26atitle%3DMolecular%2520dynamics%2520and%2520energetic%2520perceptions%2520of%2520substrate%2520recognition%2520by%2520thymidylate%2520kinase%26jtitle%3DJ.%2520Therm.%2520Anal.%2520Calorim.%26date%3D2014%26volume%3D115%26spage%3D2089%26epage%3D2097%26doi%3D10.1007%2Fs10973-013-3319-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0lhVZKQYTV88rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bussenius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcalas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowles, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhr, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFina, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lougheed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manalo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womble, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5396</span>– <span class="NLM_lpage">5404</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bmcl.2012.07.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22877636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5396-5404&author=J.+Busseniusauthor=C.+M.+Blazeyauthor=N.+Aayauthor=N.+K.+Anandauthor=A.+Arcalasauthor=T.+Baikauthor=O.+J.+Bowlesauthor=C.+A.+Buhrauthor=S.+Costanzoauthor=J.+K.+Curtisauthor=S.+C.+DeFinaauthor=L.+Dubenkoauthor=T.+S.+Heuerauthor=P.+Huangauthor=C.+Jaegerauthor=A.+Joshiauthor=A.+R.+Kennedyauthor=A.+I.+Kimauthor=K.+Laraauthor=J.+Leeauthor=J.+Liauthor=J.+C.+Lougheedauthor=S.+Maauthor=S.+Malekauthor=J.+C.+Manaloauthor=J.+F.+Martiniauthor=G.+McGrathauthor=M.+Nicollauthor=J.+M.+Nussauthor=M.+Packauthor=C.+J.+Petoauthor=T.+H.+Tsangauthor=L.+Wangauthor=S.+W.+Wombleauthor=M.+Yakesauthor=W.+Zhangauthor=K.+D.+Rice&title=Discovery+of+XL888%3A+a+novel+tropane-derived+small+molecule+inhibitor+of+HSP90&doi=10.1016%2Fj.bmcl.2012.07.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90</span></div><div class="casAuthors">Bussenius, Joerg; Blazey, Charles M.; Aay, Naing; Anand, Neel K.; Arcalas, Arlyn; Baik, TaeGon; Bowles, Owen J.; Buhr, Chris A.; Costanzo, Simona; Curtis, Jeffrey K.; DeFina, Steven C.; Dubenko, Larisa; Heuer, Timothy S.; Huang, Ping; Jaeger, Christopher; Joshi, Anagha; Kennedy, Abigail R.; Kim, Angie I.; Lara, Katherine; Lee, Jae; Li, Jonathan; Lougheed, Julie C.; Ma, Sunghoon; Malek, Shiva; Manalo, Jean-Claire L.; Martini, Jean-Francois; McGrath, Garth; Nicoll, Monique; Nuss, John M.; Pack, Michael; Peto, Csaba J.; Tsang, Tsze H.; Wang, Longcheng; Womble, Scott W.; Yakes, Michael; Zhang, Wentao; Rice, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5396-5404</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With structural guidance, tropane-derived HTS hits were modified to optimize for HSP90 inhibition and a desirable in vivo profile.  Through an iterative SAR development process 12i [I; X = cyclopropyl, R1 = Me, R2 = (R)-sec-Bu, XL888] was discovered and shown to reduce HSP90 client protein content in PD studies.  Furthermore, efficacy expts. performed in a NCI-N87 mouse xenograft model demonstrated tumor regression in some dosing regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYT__qJeDg0rVg90H21EOLACvtfcHk0lgKvNCOP7yixA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL&md5=d62d69690c1f80ae0489a6a1350f2abe</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DBussenius%26aufirst%3DJ.%26aulast%3DBlazey%26aufirst%3DC.%2BM.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DAnand%26aufirst%3DN.%2BK.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DBowles%26aufirst%3DO.%2BJ.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DCostanzo%26aufirst%3DS.%26aulast%3DCurtis%26aufirst%3DJ.%2BK.%26aulast%3DDeFina%26aufirst%3DS.%2BC.%26aulast%3DDubenko%26aufirst%3DL.%26aulast%3DHeuer%26aufirst%3DT.%2BS.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DA.%2BI.%26aulast%3DLara%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLougheed%26aufirst%3DJ.%2BC.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DManalo%26aufirst%3DJ.%2BC.%26aulast%3DMartini%26aufirst%3DJ.%2BF.%26aulast%3DMcGrath%26aufirst%3DG.%26aulast%3DNicoll%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DPack%26aufirst%3DM.%26aulast%3DPeto%26aufirst%3DC.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWomble%26aufirst%3DS.%2BW.%26aulast%3DYakes%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRice%26aufirst%3DK.%2BD.%26atitle%3DDiscovery%2520of%2520XL888%253A%2520a%2520novel%2520tropane-derived%2520small%2520molecule%2520inhibitor%2520of%2520HSP90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5396%26epage%3D5404%26doi%3D10.1016%2Fj.bmcl.2012.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawasaki, T.</span></span> <span> </span><span class="NLM_article-title">Simple screening method for autoantigen proteins using the N-terminal biotinylated protein library produced by wheat cell-free synthesis</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4264</span>– <span class="NLM_lpage">4273</span>, <span class="refDoi"> DOI: 10.1021/pr9010553</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr9010553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFegs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=4264-4273&issue=8&author=K.+Matsuokaauthor=H.+Komoriauthor=M.+Noseauthor=Y.+Endoauthor=T.+Sawasaki&title=Simple+screening+method+for+autoantigen+proteins+using+the+N-terminal+biotinylated+protein+library+produced+by+wheat+cell-free+synthesis&doi=10.1021%2Fpr9010553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Simple Screening Method for Autoantigen Proteins Using the N-Terminal Biotinylated Protein Library Produced by Wheat Cell-Free Synthesis</span></div><div class="casAuthors">Matsuoka, Kazuhiro; Komori, Hiroaki; Nose, Masato; Endo, Yaeta; Sawasaki, Tatsuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4264-4273</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autoimmune diseases are a heterogeneous group of diseases characterized by immune reactions against either a major or a limited no. of the bodies own autoantigens, causing inflammation and damage to tissues and organs.  Thus, identification of autoantigens is an important first step to understanding autoimmune diseases.  Here the authors demonstrate a simple screening method for identification of autoantigens reacting with patient serum antibodies by combination of an N-terminal biotinylated protein library (BPL), produced using a wheat cell-free protein prodn. system, and a com. available luminescence system.  Optimization studies using well-characterized autoantigens showed specific interactions between N-terminal biotinylated proteins and antibody that were sensitively detected under homogeneous reaction conditions.  In this optimized assay, 1 μL of the translation mixt. expressing the biotinylated proteins produced significant luminescence signal by addn. of dild. serum between 1:500 and 1:10,000 in 25 μL of reaction vol.  For the BPL construction, 214 mouse genes, consisting of 103 well-known autoantigens and 111 genes in the mouse autoimmune susceptibility loci, and the sera of MRL/lpr mouse were used as an autoimmune model.  By this screening method, 25 well-known autoantigens and 71 proteins in the loci were identified as autoantigen proteins specifically reacting with sera antibodies.  Cross-referencing with the Gene Ontol. Database, 26 and 38 of autoantigen proteins were predicted to have nuclear localization and identified as membrane and/or extracellular proteins.  The immune reaction of six randomly selected proteins was confirmed by immunopptn. and/or immunoblot analyses.  Interestingly, three autoantigen proteins were recognized by immunopptn. but not by immunoblot anal.  These results suggest that the BPL-based method could provide a simple system for screening of autoantigen proteins and would help with identification of autoantigen proteins reacting with antibodies that recognize folded proteins, rather than denatured or unfolded forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_25Ve-t_ZWbVg90H21EOLACvtfcHk0lgKvNCOP7yixA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFegs7Y%253D&md5=db5b2991c71891e8e210ed2ffc2dc89f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fpr9010553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr9010553%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DKomori%26aufirst%3DH.%26aulast%3DNose%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DSawasaki%26aufirst%3DT.%26atitle%3DSimple%2520screening%2520method%2520for%2520autoantigen%2520proteins%2520using%2520the%2520N-terminal%2520biotinylated%2520protein%2520library%2520produced%2520by%2520wheat%2520cell-free%2520synthesis%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2010%26volume%3D9%26issue%3D8%26spage%3D4264%26epage%3D4273%26doi%3D10.1021%2Fpr9010553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makoto, K.</span>; <span class="NLM_string-name">Satoshi, Y.</span>; <span class="NLM_string-name">Shuichi, O.</span></span> <span> </span><span class="NLM_article-title">Novel bicyclic compound or salt there of</span>. <span class="NLM_patent">WO2012093708A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+Makoto&author=Y.+Satoshi&author=O.+Shuichi&title=Novel+bicyclic+compound+or+salt+there+of"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMakoto%26aufirst%3DK.%26atitle%3DNovel%2520bicyclic%2520compound%2520or%2520salt%2520there%2520of%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makoto, K.</span>; <span class="NLM_string-name">Shuichi, O.</span>; <span class="NLM_string-name">Chihoko, Y.</span>; <span class="NLM_string-name">Satoshi, Y.</span>; <span class="NLM_string-name">Hiromi, O.</span>; <span class="NLM_string-name">Takao, U.</span>; <span class="NLM_string-name">Yuichi, K.</span></span>, <span class="NLM_patent">WO2011004610A1</span>. <span> </span><span class="NLM_article-title">Azabicyclo compound and salt thereof</span>. <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Makoto&author=O.+Shuichi&author=Y.+Chihoko&author=Y.+Satoshi&author=O.+Hiromi&author=U.+Takao&author=K.+Yuichi&title=Azabicyclo+compound+and+salt+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMakoto%26aufirst%3DK.%26atitle%3DAzabicyclo%2520compound%2520and%2520salt%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span> <span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of Hsp90</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2005.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.ab.2005.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=16460658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVeht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+Hsp90&doi=10.1016%2Fj.ab.2005.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence polarization assay for inhibitors of Hsp90</span></div><div class="casAuthors">Howes, R.; Barril, X.; Dymock, B. W.; Grant, K.; Northfield, C. J.; Robertson, A. G. S.; Surgenor, A.; Wayne, J.; Wright, L.; James, K.; Matthews, T.; Cheung, K.-M.; McDonald, E.; Workman, P.; Drysdale, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-213</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hsp90 encodes a ubiquitous mol. chaperone protein conserved among species which acts on multiple substrates, many of which are important cell-signaling proteins.  Inhibition of Hsp90 function has been promoted as a mechanism to degrade client proteins involved in tumorigenesis and disease progression.  Several assays to monitor inhibition of Hsp90 function currently exist but are limited in their use for a drug discovery campaign.  Using data from the crystal structure of an initial hit compd., we have synthesized a fluorescent probe to be used in a fluorescence polarization assay to monitor binding of compds. to the ATP-binding site of Hsp90.  This assay is very robust (Z' > 0.9) and can detect affinity of compds. with IC50s to 40 nM.  We have used this assay in conjunction with cocrystal structures of small mols. to drive a structure-based design program aimed at the discovery and optimization of a novel class of potent Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoag8hYDpa7BrVg90H21EOLACvtfcHk0ljii24XXtMc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVeht74%253D&md5=59b8bce204a19c6618f9bce225eeb7df</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2005.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2005.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520Hsp90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213%26doi%3D10.1016%2Fj.ab.2005.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence polarization assays in small molecule screening</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1517/17460441.2011.537322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1517%2F17460441.2011.537322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22328899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SrtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=17-32&author=W.+A.+Leaauthor=A.+Simeonov&title=Fluorescence+polarization+assays+in+small+molecule+screening&doi=10.1517%2F17460441.2011.537322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence polarization assays in small molecule screening</span></div><div class="casAuthors">Lea, Wendy A.; Simeonov, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-32</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Fluorescence polarization (FP) is a homogeneous method that allows rapid and quant. anal. of diverse mol. interactions and enzyme activities.  This technique has been widely utilized in clin. and biomedical settings, including the diagnosis of certain diseases and monitoring therapeutic drug levels in body fluids.  Recent developments in the field have been symbolized by the facile adoption of FP in high-throughput screening and small mol. drug discovery of an increasing range of target classes.  Areas covered in this review: The article provides a brief overview of the theor. foundation of FP, followed by updates on recent advancements in its application for various drug target classes, including GPCRs, enzymes and protein-protein interactions.  The strengths and weaknesses of this method, practical considerations in assay design, novel applications and future directions are also discussed.  What the reader will gain: The reader is informed of the most recent advancements and future directions of FP application to small mol. screening.  Take home message: In addn. to its continued utilization in high-throughput screening, FP has expanded into new disease and target areas and has been marked by increased use of labeled small mol. ligands for receptor-binding studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqudLso-a4wR7Vg90H21EOLACvtfcHk0ljii24XXtMc8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SrtbvP&md5=6f102f40b56fd7a13c4fb59b64a3f883</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.537322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.537322%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DFluorescence%2520polarization%2520assays%2520in%2520small%2520molecule%2520screening%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D17%26epage%3D32%26doi%3D10.1517%2F17460441.2011.537322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span> <i>Molecular Operating
Environment</i>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal,
Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C%0ACanada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, S. J.</span>; <span class="NLM_string-name">Thornton, J. M.</span></span> <i>NACCESS</i>; <span class="NLM_publisher-name">Department of Biochemistry and Molecular Biology, University College</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=S.+J.+Hubbard&author=J.+M.+Thornton&title=NACCESS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BJ.%26jtitle%3DNACCESS%26pub%3DDepartment%2520of%2520Biochemistry%2520and%2520Molecular%2520Biology%252C%2520University%2520College%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Chemical structure of TAS-116 and 16d. (b) Co-crystal structures of Hsp90α NTD with 16d (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3">5ZR3</a>) and THS-828 (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9">3WQ9</a>). (c–f) A model of the complex of Hsp90α and TAS-116 was created using the MOE software. Shown are (c) a cartoon model of (d) the ATP-binding pocket, (e) the second pocket, and (f) the third pocket. The Hsp90α is shown in brown. TAS-116 is shown in a ball-and-stick rendering in orange.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) SPR analysis of the interaction between Hsp90α and TAS-116. (b) Binding locations of various inhibitors to Hsp90α (gray). The proteins in complexes with AUY922 (magenta) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>) and BIIB021 (green) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD">3QDD</a>) were aligned. TAS-116 (orange) was docked into the Hsp90α structure. (c) Fold difference in <i>K</i><sub>i</sub> values of inhibitors for mutant relative to wild-type Hsp90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Characteristics of the interaction of THS-975 and THS-510 with Hsp90. (a, d) Chemical structure of THS-975 and THS-510. (b, e) Isoform selectivity of THS-975 and THS-510. Plotted is the percent ratio of the intensity of the test and control lines versus concentration of inhibitor. The data are the means of two independent experiments. (c, f) Enthalpy change on the binding of THS-975 and THS-510 to the human Hsp90α NTD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Schematic of complex of human Hsp90α NTD with AUY922 and the competitive binding titration of THS-510 (upper). The ITC profile of the titration of THS-510 into human Hsp90 NTD in the presence of AUY922 (lower). (b) Schematic of the complex of human Hsp90α NTD with BIIB021 and the competitive binding titration of THS-510 (upper). The ITC profile of the titration of THS-510 into human Hsp90 NTD in the presence of BIIB021 (lower).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/medium/jm0c01715_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Thermodynamic parameters for the interactions of THS-510, THS-762, and TAS-116 with human Hsp90α NTD. (b) Temperature dependence of the binding enthalpy change for THS-510 and TAS-116 binding to the human Hsp90α NTD. (c) Chemical structure of THS-762 and predicted regions of Hsp90 bound by each part of the molecule.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c01715/20210421/images/large/jm0c01715_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01715&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 46 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifshits, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iafrate, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, A. T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">7535</span>– <span class="NLM_lpage">7340</span>, <span class="refDoi"> DOI: 10.1073/pnas.1019559108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1073%2Fpnas.1019559108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=21502504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=7535-7340&author=R.+Katayamaauthor=T.+M.+Khanauthor=C.+Benesauthor=E.+Lifshitsauthor=H.+Ebiauthor=V.+M.+Riveraauthor=W.+C.+Shakespeareauthor=A.+J.+Iafrateauthor=J.+A.+Engelmanauthor=A.+T.+Shaw&title=Therapeutic+strategies+to+overcome+crizotinib+resistance+in+non-small+cell+lung+cancers+harboring+the+fusion+oncogene+EML4-ALK&doi=10.1073%2Fpnas.1019559108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK</span></div><div class="casAuthors">Katayama, Ryohei; Khan, Tahsin M.; Benes, Cyril; Lifshits, Eugene; Ebi, Hiromichi; Rivera, Victor M.; Shakespeare, William C.; Iafrate, A. John; Engelman, Jeffrey A.; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7535-7540, S7535/1-S7535/17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The echinoderm microtubule-assocd. protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion oncogene represents a mol. target in a small subset of non-small cell lung cancers (NSCLCs).  This fusion leads to constitutive ALK activation with potent transforming activity.  In a pivotal phase 1 clin. trial, the ALK tyrosine kinase inhibitor (TKI) crizotinib (PF-02341066) demonstrated impressive antitumor activity in the majority of patients with NSCLC harboring ALK fusions.  However, despite these remarkable initial responses, cancers eventually develop resistance to crizotinib, usually within 1 y, thereby limiting the potential clin. benefit.  To det. how cancers acquire resistance to ALK inhibitors, we established a model of acquired resistance to crizotinib by exposing a highly sensitive EML4-ALK-pos. NSCLC cell line to increasing doses of crizotinib until resistance emerged.  We found that cells resistant to intermediate doses of crizotinib developed amplification of the EML4-ALK gene.  Cells resistant to higher doses (1 μM) also developed a gatekeeper mutation, L1196M, within the kinase domain, rendering EML4-ALK insensitive to crizotinib.  This gatekeeper mutation was readily detected using a unique and highly sensitive allele-specific PCR assay.  Although crizotinib was ineffectual against EML4-ALK harboring the gatekeeper mutation, we obsd. that two structurally different ALK inhibitors, NVPTAE684 and AP26113, were highly active against the resistant cancer cells in vitro and in vivo.  Furthermore, these resistant cells remained highly sensitive to the Hsp90 inhibitor 17-AAG.  Thus, we have developed a model of acquired resistance to ALK inhibitors and have shown that second-generation ALK TKIs or Hsp90 inhibitors are effective in treating crizotinib-resistant tumors harboring secondary gatekeeper mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPbiLG5xpg0LVg90H21EOLACvtfcHk0liV294MyDlUcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFSrsbY%253D&md5=82f47736429e6f71f9fd5852e4df64cb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1019559108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1019559108%26sid%3Dliteratum%253Aachs%26aulast%3DKatayama%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DBenes%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DEbi%26aufirst%3DH.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DTherapeutic%2520strategies%2520to%2520overcome%2520crizotinib%2520resistance%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520the%2520fusion%2520oncogene%2520EML4-ALK%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D7535%26epage%3D7340%26doi%3D10.1073%2Fpnas.1019559108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0li310IZUPRhFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sreedhar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Csermely, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y. F.</span></span> <span> </span><span class="NLM_article-title">Hsp90 isoforms: functions, expression and clinical importance</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>562</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(04)00229-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2FS0014-5793%2804%2900229-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=15069952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=562&publication_year=2004&pages=11-15&author=A.+S.+Sreedharauthor=E.+Kalmarauthor=P.+Csermelyauthor=Y.+F.+Shen&title=Hsp90+isoforms%3A+functions%2C+expression+and+clinical+importance&doi=10.1016%2FS0014-5793%2804%2900229-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 isoforms: functions, expression and clinical importance</span></div><div class="casAuthors">Sreedhar Amere Subbarao; Kalmar Eva; Csermely Peter; Shen Yu-Fei</div><div class="citationInfo"><span class="NLM_cas:title">FEBS letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">562</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">11-5</span>
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The 90 kDa heat shock protein, Hsp90, is a main functional component of an important cytoplasmic chaperone complex, and it is involved in various cellular processes, such as cell proliferation, differentiation and apoptosis.  Identification of Hsp90 as a molecular target of various anticancer drugs highlighted its importance from the clinical point of view.  Here we summarize the current knowledge of various Hsp90 isoforms regarding their genomic location, molecular evolution, functional differences, differential induction after various environmental stresses and in pathological conditions as well as the growing importance of discriminating between Hsp90 isoforms in clinical practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPSA2r_aCgUoNpW7w2tapOfW6udTcc2eYl1Ox1TLXjD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c7nsFOktA%253D%253D&md5=d5340d922f408298ba90a5cc906b60f2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2804%2900229-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252804%252900229-7%26sid%3Dliteratum%253Aachs%26aulast%3DSreedhar%26aufirst%3DA.%2BS.%26aulast%3DKalmar%26aufirst%3DE.%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DShen%26aufirst%3DY.%2BF.%26atitle%3DHsp90%2520isoforms%253A%2520functions%252C%2520expression%2520and%2520clinical%2520importance%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D562%26spage%3D11%26epage%3D15%26doi%3D10.1016%2FS0014-5793%2804%2900229-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosz, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span> <span> </span><span class="NLM_article-title">HSP90 at the hub of protein homeostasis: emerging mechanistic insights</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">515</span>– <span class="NLM_lpage">528</span>, <span class="refDoi"> DOI: 10.1038/nrm2918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fnrm2918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=20531426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=515-528&author=M.+Taipaleauthor=D.+F.+Jaroszauthor=S.+Lindquist&title=HSP90+at+the+hub+of+protein+homeostasis%3A+emerging+mechanistic+insights&doi=10.1038%2Fnrm2918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90 at the hub of protein homeostasis: emerging mechanistic insights</span></div><div class="casAuthors">Taipale, Mikko; Jarosz, Daniel F.; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">515-528</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Heat-shock protein 90 (HSP90) is a highly conserved mol. chaperone that facilitates the maturation of a wide range of proteins (known as clients).  Clients are enriched in signal transducers, including kinases and transcription factors.  Therefore, HSP90 regulates diverse cellular functions and exerts marked effects on normal biol., disease, and evolutionary processes.  Recent structural and functional analyses have provided new insights on the transcriptional and biochem. regulation of HSP90 and the structural dynamics it uses to act on a diverse client repertoire.  A comprehensive understanding of how HSP90 functions promises not only to provide new avenues for therapeutic intervention, but to shed light on fundamental biol. questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuMRSaY8uzGbVg90H21EOLACvtfcHk0li310IZUPRhFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntFSmt7c%253D&md5=492dca92cea32384d2ab4145230f53dd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrm2918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2918%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DJarosz%26aufirst%3DD.%2BF.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DHSP90%2520at%2520the%2520hub%2520of%2520protein%2520homeostasis%253A%2520emerging%2520mechanistic%2520insights%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D515%26epage%3D528%26doi%3D10.1038%2Fnrm2918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taipale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krykbaeva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koeva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayatekin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westover, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karras, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindquist, S.</span></span> <span> </span><span class="NLM_article-title">Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">987</span>– <span class="NLM_lpage">1001</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.cell.2012.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22939624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSns7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2012&pages=987-1001&author=M.+Taipaleauthor=I.+Krykbaevaauthor=M.+Koevaauthor=C.+Kayatekinauthor=K.+D.+Westoverauthor=G.+I.+Karrasauthor=S.+Lindquist&title=Quantitative+analysis+of+HSP90-client+interactions+reveals+principles+of+substrate+recognition&doi=10.1016%2Fj.cell.2012.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition</span></div><div class="casAuthors">Taipale, Mikko; Krykbaeva, Irina; Koeva, Martina; Kayatekin, Can; Westover, Kenneth D.; Karras, Georgios I.; Lindquist, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">987-1001</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HSP90 is a mol. chaperone that assocs. with numerous substrate proteins called clients.  It plays many important roles in human biol. and medicine, but determinants of client recognition by HSP90 have remained frustratingly elusive.  We systematically and quant. surveyed most human kinases, transcription factors, and E3 ligases for interaction with HSP90 and its cochaperone CDC37.  Unexpectedly, many more kinases than transcription factors bound HSP90.  CDC37 interacted with kinases, but not with transcription factors or E3 ligases.  HSP90::kinase interactions varied continuously over a 100-fold range and provided a platform to study client protein recognition.  In wild-type clients, HSP90 did not bind particular sequence motifs, but rather assocd. with intrinsically unstable kinases.  Stabilization of the kinase in either its active or inactive conformation with diverse small mols. decreased HSP90 assocn.  Our results establish HSP90 client recognition as a combinatorial process: CDC37 provides recognition of the kinase family, whereas thermodn. parameters det. client binding within the family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHzMXLTn5hx7Vg90H21EOLACvtfcHk0lhNXTl1WZeXqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSns7bF&md5=2ebda06d0ce0b8f65edff9f08f10dd31</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DTaipale%26aufirst%3DM.%26aulast%3DKrykbaeva%26aufirst%3DI.%26aulast%3DKoeva%26aufirst%3DM.%26aulast%3DKayatekin%26aufirst%3DC.%26aulast%3DWestover%26aufirst%3DK.%2BD.%26aulast%3DKarras%26aufirst%3DG.%2BI.%26aulast%3DLindquist%26aufirst%3DS.%26atitle%3DQuantitative%2520analysis%2520of%2520HSP90-client%2520interactions%2520reveals%2520principles%2520of%2520substrate%2520recognition%26jtitle%3DCell%26date%3D2012%26volume%3D150%26spage%3D987%26epage%3D1001%26doi%3D10.1016%2Fj.cell.2012.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J. B.</span></span> <span> </span><span class="NLM_article-title">Stressing the development of small molecules targeting HSP90</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">277</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1078-0432.CCR-13-2571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=24166908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=275-277&author=L.+Neckersauthor=J.+B.+Trepel&title=Stressing+the+development+of+small+molecules+targeting+HSP90&doi=10.1158%2F1078-0432.CCR-13-2571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Stressing the Development of Small Molecules Targeting HSP90</span></div><div class="casAuthors">Neckers, Len; Trepel, Jane B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-277</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the mol. chaperone HSP90 have been in clin. development as anticancer agents since 1999.  Recent clin. studies, including the work of Saif and colleagues in this issue of Clin. Cancer Research, demonstrate that significant progress has been made in overcoming the obstacles preventing regulatory approval.  Clin Cancer Res; 20(2); 275-7. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokmt4J2prgYrVg90H21EOLACvtfcHk0lhNXTl1WZeXqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFKrsr8%253D&md5=a81694c35395f63f394263843ba5fe3d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2571%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DTrepel%26aufirst%3DJ.%2BB.%26atitle%3DStressing%2520the%2520development%2520of%2520small%2520molecules%2520targeting%2520HSP90%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D275%26epage%3D277%26doi%3D10.1158%2F1078-0432.CCR-13-2571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: are we there yet?</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">76</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+are+we+there+yet%3F&doi=10.1158%2F1078-0432.CCR-11-1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lgl93s5cfKQiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76%26doi%3D10.1158%2F1078-0432.CCR-11-1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patki, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, S. S.</span></span> <span> </span><span class="NLM_article-title">HSP90: chaperone-me-not</span>. <i>Pathol. Oncol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1007/s12253-013-9675-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1007%2Fs12253-013-9675-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=23900891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=631-640&author=J.+M.+Patkiauthor=S.+S.+Pawar&title=HSP90%3A+chaperone-me-not&doi=10.1007%2Fs12253-013-9675-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90: Chaperone-me-not</span></div><div class="casAuthors">Patki, J. M.; Pawar, S. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  With increasing understanding of the mol. basis of carcinogenesis, its progression and metastasis, the cancer therapy has shifted from empirical approaches to targeting specific mols. that regulate the complex network of signalling pathways for cell survival and proliferation.  These include key players in malignant transformation like protein kinases, transcription factors, steroid hormone receptors, cell cycle regulators, signal transduction proteins and regulators of apoptosis.  Almost all these proteins depend upon the mol. chaperone Hsp90 for their proper folding, stability and function and thus are a part of the Hsp90 clientele.  Dependence of these proteins on Hsp90 makes this chaperone an appealing target for cancer therapeutics.  Inhibition of Hsp90 can affect multiple oncogenic pathways simultaneously.  Moreover Hsp90 inhibitors selectively kill cancer cells compared to normal cells and cancer cells have greater dependence on Hsp90 for the maintenance of intracellular protein homeostasis.  All this has led to a rapid pace discovery of Hsp90 clients as well as chem. inhibitors of Hsp90.  The role of hsp90 in cancer, tumor selectivity of Hsp90 inhibitors and the current status of Hsp90 inhibitors are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-L7_keMms8rVg90H21EOLACvtfcHk0lgl93s5cfKQiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM&md5=31ad299d632f57170a06a6d00dc79c4b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs12253-013-9675-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-013-9675-4%26sid%3Dliteratum%253Aachs%26aulast%3DPatki%26aufirst%3DJ.%2BM.%26aulast%3DPawar%26aufirst%3DS.%2BS.%26atitle%3DHSP90%253A%2520chaperone-me-not%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D631%26epage%3D640%26doi%3D10.1007%2Fs12253-013-9675-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, T. F.</span></span> <span> </span><span class="NLM_article-title">Targeting heat shock proteins in cancer: a promising therapeutic approach</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1978</span>, <span class="refDoi"> DOI: 10.3390/ijms18091978</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.3390%2Fijms18091978" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOlsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1978&author=S.+Chatterjeeauthor=T.+F.+Burns&title=Targeting+heat+shock+proteins+in+cancer%3A+a+promising+therapeutic+approach&doi=10.3390%2Fijms18091978"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting heat shock proteins in cancer: a promising therapeutic approach</span></div><div class="casAuthors">Chatterjee, Suman; Burns, Timothy F.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1978/1-1978/39</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Heat shock proteins (HSPs) are a large family of chaperones that are involved in protein folding and maturation of a variety of "client" proteins protecting them from degrdn., oxidative stress, hypoxia, and thermal stress.  Hence, they are significant regulators of cellular proliferation, differentiation and strongly implicated in the mol. orchestration of cancer development and progression as many of their clients are well established oncoproteins in multiple tumor types.  Interestingly, tumor cells are more HSP chaperonage-dependent than normal cells for proliferation and survival because the oncoproteins in cancer cells are often misfolded and require augmented chaperonage activity for correction.  This led to the development of several inhibitors of HSP90 and other HSPs that have shown promise both preclinically and clin. in the treatment of cancer.  In this article, we comprehensively review the roles of some of the important HSPs in cancer, and how targeting them could be efficacious, esp. when traditional cancer therapies fail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK0ySBoTnoS7Vg90H21EOLACvtfcHk0lgl93s5cfKQiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOlsrbM&md5=2822359c852259c99f266ab277e19eee</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fijms18091978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18091978%26sid%3Dliteratum%253Aachs%26aulast%3DChatterjee%26aufirst%3DS.%26aulast%3DBurns%26aufirst%3DT.%2BF.%26atitle%3DTargeting%2520heat%2520shock%2520proteins%2520in%2520cancer%253A%2520a%2520promising%2520therapeutic%2520approach%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1978%26doi%3D10.3390%2Fijms18091978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McLaughlin, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, S. E.</span></span> <span> </span><span class="NLM_article-title">Stimulation of the weak ATPase activity of human hsp90 by a client protein</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>315</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">798</span>, <span class="refDoi"> DOI: 10.1006/jmbi.2001.5245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1006%2Fjmbi.2001.5245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=11812147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD38XntlKrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2002&pages=787-798&author=S.+H.+McLaughlinauthor=H.+W.+Smithauthor=S.+E.+Jackson&title=Stimulation+of+the+weak+ATPase+activity+of+human+hsp90+by+a+client+protein&doi=10.1006%2Fjmbi.2001.5245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of the Weak ATPase Activity of Human Hsp90 by a Client Protein</span></div><div class="casAuthors">McLaughlin, Stephen H.; Smith, Harvey W.; Jackson, Sophie E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-798</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone involved in the folding and assembly of a limited set of "client" proteins, many of which are involved in signal transduction pathways.  In vivo, it is found in complex with addnl. proteins, including the chaperones Hsp70, Hsp40, Hip and Hop (Hsp-interacting and Hsp-organizing proteins, resp.), as well as high mol. mass immunophilins, such as FKBP59, and the small acidic protein p23.  The role of these proteins in Hsp90-mediated assembly processes is poorly understood.  It is known that ATP binding and hydrolysis are essential for Hsp90 function in vivo and in vitro.  Here we show, for the first time, that human Hsp90 has ATPase activity in vitro.  The ATPase activity is characterized using a sensitive assay based on a chem. modified form of the phosphate-binding protein from Escherichia coli.  Human Hsp90 is a very weak ATPase, its activity is significantly lower than that of the yeast homolog, and it has a half-life of ATP hydrolysis of eight minutes at 37°. Using a physiol. substrate of Hsp90, the ligand-binding domain of the glucocorticoid receptor, we show that this "client" protein can stimulate the ATPase activity up to 200-fold.  This effect is highly specific and unfolded or partially folded proteins, which are known to bind to Hsp90, do not affect the ATPase activity.  In addn., the peroxisome proliferator-activated receptor, which is related in both sequence and structure to the glucocorticoid receptor but which does not bind Hsp90, has no observable effect on the ATPase activity.  We establish the effect of the co-chaperones Hop, FKBP59 and p23 on the basal ATPase activity as well as the client protein-stimulated ATPase activity of human Hsp90.  In contrast with the yeast system, human Hop has little effect on the basal rate of ATP hydrolysis but significantly inhibits the client-protein stimulated rate.  Similarly, FKBP59 has little effect on the basal rate but stimulates the client-protein stimulated rate further.  In contrast, p23 inhibits both the basal and stimulated rates of ATP hydrolysis.  Our results show that the ATPase activity of human Hsp90 is highly regulated by both client protein and co-chaperone binding.  We suggest that the rate of ATP hydrolysis is crit. to the mode of action of Hsp90, consistent with results that have shown that both over and under-active ATPase mutants of yeast Hsp90 have impaired function in vivo.  We suggest that the tight regulation of the ATPase activity of Hsp90 is important and allows the client protein to remain bound to Hsp90 for sufficient time for activation to occur.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq24_NNwfowvLVg90H21EOLACvtfcHk0ljqH7X5PXGdAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntlKrtQ%253D%253D&md5=0a506378cd14dc241eb51c564c26ffb0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.2001.5245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.2001.5245%26sid%3Dliteratum%253Aachs%26aulast%3DMcLaughlin%26aufirst%3DS.%2BH.%26aulast%3DSmith%26aufirst%3DH.%2BW.%26aulast%3DJackson%26aufirst%3DS.%2BE.%26atitle%3DStimulation%2520of%2520the%2520weak%2520ATPase%2520activity%2520of%2520human%2520hsp90%2520by%2520a%2520client%2520protein%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D315%26spage%3D787%26epage%3D798%26doi%3D10.1006%2Fjmbi.2001.5245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perret, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. C.</span></span> <span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1021/jm9004708</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.+C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials&doi=10.1021%2Fjm9004708"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0ljqH7X5PXGdAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.%2BC.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17%26doi%3D10.1021%2Fjm9004708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brough, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgognoni, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cansfield, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martins, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prodromou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raynaud, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webb, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span> <span> </span><span class="NLM_article-title">4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">196</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1021/jm701018h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.+M.+Cheungauthor=I.+Collinsauthor=N.+G.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+A.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1021%2Fjm701018h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer</span></div><div class="casAuthors">Brough, Paul A.; Aherne, Wynne; Barril, Xavier; Borgognoni, Jennifer; Boxall, Kathy; Cansfield, Julie E.; Cheung, Kwai-Ming J.; Collins, Ian; Davies, Nicholas G. M.; Drysdale, Martin J.; Dymock, Brian; Eccles, Suzanne A.; Finch, Harry; Fink, Alexandra; Hayes, Angela; Howes, Robert; Hubbard, Roderick E.; James, Karen; Jordan, Allan M.; Lockie, Andrea; Martins, Vanessa; Massey, Andrew; Matthews, Thomas P.; McDonald, Edward; Northfield, Christopher J.; Pearl, Laurence H.; Prodromou, Chrisostomos; Ray, Stuart; Raynaud, Florence I.; Roughley, Stephen D.; Sharp, Swee Y.; Surgenor, Allan; Walmsley, D. Lee; Webb, Paul; Wood, Mike; Workman, Paul; Wright, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">196-218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the Hsp90 [heat shock protein 90] mol. chaperone show considerable promise as potential chemotherapeutic agents for cancer.  The structure-based design, synthesis, structure-activity relationships, and pharmacokinetics of potent small-mol. inhibitors of Hsp90 based on the 4,5-diarylisoxazole scaffold were studied.  Analogs from this series have high affinity for Hsp90, as measured in a fluorescence polarization competitive binding assay, and are active in cancer cell lines where they inhibit proliferation and exhibit a characteristic profile of depletion of oncogenic proteins and concomitant elevation of Hsp72.  The [(morpholinomethyl)phenyl]isoxazolecarboxamide I (VER-52296/NVP-AUY922) is potent in the Hsp90 FP binding assay and inhibits proliferation of various human cancer cell lines in vitro, with GI50 averaging 9 nM.  I is retained in tumors in vivo when administered i.p., as evaluated by cassette dosing in tumor-bearing mice.  In a human colon cancer xenograft model, I inhibits tumor growth by ∼50%.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTNA9AoWb8gLVg90H21EOLACvtfcHk0lhgV4-DH9mT8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWqsL%252FK&md5=fdb98dec600987e862b9b05555427948</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218%26doi%3D10.1021%2Fjm701018h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woodhead, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angove, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosme, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feltell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederickson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMenamin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parra, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trewartha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinkovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, A. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of (2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydrois oindol-2-yl]methanone (AT13387), a novel inhibitor of the molecular chaperone Hsp90 by fragment based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5956</span>– <span class="NLM_lpage">5969</span>, <span class="refDoi"> DOI: 10.1021/jm100060b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100060b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5956-5969&author=A.+J.+Woodheadauthor=H.+Angoveauthor=M.+G.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=J.+E.+Coyleauthor=J.+Cosmeauthor=B.+Grahamauthor=P.+J.+Dayauthor=R.+Downhamauthor=L.+Fazalauthor=R.+Feltellauthor=E.+Figueroaauthor=M.+Fredericksonauthor=J.+Lewisauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=M.+A.+O%E2%80%99Brienauthor=L.+Parraauthor=S.+Patelauthor=T.+Phillipsauthor=D.+C.+Reesauthor=S.+Richauthor=D.+M.+Smithauthor=G.+Trewarthaauthor=M.+Vinkovicauthor=B.+Williamsauthor=A.+J.+Woolford&title=Discovery+of+%282%2C4-dihydroxy-5-isopropylphenyl%29-%5B5-%284-methylpiperazin-1-ylmethyl%29-1%2C3-dihydrois+oindol-2-yl%5Dmethanone+%28AT13387%29%2C+a+novel+inhibitor+of+the+molecular+chaperone+Hsp90+by+fragment+based+drug+design&doi=10.1021%2Fjm100060b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (2,4-Dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone (AT13387), a Novel Inhibitor of the Molecular Chaperone Hsp90 by Fragment Based Drug Design</span></div><div class="casAuthors">Woodhead, Andrew J.; Angove, Hayley; Carr, Maria G.; Chessari, Gianni; Congreve, Miles; Coyle, Joseph E.; Cosme, Jose; Graham, Brent; Day, Philip J.; Downham, Robert; Fazal, Lynsey; Feltell, Ruth; Figueroa, Eva; Frederickson, Martyn; Lewis, Jonathan; McMenamin, Rachel; Murray, Christopher W.; O'Brien, M. Alistair; Parra, Lina; Patel, Sahil; Phillips, Theresa; Rees, David C.; Rich, Sharna; Smith, Donna-Michelle; Trewartha, Gary; Vinkovic, Mladen; Williams, Brian; Woolford, Alison J.-A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5956-5969</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitors of the mol. chaperone heat shock protein 90 (Hsp90) are currently generating significant interest in clin. development as potential treatments for cancer.  In a preceding publication (DOI: 10.1021/jm100059d) we describe Astex's approach to screening fragments against Hsp90 and the subsequent optimization of two hits into leads with inhibitory activities in the low nanomolar range.  This paper describes the structure guided optimization of the 2,4-dihydroxybenzamide lead mol. 1 and details some of the drug discovery strategies employed in the identification of AT13387 (35), which has progressed through preclin. development and is currently being tested in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEEtcgAmkVk7Vg90H21EOLACvtfcHk0lhgV4-DH9mT8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVCitrg%253D&md5=a2d2ac6dd9e9ba4cb89f83c32727a1d8</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm100060b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100060b%26sid%3Dliteratum%253Aachs%26aulast%3DWoodhead%26aufirst%3DA.%2BJ.%26aulast%3DAngove%26aufirst%3DH.%26aulast%3DCarr%26aufirst%3DM.%2BG.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DJ.%2BE.%26aulast%3DCosme%26aufirst%3DJ.%26aulast%3DGraham%26aufirst%3DB.%26aulast%3DDay%26aufirst%3DP.%2BJ.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DFeltell%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DE.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%2BA.%26aulast%3DParra%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DRich%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DTrewartha%26aufirst%3DG.%26aulast%3DVinkovic%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DWoolford%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520%25282%252C4-dihydroxy-5-isopropylphenyl%2529-%255B5-%25284-methylpiperazin-1-ylmethyl%2529-1%252C3-dihydrois%2520oindol-2-yl%255Dmethanone%2520%2528AT13387%2529%252C%2520a%2520novel%2520inhibitor%2520of%2520the%2520molecular%2520chaperone%2520Hsp90%2520by%2520fragment%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5956%26epage%3D5969%26doi%3D10.1021%2Fjm100060b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beswick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fromont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aherne, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boxall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">785</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2004.03.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.chembiol.2004.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=15217611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=775-785&author=L.+Wrightauthor=X.+Barrilauthor=B.+Dymockauthor=L.+Sheridanauthor=A.+Surgenorauthor=M.+Beswickauthor=M.+Drysdaleauthor=A.+Collierauthor=A.+Masseyauthor=N.+Daviesauthor=A.+Finkauthor=C.+Fromontauthor=W.+Aherneauthor=K.+Boxallauthor=S.+Sharpauthor=P.+Workmanauthor=R.+E.+Hubbard&title=Structure-activity+relationships+in+purine-based+inhibitor+binding+to+HSP90+isoforms&doi=10.1016%2Fj.chembiol.2004.03.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships in Purine-Based Inhibitor Binding to HSP90 Isoforms</span></div><div class="casAuthors">Wright, Lisa; Barril, Xavier; Dymock, Brian; Sheridan, Louisa; Surgenor, Allan; Beswick, Mandy; Drysdale, Martin; Collier, Adam; Massey, Andy; Davies, Nick; Fink, Alex; Fromont, Christophe; Aherne, Wynne; Boxall, Kathy; Sharp, Swee; Workman, Paul; Hubbard, Roderick E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-785</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibition of the ATPase activity of the chaperone protein HSP90 is a potential strategy for treatment of cancers.  We have detd. structures of the HSP90α N-terminal domain complexed with the purine-based inhibitor, PU3, and analogs with enhanced potency both in enzyme and cell-based assays.  The compds. induce upregulation of HSP70 and downregulation of the known HSP90 client proteins Raf-1, CDK4, and ErbB2, confirming that the mols. inhibit cell growth by a mechanism dependent on HSP90 inhibition.  We have also detd. the first structure of the N-terminal domain of HSP90β, complexed with PU3.  The structures allow a detailed rationale to be developed for the obsd. affinity of the PU3 class of compds. for HSP90 and also provide a structural framework for design of compds. with improved binding affinity and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Z11Wd4hiXrVg90H21EOLACvtfcHk0ljKVdYrQOfdYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsrs%253D&md5=dd2146dba0f4b3198d5bc7023e645812</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DL.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DSheridan%26aufirst%3DL.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DBeswick%26aufirst%3DM.%26aulast%3DDrysdale%26aufirst%3DM.%26aulast%3DCollier%26aufirst%3DA.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DN.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DFromont%26aufirst%3DC.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26atitle%3DStructure-activity%2520relationships%2520in%2520purine-based%2520inhibitor%2520binding%2520to%2520HSP90%2520isoforms%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D775%26epage%3D785%26doi%3D10.1016%2Fj.chembiol.2004.03.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schopf, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biebl, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchner, J.</span></span> <span> </span><span class="NLM_article-title">The HSP90 chaperone machinery</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">360</span>, <span class="refDoi"> DOI: 10.1038/nrm.2017.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fnrm.2017.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=28429788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsV2mtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=345-360&author=F.+H.+Schopfauthor=M.+M.+Bieblauthor=J.+Buchner&title=The+HSP90+chaperone+machinery&doi=10.1038%2Fnrm.2017.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 chaperone machinery</span></div><div class="casAuthors">Schopf, Florian H.; Biebl, Maximilian M.; Buchner, Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">345-360</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The heat shock protein 90 (HSP90) chaperone machinery is a key regulator of proteostasis under both physiol. and stress conditions in eukaryotic cells.  As HSP90 has several hundred protein substrates (or 'clients'), it is involved in many cellular processes beyond protein folding, which include DNA repair, development, the immune response and neurodegenerative disease.  A large no. of co-chaperones interact with HSP90 and regulate the ATPase-assocd. conformational changes of the HSP90 dimer that occur during the processing of clients.  Recent progress has allowed the interactions of clients with HSP90 and its co-chaperones to be defined.  Owing to the importance of HSP90 in the regulation of many cellular proteins, it has become a promising drug target for the treatment of several diseases, which include cancer and diseases assocd. with protein misfolding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQAAfluC3NbVg90H21EOLACvtfcHk0ljKVdYrQOfdYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsV2mtbw%253D&md5=65931b74cf0a4fb5e60c936177829bd4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrm.2017.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm.2017.20%26sid%3Dliteratum%253Aachs%26aulast%3DSchopf%26aufirst%3DF.%2BH.%26aulast%3DBiebl%26aufirst%3DM.%2BM.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DThe%2520HSP90%2520chaperone%2520machinery%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2017%26volume%3D18%26spage%3D345%26epage%3D360%26doi%3D10.1038%2Fnrm.2017.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span> <span> </span><span class="NLM_article-title">Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">25456</span>– <span class="NLM_lpage">25467</span>, <span class="refDoi"> DOI: 10.1039/C8RA05042B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1039%2FC8RA05042B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlajtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=25456-25467&author=J.+Chenauthor=J.+Wangauthor=F.+Laiauthor=W.+Wangauthor=L.+Pangauthor=W.+Zhu&title=Dynamics+revelation+of+conformational+changes+and+binding+modes+of+heat+shock+protein+90+induced+by+inhibitor+associations&doi=10.1039%2FC8RA05042B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamics revelation of conformational changes and binding modes of heat shock protein 90 induced by inhibitor associations</span></div><div class="casAuthors">Chen, Jianzhong; Wang, Jinan; Lai, Fengbo; Wang, Wei; Pang, Laixue; Zhu, Weiliang</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">25456-25467</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) has been an attractive target of potential drug design for antitumor treatment.  The current work integrates mol. dynamics (MD) simulations, calcns. of binding free energy, and principal component (PC) anal. with scanning of inhibitor-residue interaction to probe the binding modes of inhibitors YK9, YKJ and YKI to Hsp90 and identify the hot spot of the inhibitor-Hsp90 binding.  The results suggest that the introductions of two groups G1 and G2 into YKJ and YKI strengthen the binding ability of YKJ and YKI to Hsp90 compared to YK9.  PC anal. based MD trajectories prove that inhibitor bindings exert significant effects on the conformational changes, internal dynamics and motion modes of Hsp90, esp. for the helix α2 and the loops L1 and L2.  The calcns. of residue-based free energy decompn. and scanning of the inhibitor-Hsp90 interaction suggest that six residues L107, G108, F138, Y139, W162 and F170 construct the common hot spot of the inhibitor-residue interactions.  Moreover the substitutions of the groups G1 and G2 in YKJ and YKI lead to two addnl. hydrogen bonding interactions and multiple hydrophobic interactions for bindings of YKJ and YKI to Hsp90.  This work is also expected to contribute theor. hints for the design of potent inhibitors toward Hsp90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEKKf_Jbr9ELVg90H21EOLACvtfcHk0lgaSEe4aHutKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlajtrjM&md5=f4bde81526802596822e02d6370189d4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1039%2FC8RA05042B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8RA05042B%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DW.%26atitle%3DDynamics%2520revelation%2520of%2520conformational%2520changes%2520and%2520binding%2520modes%2520of%2520heat%2520shock%2520protein%252090%2520induced%2520by%2520inhibitor%2520associations%26jtitle%3DRSC%2520Adv.%26date%3D2018%26volume%3D8%26spage%3D25456%26epage%3D25467%26doi%3D10.1039%2FC8RA05042B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartl, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80203-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2FS0092-8674%2800%2980203-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=9108479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=239-250&author=C.+E.+Stebbinsauthor=A.+A.+Russoauthor=C.+Schneiderauthor=N.+Rosenauthor=F.+U.+Hartlauthor=N.+P.+Pavletich&title=Crystal+structure+of+an+Hsp90-geldanamycin+complex%3A+targeting+of+a+protein+chaperone+by+an+antitumor+agent&doi=10.1016%2FS0092-8674%2800%2980203-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent</span></div><div class="casAuthors">Stebbins, Charles E.; Russo, Alicia A.; Schneider, Christine; Rosen, Neal; Hartl, F. Ulrich; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-250</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Hsp90 chaperone is required for the activation of several families of eukaryotic protein kinases and nuclear hormone receptors, many of which are proto-oncogenic and play a prominent role in cancer.  The geldanamycin antibiotic has antiproliferative and anti-tumor effects, as it binds to Hsp90, inhibits the Hsp90-mediated conformational maturation/refolding reaction, and results in the degrdn. of Hsp90 substrates.  The structure of the geldanamycin-binding domain of Hsp90 (residues 9-232) reveals a pronounced pocket, 15 Å deep. that is highly conserved across species.  Geldanamycin binds inside this pocket, adopting a compact structure similar to that of a polypeptide chain in a turn conformation.  This, and the pocket's similarity to substrate-binding sites, suggest that the pocket binds a portion of the polypeptide substrate and participates in the conformational maturation/refolding reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvnmleAOFITbVg90H21EOLACvtfcHk0lgaSEe4aHutKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXislCitLo%253D&md5=54a56450c509727e070f4db20a9d7b1a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980203-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980203-2%26sid%3Dliteratum%253Aachs%26aulast%3DStebbins%26aufirst%3DC.%2BE.%26aulast%3DRusso%26aufirst%3DA.%2BA.%26aulast%3DSchneider%26aufirst%3DC.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DHartl%26aufirst%3DF.%2BU.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DCrystal%2520structure%2520of%2520an%2520Hsp90-geldanamycin%2520complex%253A%2520targeting%2520of%2520a%2520protein%2520chaperone%2520by%2520an%2520antitumor%2520agent%26jtitle%3DCell%26date%3D1997%26volume%3D89%26spage%3D239%26epage%3D250%26doi%3D10.1016%2FS0092-8674%2800%2980203-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadden, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steed, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barabasz, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Partridge, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freed, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silinski, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barta, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ommen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinkley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pronk, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verleysen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haystead, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. E.</span></span> <span> </span><span class="NLM_article-title">Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">686</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2010.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.chembiol.2010.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=20659681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptleitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=686-694&author=P.+Faddenauthor=K.+H.+Huangauthor=J.+M.+Vealauthor=P.+M.+Steedauthor=A.+F.+Barabaszauthor=B.+Foleyauthor=M.+Huauthor=J.+M.+Partridgeauthor=J.+Riceauthor=A.+Scottauthor=L.+G.+Duboisauthor=T.+A.+Freedauthor=M.+A.+Silinskiauthor=T.+E.+Bartaauthor=P.+F.+Hughesauthor=A.+Ommenauthor=W.+Maauthor=E.+D.+Smithauthor=A.+W.+Spangenbergauthor=J.+Eavesauthor=G.+J.+Hansonauthor=L.+Hinkleyauthor=M.+Jenksauthor=M.+Lewisauthor=J.+Ottoauthor=G.+J.+Pronkauthor=K.+Verleysenauthor=T.+A.+Haysteadauthor=S.+E.+Hall&title=Application+of+chemoproteomics+to+drug+discovery%3A+identification+of+a+clinical+candidate+targeting+hsp90&doi=10.1016%2Fj.chembiol.2010.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Chemoproteomics to Drug Discovery: Identification of a Clinical Candidate Targeting Hsp90</span></div><div class="casAuthors">Fadden, Patrick; Huang, Kenneth H.; Veal, James M.; Steed, Paul M.; Barabasz, Amy F.; Foley, Briana; Hu, Mei; Partridge, Jeffrey M.; Rice, John; Scott, Anisa; Dubois, Laura G.; Freed, Tiffany A.; Rehder Silinski, Melanie A.; Barta, Thomas E.; Hughes, Philip F.; Ommen, Andy; Ma, Wei; Smith, Emilie D.; Woodward Spangenberg, Angela; Eaves, Jeron; Hanson, Gunnar J.; Hinkley, Lindsay; Jenks, Matthew; Lewis, Meredith; Otto, James; Pronk, Gijsbertus J.; Verleysen, Katleen; Haystead, Timothy A.; Hall, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">686-694</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: A chemoproteomics-based drug discovery strategy is presented that utilizes a highly parallel screening platform, encompassing more than 1000 targets, with a focused chem. library prior to target selection.  This chemoproteomics-based process enables a data-driven selection of both the biol. target and chem. hit after the screen is complete.  The methodol. has been exemplified for the purine binding proteome (proteins utilizing ATP, NAD, FAD).  Screening of an 8000 member library yielded over 1500 unique protein-ligand interactions, which included novel hits for the oncol. target Hsp90.  The approach, which also provides broad target selectivity information, was used to drive the identification of a potent and orally active Hsp90 inhibitor, SNX-5422, which is currently in phase 1 clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfemxEaaJVH7Vg90H21EOLACvtfcHk0lhN_0Urw9_VWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptleitL4%253D&md5=68486178a6847516af3fb5417a9b1911</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2010.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2010.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DFadden%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DK.%2BH.%26aulast%3DVeal%26aufirst%3DJ.%2BM.%26aulast%3DSteed%26aufirst%3DP.%2BM.%26aulast%3DBarabasz%26aufirst%3DA.%2BF.%26aulast%3DFoley%26aufirst%3DB.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DPartridge%26aufirst%3DJ.%2BM.%26aulast%3DRice%26aufirst%3DJ.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DL.%2BG.%26aulast%3DFreed%26aufirst%3DT.%2BA.%26aulast%3DSilinski%26aufirst%3DM.%2BA.%26aulast%3DBarta%26aufirst%3DT.%2BE.%26aulast%3DHughes%26aufirst%3DP.%2BF.%26aulast%3DOmmen%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DW.%26aulast%3DSmith%26aufirst%3DE.%2BD.%26aulast%3DSpangenberg%26aufirst%3DA.%2BW.%26aulast%3DEaves%26aufirst%3DJ.%26aulast%3DHanson%26aufirst%3DG.%2BJ.%26aulast%3DHinkley%26aufirst%3DL.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%26aulast%3DOtto%26aufirst%3DJ.%26aulast%3DPronk%26aufirst%3DG.%2BJ.%26aulast%3DVerleysen%26aufirst%3DK.%26aulast%3DHaystead%26aufirst%3DT.%2BA.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DApplication%2520of%2520chemoproteomics%2520to%2520drug%2520discovery%253A%2520identification%2520of%2520a%2520clinical%2520candidate%2520targeting%2520hsp90%26jtitle%3DChem.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D686%26epage%3D694%26doi%3D10.1016%2Fj.chembiol.2010.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Water, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamer, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weichert, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandoval, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundgren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timple, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lough, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boykin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehry, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yun, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harning, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bixler, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snodgrass-Belt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arndt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biamonte, M. A.</span></span> <span> </span><span class="NLM_article-title">EC144 is a potent inhibitor of the heat shock protein 90</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7786</span>– <span class="NLM_lpage">7795</span>, <span class="refDoi"> DOI: 10.1021/jm300810x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300810x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7786-7795&author=J.+Shiauthor=R.+Van+de+Waterauthor=K.+Hongauthor=R.+B.+Lamerauthor=K.+W.+Weichertauthor=C.+M.+Sandovalauthor=S.+R.+Kasibhatlaauthor=M.+F.+Boehmauthor=J.+Chaoauthor=K.+Lundgrenauthor=N.+Timpleauthor=R.+Loughauthor=G.+Ibanezauthor=C.+Boykinauthor=F.+J.+Burrowsauthor=M.+R.+Kehryauthor=T.+J.+Yunauthor=E.+K.+Harningauthor=C.+Ambroseauthor=J.+Thompsonauthor=S.+A.+Bixlerauthor=A.+Dunahauthor=P.+Snodgrass-Beltauthor=J.+Arndtauthor=I.+J.+Enyedyauthor=P.+Liauthor=V.+S.+Hongauthor=A.+McKenzieauthor=M.+A.+Biamonte&title=EC144+is+a+potent+inhibitor+of+the+heat+shock+protein+90&doi=10.1021%2Fjm300810x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">EC144 Is a Potent Inhibitor of the Heat Shock Protein 90</span></div><div class="casAuthors">Shi, Jiandong; Van de Water, Ryan; Hong, Kevin; Lamer, Ryan B.; Weichert, Kenneth W.; Sandoval, Cristina M.; Kasibhatla, Srinivas R.; Boehm, Marcus F.; Chao, Jianhua; Lundgren, Karen; Timple, Noelito; Lough, Rachel; Ibanez, Gerardo; Boykin, Christina; Burrows, Francis J.; Kehry, Marilyn R.; Yun, Theodore J.; Harning, Erin K.; Ambrose, Christine; Thompson, Jeffrey; Bixler, Sarah A.; Dunah, Anthone; Snodgrass-Belt, Pamela; Arndt, Joseph; Enyedy, Istvan J.; Li, Ping; Hong, Victor S.; McKenzie, Andres; Biamonte, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7786-7795</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alkyne 5-(2-amino-4-chloro-7-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-methylpent-4-yn-2-ol (EC144), is a second generation inhibitor of heat shock protein 90 (Hsp90) and is substantially more potent in vitro and in vivo than the first generation inhibitor (BIIB021) that completed phase II clin. trials.  Alkyne (EC144) is more potent than (BIIB021) in an Hsp90α binding assay (IC50 = 1.1 vs. 5.1 nM) as well as in its ability to degrade Her-2 in MCF-7 cells (EC50 = 14 vs. 38 nM).  In a mouse model of gastric tumors (N87), (EC144) stops tumor growth at 5 mg/kg and causes partial tumor regressions at 10 mg/kg (po, qd×5).  Under the same conditions, (BIIB021) stops tumor growth only at 120 mg/kg, and does not induce partial regressions.  Thus, alkyne (EC144) is approx. 20-fold more efficacious than (BIIB021) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRtKyDCD2OLVg90H21EOLACvtfcHk0lj5BsfYF0X-VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12it7%252FE&md5=201153ad61f71af267f1e1ba2ca7c2e7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300810x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300810x%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DK.%26aulast%3DLamer%26aufirst%3DR.%2BB.%26aulast%3DWeichert%26aufirst%3DK.%2BW.%26aulast%3DSandoval%26aufirst%3DC.%2BM.%26aulast%3DKasibhatla%26aufirst%3DS.%2BR.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DTimple%26aufirst%3DN.%26aulast%3DLough%26aufirst%3DR.%26aulast%3DIbanez%26aufirst%3DG.%26aulast%3DBoykin%26aufirst%3DC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26aulast%3DKehry%26aufirst%3DM.%2BR.%26aulast%3DYun%26aufirst%3DT.%2BJ.%26aulast%3DHarning%26aufirst%3DE.%2BK.%26aulast%3DAmbrose%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DBixler%26aufirst%3DS.%2BA.%26aulast%3DDunah%26aufirst%3DA.%26aulast%3DSnodgrass-Belt%26aufirst%3DP.%26aulast%3DArndt%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DMcKenzie%26aufirst%3DA.%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26atitle%3DEC144%2520is%2520a%2520potent%2520inhibitor%2520of%2520the%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7786%26epage%3D7795%26doi%3D10.1021%2Fjm300810x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Altieri, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lian, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Languino, L. R.</span></span> <span> </span><span class="NLM_article-title">TRAP-1, the mitochondrial Hsp90</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1823</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bbamcr.2011.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtV2qs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=767-73&author=D.+C.+Altieriauthor=G.+S.+Steinauthor=J.+B.+Lianauthor=L.+R.+Languino&title=TRAP-1%2C+the+mitochondrial+Hsp90&doi=10.1016%2Fj.bbamcr.2011.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">TRAP-1, the mitochondrial Hsp90</span></div><div class="casAuthors">Altieri, Dario C.; Stein, Gary S.; Lian, Jane B.; Languino, Lucia R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">767-773</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein folding quality control does not occur randomly in cells, but requires the action of specialized mol. chaperones compartmentalized in subcellular microenvironments and organelles.  Fresh exptl. evidence has now linked a mitochondrial-sp. heat Shock Protein-90 (Hsp90) homolog, Tumor Necrosis Factor Receptor-Assocd. Protein-1 (TRAP-1) to pleiotropic signaling circuitries of organelle integrity and cellular homeostasis.  TRAP-1-directed compartmentalized protein folding is broadly exploited in cancer and neurodegenerative diseases, presenting new opportunities for therapeutic intervention in humans.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (Hsp90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN8nsThSefvLVg90H21EOLACvtfcHk0lj5BsfYF0X-VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtV2qs74%253D&md5=3b14ed8cb8c961b07f7513c225d725bf</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DAltieri%26aufirst%3DD.%2BC.%26aulast%3DStein%26aufirst%3DG.%2BS.%26aulast%3DLian%26aufirst%3DJ.%2BB.%26aulast%3DLanguino%26aufirst%3DL.%2BR.%26atitle%3DTRAP-1%252C%2520the%2520mitochondrial%2520Hsp90%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D767%26epage%3D73%26doi%3D10.1016%2Fj.bbamcr.2011.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenbach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiles, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. S.</span></span> <span> </span><span class="NLM_article-title">Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis</span>. <i>Hepatology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">957</span>, <span class="refDoi"> DOI: 10.1002/hep.26711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1002%2Fhep.26711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=24027047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVeltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2014&pages=947-957&author=W.+T.+Chenauthor=C.+C.+Tsengauthor=K.+Pfaffenbachauthor=G.+Kanelauthor=B.+Luoauthor=B.+L.+Stilesauthor=A.+S.+Lee&title=Liver-specific+knockout+of+GRP94+in+mice+disrupts+cell+adhesion%2C+activates+liver+progenitor+cells%2C+and+accelerates+liver+tumorigenesis&doi=10.1002%2Fhep.26711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis</span></div><div class="casAuthors">Chen, Wan-Ting; Tseng, Chun-Chih; Pfaffenbach, Kyle; Kanel, Gary; Luo, Biquan; Stiles, Bangyan L.; Lee, Amy S.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">947-957</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Liver cancer is one of the most common solid tumors, with poor prognosis and high mortality.  Mutation or deletion of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is strongly correlated with human liver cancer.  Glucose-regulated protein 94 (GRP94) is a major endoplasmic reticulum (ER) chaperone protein, but its in vivo function is still emerging.  To study the role of GRP94 in maintaining liver homeostasis and tumor development, we created two liver-specific knockout mouse models with the deletion of Grp94 alone, or in combination with Pten, using the albumin-cre system.  We demonstrated that while deletion of GRP94 in the liver led to hyperproliferation of liver progenitor cells, deletion of both GRP94 and PTEN accelerated development of liver tumors, including both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), suggestive of progenitor cell origin.  Furthermore, at the premalignant stage we obsd. disturbance of cell adhesion proteins and minor liver injury.  When GRP94 was deleted in PTEN-null livers, ERK was selectively activated.  Conclusion: GRP94 is a novel regulator of cell adhesion, liver homeostasis, and tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFKC3nNU6dabVg90H21EOLACvtfcHk0lj5BsfYF0X-VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVeltrc%253D&md5=03684dbe377452c37b1206efb08df044</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fhep.26711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.26711%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26aulast%3DTseng%26aufirst%3DC.%2BC.%26aulast%3DPfaffenbach%26aufirst%3DK.%26aulast%3DKanel%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DStiles%26aufirst%3DB.%2BL.%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DLiver-specific%2520knockout%2520of%2520GRP94%2520in%2520mice%2520disrupts%2520cell%2520adhesion%252C%2520activates%2520liver%2520progenitor%2520cells%252C%2520and%2520accelerates%2520liver%2520tumorigenesis%26jtitle%3DHepatology%26date%3D2014%26volume%3D59%26spage%3D947%26epage%3D957%26doi%3D10.1002%2Fhep.26711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosson, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">6877</span>– <span class="NLM_lpage">6882</span>, <span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+grp94+in+gut+homeostasis+via+chaperoning+canonical+Wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0lib6Koe8GPJmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520Wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurokawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishida, T.</span></span> <span> </span><span class="NLM_article-title">Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1016/j.ejca.2019.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.ejca.2019.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=31536852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsleltrbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2019&pages=29-39&author=T.+Doiauthor=Y.+Kurokawaauthor=A.+Sawakiauthor=Y.+Komatsuauthor=M.+Ozakaauthor=T.+Takahashiauthor=Y.+Naitoauthor=S.+Ohkuboauthor=T.+Nishida&title=Efficacy+and+safety+of+TAS-116%2C+an+oral+inhibitor+of+heat+shock+protein+90%2C+in+patients+with+metastatic+or+unresectable+gastrointestinal+stromal+tumour+refractory+to+imatinib%2C+sunitinib+and+regorafenib%3A+a+phase+II%2C+single-arm+trial&doi=10.1016%2Fj.ejca.2019.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial</span></div><div class="casAuthors">Doi, Toshihiko; Kurokawa, Yukinori; Sawaki, Akira; Komatsu, Yoshito; Ozaka, Masato; Takahashi, Tsuyoshi; Naito, Yoichi; Ohkubo, Shuichi; Nishida, Toshirou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-39</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We evaluated the efficacy and safety of TAS-116, a novel class of an orally active selective inhibitor of heat shock protein 90, in patients with advanced gastrointestinal stromal tumor (GIST) after failure of three or more lines of std. treatment with imatinib, sunitinib and regorafenib.In this single-arm phase II study, patients received 160 mg/day oral TAS-116 for five consecutive days, followed by a 2-day rest.  The primary end-point was centrally assessed progression-free survival (PFS).  The secondary end-points were objective response rate, disease control rate, overall survival (OS), metabolic response rate, safety, pharmacokinetics and pharmacogenomics.Forty-one patients were enrolled in Japan, and 40 patients underwent efficacy and safety evaluation.  At the cut-off date, the median PFS was 4.4 mo (95% confidence interval [CI], 2.8-6.0) and 12-wk progression-free rate was 73.4% (95% CI, 58.1-88.7).  Thirty-four patients (85.0%) had stable disease for ≥ 6 wk.  The median OS was 11.5 mo (95% CI, 7.0-not reached).  All patients experienced at least one treatment-related adverse event (AE), including diarrhoea (80.0%), decreased appetite (45.0%) and increase in blood creatinine level (42.5%).  Grade ≥3 AEs and treatment-related grade ≥3 AEs occurred in 23 (57.5%) and 21 (52.5%) patients, resp.  All AEs resolved after dose modification, and no TAS-116-related AEs led to treatment discontinuation.TAS-116 showed significant activity in advanced GIST refractory to std. treatment.  Further development of TAS-116 is warranted.JapicCTI-163182.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5lbmkeSpxh7Vg90H21EOLACvtfcHk0lib6Koe8GPJmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsleltrbL&md5=1fdb2d9f27376bd4c5f27fb506a9bd7f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2019.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2019.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DY.%26aulast%3DSawaki%26aufirst%3DA.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DOzaka%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DNaito%26aufirst%3DY.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DNishida%26aufirst%3DT.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520TAS-116%252C%2520an%2520oral%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090%252C%2520in%2520patients%2520with%2520metastatic%2520or%2520unresectable%2520gastrointestinal%2520stromal%2520tumour%2520refractory%2520to%2520imatinib%252C%2520sunitinib%2520and%2520regorafenib%253A%2520a%2520phase%2520II%252C%2520single-arm%2520trial%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2019%26volume%3D121%26spage%3D29%26epage%3D39%26doi%3D10.1016%2Fj.ejca.2019.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimomura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujiwara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagitani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horiike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitazono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohyanagi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuboki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawazoe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shitara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohno, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerji, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calleja, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishio, M.</span></span> <span> </span><span class="NLM_article-title">First-in-human phase I study of an oral HSP90 inhibitor, TAS-116, in patients with advanced solid tumors</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-18-0831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1535-7163.MCT-18-0831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=30679388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=531-540&author=A.+Shimomuraauthor=N.+Yamamotoauthor=S.+Kondoauthor=Y.+Fujiwaraauthor=S.+Suzukiauthor=N.+Yanagitaniauthor=A.+Horiikeauthor=S.+Kitazonoauthor=F.+Ohyanagiauthor=T.+Doiauthor=Y.+Kubokiauthor=A.+Kawazoeauthor=K.+Shitaraauthor=I.+Ohnoauthor=U.+Banerjiauthor=R.+Sundarauthor=S.+Ohkuboauthor=E.+M.+Callejaauthor=M.+Nishio&title=First-in-human+phase+I+study+of+an+oral+HSP90+inhibitor%2C+TAS-116%2C+in+patients+with+advanced+solid+tumors&doi=10.1158%2F1535-7163.MCT-18-0831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-human phase I study of an oral HSP90 inhibitor, TAS-116, in patients with advanced solid tumors</span></div><div class="casAuthors">Shimomura, Akihiko; Yamamoto, Noboru; Kondo, Shunsuke; Fujiwara, Yutaka; Suzuki, Shigenobu; Yanagitani, Noriko; Horiike, Atsushi; Kitazono, Satoru; Ohyanagi, Fumiyoshi; Doi, Toshihiko; Kuboki, Yasutoshi; Kawazoe, Akihito; Shitara, Kohei; Ohno, Izumi; Banerji, Udai; Sundar, Raghav; Ohkubo, Shuichi; Calleja, Elizabeth M.; Nishio, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">531-540</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">HSP90 is involved in stability and function of cancer-related proteins.  This study was conducted to define the MTD, safety, pharmacokinetics, pharmacodynamics, and preliminary antitumor efficacy of TAS-116, a novel class, orally available, highly selective inhibitor of HSP90.  Patients with advanced solid tumors received TAS-116 orally once daily (QD, step 1) or every other day (QOD, step 2) in 21-day cycles.  Each step comprised a dose escalation phase to det. MTD and an expansion phase at the MTD.  In the dose escalation phase, an accelerated dose-titrn. design and a "3 + 3" design were used.  Sixty-one patients were enrolled in Japan and the United Kingdom.  MTD was detd. to be 107.5 mg/m2/day for QD, and 210.7 mg/m2/day for QOD.  Eye disorders have been reported with HSP90 inhibitors; however, those obsd. with TAS-116 in the expansion phases were limited to grade 1.  The systemic exposure of TAS-116 increased dose-proportionally with QD and QOD regimens.  Two patients with non-small cell lung cancer and one patient with gastrointestinal stromal tumor (GIST) achieved a confirmed partial response.  TAS-116 had an acceptable safety profile with some antitumor activity, supporting further development of this HSP90 inhibitor.  This is a result from a first-in-human study, in which the HSP90 inhibitor TAS-116 demonstrated preliminary antitumor efficacy in patients with advanced solid tumors, including those with heavily pretreated GIST.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHzu4ZpCONq7Vg90H21EOLACvtfcHk0lgmuGYKRVfj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFGgs7vM&md5=79a9b187f299ee566a7291bf8e19d7ca</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-18-0831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-18-0831%26sid%3Dliteratum%253Aachs%26aulast%3DShimomura%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DYanagitani%26aufirst%3DN.%26aulast%3DHoriike%26aufirst%3DA.%26aulast%3DKitazono%26aufirst%3DS.%26aulast%3DOhyanagi%26aufirst%3DF.%26aulast%3DDoi%26aufirst%3DT.%26aulast%3DKuboki%26aufirst%3DY.%26aulast%3DKawazoe%26aufirst%3DA.%26aulast%3DShitara%26aufirst%3DK.%26aulast%3DOhno%26aufirst%3DI.%26aulast%3DBanerji%26aufirst%3DU.%26aulast%3DSundar%26aufirst%3DR.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DCalleja%26aufirst%3DE.%2BM.%26aulast%3DNishio%26aufirst%3DM.%26atitle%3DFirst-in-human%2520phase%2520I%2520study%2520of%2520an%2520oral%2520HSP90%2520inhibitor%252C%2520TAS-116%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2019%26volume%3D18%26spage%3D531%26epage%3D540%26doi%3D10.1158%2F1535-7163.MCT-18-0831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hitotsumachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanoh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonekura, K.</span></span> <span> </span><span class="NLM_article-title">TAS-116, a highly selective inhibitor of heat shock protein 90alpha and beta, demonstrates potent antitumor activity and minimal ocular toxicity in preclinical models</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1158%2F1535-7163.MCT-14-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=25416789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=14-22&author=S.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=H.+Hitotsumachiauthor=C.+Yoshimuraauthor=M.+Kitadeauthor=A.+Hashimotoauthor=K.+Itoauthor=A.+Gomoriauthor=K.+Takahashiauthor=Y.+Shibataauthor=A.+Kanohauthor=K.+Yonekura&title=TAS-116%2C+a+highly+selective+inhibitor+of+heat+shock+protein+90alpha+and+beta%2C+demonstrates+potent+antitumor+activity+and+minimal+ocular+toxicity+in+preclinical+models&doi=10.1158%2F1535-7163.MCT-14-0219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">TAS-116, a Highly Selective Inhibitor of Heat Shock Protein 90α and β, Demonstrates Potent Antitumor Activity and Minimal Ocular Toxicity in Preclinical Models</span></div><div class="casAuthors">Ohkubo, Shuichi; Kodama, Yasuo; Muraoka, Hiromi; Hitotsumachi, Hiroko; Yoshimura, Chihoko; Kitade, Makoto; Hashimoto, Akihiro; Ito, Kenjiro; Gomori, Akira; Takahashi, Koichi; Shibata, Yoshihiro; Kanoh, Akira; Yonekura, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-22</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The mol. chaperone HSP90 plays a crucial role in cancer cell growth and survival by stabilizing cancer-related proteins.  A no. of HSP90 inhibitors have been developed clin. for cancer therapy; however, potential off-target and/or HSP90-related toxicities have proved problematic.  The 4-(1H-pyrazolo[3,4-b]pyridine-1-yl)benzamide TAS-116 is a selective inhibitor of cytosolic HSP90α and β that does not inhibit HSP90 paralogs such as endoplasmic reticulum GRP94 or mitochondrial TRAP1.  Oral administration of TAS-116 led to tumor shrinkage in human tumor xenograft mouse models accompanied by depletion of multiple HSP90 clients, demonstrating that the inhibition of HSP90α and β alone was sufficient to exert antitumor activity in certain tumor models.  One of the most notable HSP90-related adverse events universally obsd. to differing degrees in the clin. setting is visual disturbance.  A two-week administration of the isoxazole resorcinol NVP-AUY922, an HSP90 inhibitor, caused marked degeneration and disarrangement of the outer nuclear layer of the retina and induced photoreceptor cell death in rats.  In contrast, TAS-116 did not produce detectable photoreceptor injury in rats, probably due to its lower distribution in retinal tissue.  Importantly, in a rat model, the antitumor activity of TAS-116 was accompanied by a higher distribution of the compd. in s.c. xenografted NCI-H1975 non-small cell lung carcinoma tumors than in retina.  Moreover, TAS-116 showed activity against orthotopically transplanted NCI-H1975 lung tumors.  Together, these data suggest that TAS-116 has a potential to maximize antitumor activity while minimizing adverse effects such as visual disturbances that are obsd. with other compds. of this class.  Mol Cancer Ther; 14(1); 14-22. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB25Txc_IcKbVg90H21EOLACvtfcHk0lgiKcYUNP60xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslWgug%253D%253D&md5=3ffdc26a7f0178d4e44413e22c003f77</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0219%26sid%3Dliteratum%253Aachs%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DHitotsumachi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DKitade%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DGomori%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DKanoh%26aufirst%3DA.%26aulast%3DYonekura%26aufirst%3DK.%26atitle%3DTAS-116%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520heat%2520shock%2520protein%252090alpha%2520and%2520beta%252C%2520demonstrates%2520potent%2520antitumor%2520activity%2520and%2520minimal%2520ocular%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26spage%3D14%26epage%3D22%26doi%3D10.1158%2F1535-7163.MCT-14-0219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ernst, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccola, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turnbull, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vought, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamos, D.</span></span> <span> </span><span class="NLM_article-title">Correlation between chemotype-dependent binding conformations of HSP90alpha/beta and isoform selectivity-Implications for the structure-based design of HSP90alpha/beta selective inhibitors for treating neurodegenerative diseases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">204</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bmcl.2013.11.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=24332488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=204-208&author=J.+T.+Ernstauthor=M.+Liuauthor=H.+Zuccolaauthor=T.+Neubertauthor=K.+Beaumontauthor=A.+Turnbullauthor=A.+Kallelauthor=B.+Voughtauthor=D.+Stamos&title=Correlation+between+chemotype-dependent+binding+conformations+of+HSP90alpha%2Fbeta+and+isoform+selectivity-Implications+for+the+structure-based+design+of+HSP90alpha%2Fbeta+selective+inhibitors+for+treating+neurodegenerative+diseases&doi=10.1016%2Fj.bmcl.2013.11.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases</span></div><div class="casAuthors">Ernst, Justin T.; Liu, Michael; Zuccola, Harmon; Neubert, Timothy; Beaumont, Kevin; Turnbull, Amy; Kallel, Adam; Vought, Bryan; Stamos, Dean</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">204-208</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HSP90 continues to be a target of interest for neurodegeneration indications.  Selective knockdown of the HSP90 cytosolic isoforms α and β is sufficient to reduce mutant huntingtin protein levels in vitro.  Chemotype-dependent binding conformations of HSP90α/β appear to strongly influence isoform selectivity.  The rational design of HSP90α/β inhibitors selective vs. the mitochondrial (TRAP1) and endoplasmic reticulum (GRP94) isoforms offers a potential mitigating strategy for mechanism-based toxicities.  Better tolerated HSP90 inhibitors would be attractive for targeting chronic neurodegenerative diseases such as Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq64ZOr5JsRerVg90H21EOLACvtfcHk0lgiKcYUNP60xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOlt7jO&md5=6799a46090ee297d70700f7c42b79f80</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.036%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DJ.%2BT.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZuccola%26aufirst%3DH.%26aulast%3DNeubert%26aufirst%3DT.%26aulast%3DBeaumont%26aufirst%3DK.%26aulast%3DTurnbull%26aufirst%3DA.%26aulast%3DKallel%26aufirst%3DA.%26aulast%3DVought%26aufirst%3DB.%26aulast%3DStamos%26aufirst%3DD.%26atitle%3DCorrelation%2520between%2520chemotype-dependent%2520binding%2520conformations%2520of%2520HSP90alpha%252Fbeta%2520and%2520isoform%2520selectivity-Implications%2520for%2520the%2520structure-based%2520design%2520of%2520HSP90alpha%252Fbeta%2520selective%2520inhibitors%2520for%2520treating%2520neurodegenerative%2520diseases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D204%26epage%3D208%26doi%3D10.1016%2Fj.bmcl.2013.11.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oshiumi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muraoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funabashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 3-Ethyl-4-(3-isopropyl-4-(4-(1-methyl-1 H-pyrazol-4-yl)-1 H-imidazol-1-yl)-1 H-pyrazolo[3,4- b]pyridin-1-yl)benzamide (TAS-116) as a Potent, Selective, and Orally Available HSP90 Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01085</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01085" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGnsLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=531-551&author=T.+Unoauthor=Y.+Kawaiauthor=S.+Yamashitaauthor=H.+Oshiumiauthor=C.+Yoshimuraauthor=T.+Mizutaniauthor=T.+Suzukiauthor=K.+T.+Chongauthor=K.+Shigenoauthor=M.+Ohkuboauthor=Y.+Kodamaauthor=H.+Muraokaauthor=K.+Funabashiauthor=K.+Takahashiauthor=S.+Ohkuboauthor=M.+Kitade&title=Discovery+of+3-Ethyl-4-%283-isopropyl-4-%284-%281-methyl-1+H-pyrazol-4-yl%29-1+H-imidazol-1-yl%29-1+H-pyrazolo%5B3%2C4-+b%5Dpyridin-1-yl%29benzamide+%28TAS-116%29+as+a+Potent%2C+Selective%2C+and+Orally+Available+HSP90+Inhibitor&doi=10.1021%2Facs.jmedchem.8b01085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 3-ethyl-4-(3-isopropyl-4-(4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl)benzamide (TAS-116) as a potent, selective, and orally available HSP90 inhibitor</span></div><div class="casAuthors">Uno, Takao; Kawai, Yuichi; Yamashita, Satoshi; Oshiumi, Hiromi; Yoshimura, Chihoko; Mizutani, Takashi; Suzuki, Tatsuya; Chong, Khoon Tee; Shigeno, Kazuhiko; Ohkubo, Mitsuru; Kodama, Yasuo; Muraoka, Hiromi; Funabashi, Kaoru; Takahashi, Koichi; Ohkubo, Shuichi; Kitade, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">531-551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mol. chaperone heat shock protein 90 (HSP90) is a promising target for cancer therapy, as it assists in the stabilization of cancer-related proteins, promoting cancer cell growth, and survival.  A novel series of HSP90 inhibitors were discovered by structure-activity relationship (SAR)-based optimization of an initial hit compd. having a 4-(4-(quinolin-3-yl)-1H-indol-1-yl)benzamide structure.  The pyrazolo[3,4-b]pyridine deriv., I (TAS-116), is a selective inhibitor of HSP90α and HSP90β among the HSP90 family proteins and exhibits oral availability in mice.  The X-ray cocrystal structure of the I analog II demonstrated a unique binding mode at the N-terminal ATP binding site.  Oral administration of I demonstrated potent antitumor effects in an NCI-H1975 xenograft mouse model without significant body wt. loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBSBSC2j6FrVg90H21EOLACvtfcHk0ljd_jnYGWQUwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGnsLjK&md5=0e7673a985350bd5cb52a1263449a9da</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01085%26sid%3Dliteratum%253Aachs%26aulast%3DUno%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DOshiumi%26aufirst%3DH.%26aulast%3DYoshimura%26aufirst%3DC.%26aulast%3DMizutani%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DChong%26aufirst%3DK.%2BT.%26aulast%3DShigeno%26aufirst%3DK.%26aulast%3DOhkubo%26aufirst%3DM.%26aulast%3DKodama%26aufirst%3DY.%26aulast%3DMuraoka%26aufirst%3DH.%26aulast%3DFunabashi%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DOhkubo%26aufirst%3DS.%26aulast%3DKitade%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25203-Ethyl-4-%25283-isopropyl-4-%25284-%25281-methyl-1%2520H-pyrazol-4-yl%2529-1%2520H-imidazol-1-yl%2529-1%2520H-pyrazolo%255B3%252C4-%2520b%255Dpyridin-1-yl%2529benzamide%2520%2528TAS-116%2529%2520as%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Orally%2520Available%2520HSP90%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D531%26epage%3D551%26doi%3D10.1021%2Facs.jmedchem.8b01085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caaveiro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajihara, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikkawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Incorporation of rapid thermodynamic data in fragment-based drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2155</span>– <span class="NLM_lpage">2159</span>, <span class="refDoi"> DOI: 10.1021/jm301603n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301603n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislOnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2155-2159&author=A.+Kobeauthor=J.+M.+Caaveiroauthor=S.+Tashiroauthor=D.+Kajiharaauthor=M.+Kikkawaauthor=T.+Mitaniauthor=K.+Tsumoto&title=Incorporation+of+rapid+thermodynamic+data+in+fragment-based+drug+discovery&doi=10.1021%2Fjm301603n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Incorporation of Rapid Thermodynamic Data in Fragment-Based Drug Discovery</span></div><div class="casAuthors">Kobe, Akihiro; Caaveiro, Jose M. M.; Tashiro, Shinya; Kajihara, Daisuke; Kikkawa, Masato; Mitani, Tomoya; Tsumoto, Kouhei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2155-2159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based drug discovery (FBDD) has enjoyed increasing popularity in recent years.  We introduce SITE (single-injection thermal extinction), a novel thermodn. methodol. that selects high-quality hits early in FBDD.  SITE is a fast calorimetric competitive assay suitable for automation that captures the essence of isothermal titrn. calorimetry but using significantly fewer resources.  We describe the principles of SITE and identify a novel family of fragment inhibitors of the enzyme ketosteroid isomerase displaying high values of enthalpic efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq38swGDujGtrVg90H21EOLACvtfcHk0ljd_jnYGWQUwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislOnsb8%253D&md5=c87d21b6629d0f1b482f0e79d54ab2fc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm301603n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301603n%26sid%3Dliteratum%253Aachs%26aulast%3DKobe%26aufirst%3DA.%26aulast%3DCaaveiro%26aufirst%3DJ.%2BM.%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DKajihara%26aufirst%3DD.%26aulast%3DKikkawa%26aufirst%3DM.%26aulast%3DMitani%26aufirst%3DT.%26aulast%3DTsumoto%26aufirst%3DK.%26atitle%3DIncorporation%2520of%2520rapid%2520thermodynamic%2520data%2520in%2520fragment-based%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2155%26epage%3D2159%26doi%3D10.1021%2Fjm301603n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chigira, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyafusa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caaveiro, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">15337</span>, <span class="refDoi"> DOI: 10.1038/srep15337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fsrep15337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=26471247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ylurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=15337&author=K.+Nakanoauthor=T.+Chigiraauthor=T.+Miyafusaauthor=S.+Nagatoishiauthor=J.+M.+Caaveiroauthor=K.+Tsumoto&title=Discovery+and+characterization+of+natural+tropolones+as+inhibitors+of+the+antibacterial+target+CapF+from+Staphylococcus+aureus&doi=10.1038%2Fsrep15337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of natural tropolones as inhibitors of the antibacterial target CapF from Staphylococcus aureus</span></div><div class="casAuthors">Nakano, Koichiro; Chigira, Takeru; Miyafusa, Takamitsu; Nagatoishi, Satoru; Caaveiro, Jose M. M.; Tsumoto, Kouhei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15337</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The rapid spread of antibiotic-resistance among pathogenic bacteria poses a serious risk for public health.  The search for novel therapeutic strategies and antimicrobial compds. is needed to ameliorate this menace.  The bifunctional metalloenzyme CapF is an antibacterial target produced by certain pathogenic bacteria essential in the biosynthetic route of capsular polysaccharide, a mucous layer on the surface of bacterium that facilitates immune evasion and infection.  The authors report the first inhibitor of CapF from Staphylococcus aureus that was identified by employing fragment-based methodologies.  The hit compd. 3-isopropenyl-tropolone inhibits the first reaction catalyzed by CapF, disrupting the synthesis of a key precursor of capsular polysaccharide.  Isothermal titrn. calorimetry demonstrates that 3-isopropenyl-tropolone binds tightly (KD = 27 ± 7 μM) to the cupin domain of CapF.  In addn., the crystal structure of the enzyme-inhibitor complex shows that the compd. engages the essential Zn2+ ion necessary for the first reaction catalyzed by the enzyme, explaining its inhibitory effect.  Moreover, the tropolone compd. alters the coordination sphere of the metal, leading to the overall destabilization of the enzyme.  The authors propose 3-isopropenyl-tropolone as a precursor to develop stronger inhibitors for this family of enzymes to impair the synthesis of capsular polysaccharide in Staphylococcus aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNaUw71IAPvbVg90H21EOLACvtfcHk0lh41tjcXIbhyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ylurzN&md5=fbbe52935544d25e73996945a78b8b6b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsrep15337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep15337%26sid%3Dliteratum%253Aachs%26aulast%3DNakano%26aufirst%3DK.%26aulast%3DChigira%26aufirst%3DT.%26aulast%3DMiyafusa%26aufirst%3DT.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DCaaveiro%26aufirst%3DJ.%2BM.%26aulast%3DTsumoto%26aufirst%3DK.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520natural%2520tropolones%2520as%2520inhibitors%2520of%2520the%2520antibacterial%2520target%2520CapF%2520from%2520Staphylococcus%2520aureus%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D15337%26doi%3D10.1038%2Fsrep15337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mochidome, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugihara, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakusagi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sando, S.</span></span> <span> </span><span class="NLM_article-title">Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">876</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-08833-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fs41467-019-08833-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=30787298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A280%3ADC%252BB3cflslOkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=876&author=H.+Nonakaauthor=Y.+Nakanishiauthor=S.+Kunoauthor=T.+Otaauthor=K.+Mochidomeauthor=Y.+Saitoauthor=F.+Sugiharaauthor=Y.+Takakusagiauthor=I.+Aokiauthor=S.+Nagatoishiauthor=K.+Tsumotoauthor=S.+Sando&title=Design+strategy+for+serine+hydroxymethyltransferase+probes+based+on+retro-aldol-type+reaction&doi=10.1038%2Fs41467-019-08833-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Design strategy for serine hydroxymethyltransferase probes based on retro-aldol-type reaction</span></div><div class="casAuthors">Nonaka Hiroshi; Nakanishi Yuki; Kuno Satoshi; Ota Tomoki; Mochidome Kentaro; Saito Yutaro; Sando Shinsuke; Sugihara Fuminori; Takakusagi Yoichi; Aoki Ichio; Takakusagi Yoichi; Aoki Ichio; Nagatoishi Satoru; Tsumoto Kouhei; Nagatoishi Satoru; Tsumoto Kouhei; Sando Shinsuke</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">876</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Serine hydroxymethyltransferase (SHMT) is an enzyme that catalyzes the reaction that converts serine to glycine.  It plays an important role in one-carbon metabolism.  Recently, SHMT has been shown to be associated with various diseases.  Therefore, SHMT has attracted attention as a biomarker and drug target.  However, the development of molecular probes responsive to SHMT has not yet been realized.  This is because SHMT catalyzes an essential yet simple reaction; thus, the substrates that can be accepted into the active site of SHMT are limited.  Here, we focus on the SHMT-catalyzed retro-aldol reaction rather than the canonical serine-glycine conversion and succeed in developing fluorescent and (19)F NMR molecular probes.  Taking advantage of the facile and direct detection of SHMT, the developed fluorescent probe is used in the high-throughput screening for human SHMT inhibitors, and two hit compounds are obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSF_WgJkdtmgzAEfvC7EH1LfW6udTcc2eZTCYc1w6Hlprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cflslOkug%253D%253D&md5=06891eb7a710a3919a09c4757fea35a5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-08833-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-08833-7%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DS.%26aulast%3DOta%26aufirst%3DT.%26aulast%3DMochidome%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DSugihara%26aufirst%3DF.%26aulast%3DTakakusagi%26aufirst%3DY.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DTsumoto%26aufirst%3DK.%26aulast%3DSando%26aufirst%3DS.%26atitle%3DDesign%2520strategy%2520for%2520serine%2520hydroxymethyltransferase%2520probes%2520based%2520on%2520retro-aldol-type%2520reaction%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D876%26doi%3D10.1038%2Fs41467-019-08833-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tashiro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caaveiro, J. M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakakido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoang, Q. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of inhibitors of the Parkinson’s disease associated protein DJ-1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">2783</span>– <span class="NLM_lpage">2793</span>, <span class="refDoi"> DOI: 10.1021/acschembio.8b00701</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.8b00701" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVWitbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=2783-2793&author=S.+Tashiroauthor=J.+M.+M.+Caaveiroauthor=M.+Nakakidoauthor=A.+Tanabeauthor=S.+Nagatoishiauthor=Y.+Tamuraauthor=N.+Matsudaauthor=D.+Liuauthor=Q.+Q.+Hoangauthor=K.+Tsumoto&title=Discovery+and+optimization+of+inhibitors+of+the+Parkinson%E2%80%99s+disease+associated+protein+DJ-1&doi=10.1021%2Facschembio.8b00701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Inhibitors of the Parkinson's Disease Associated Protein DJ-1</span></div><div class="casAuthors">Tashiro, Shinya; Caaveiro, Jose M. M.; Nakakido, Makoto; Tanabe, Aki; Nagatoishi, Satoru; Tamura, Yasushi; Matsuda, Noriyuki; Liu, Dali; Hoang, Quyen Q.; Tsumoto, Kouhei</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2783-2793</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DJ-1 is a Parkinson's disease assocd. protein endowed with enzymic, redox sensing, regulatory, chaperoning, and neuroprotective activities.  Although DJ-1 has been vigorously studied for the past decade and a half, its exact role in the progression of the disease remains uncertain.  In addn., little is known about the spatiotemporal regulation of DJ-1, or the biochem. basis explaining its numerous biol. functions.  Progress has been hampered by the lack of inhibitors with precisely known mechanisms of action.  Herein, we have employed biophys. methodologies and X-ray crystallog. to identify and to optimize a family of compds. inactivating the crit. Cys106 residue of human DJ-1.  We demonstrate these compds. are potent inhibitors of various activities of DJ-1 in vitro and in cell-based assays.  This study reports a new family of DJ-1 inhibitors with a defined mechanism of action, and contributes toward the understanding of the biol. function of DJ-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIpuF6tAj7_LVg90H21EOLACvtfcHk0lgpYnMmlbgIhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWitbrL&md5=b7325ba7c546acd7ad8db1827228c82a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facschembio.8b00701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.8b00701%26sid%3Dliteratum%253Aachs%26aulast%3DTashiro%26aufirst%3DS.%26aulast%3DCaaveiro%26aufirst%3DJ.%2BM.%2BM.%26aulast%3DNakakido%26aufirst%3DM.%26aulast%3DTanabe%26aufirst%3DA.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DTamura%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHoang%26aufirst%3DQ.%2BQ.%26aulast%3DTsumoto%26aufirst%3DK.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520inhibitors%2520of%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520associated%2520protein%2520DJ-1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D2783%26epage%3D2793%26doi%3D10.1021%2Facschembio.8b00701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vallee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilorge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamberton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrebola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerif, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohaut, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Certal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruxer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouyon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delorme, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jouanen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grepin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combeau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulaouic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dereu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikol, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailliet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minoux, H.</span></span> <span> </span><span class="NLM_article-title">Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7206</span>– <span class="NLM_lpage">7219</span>, <span class="refDoi"> DOI: 10.1021/jm200784m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200784m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7206-7219&author=F.+Valleeauthor=C.+Carrezauthor=F.+Pilorgeauthor=A.+Dupuyauthor=A.+Parentauthor=L.+Bertinauthor=F.+Thompsonauthor=P.+Ferrariauthor=F.+Fassyauthor=A.+Lambertonauthor=A.+Thomasauthor=R.+Arrebolaauthor=S.+Guerifauthor=A.+Rohautauthor=V.+Certalauthor=J.+M.+Ruxerauthor=T.+Gouyonauthor=C.+Delormeauthor=A.+Jouanenauthor=J.+Dumasauthor=C.+Grepinauthor=C.+Combeauauthor=H.+Goulaouicauthor=N.+Dereuauthor=V.+Mikolauthor=P.+Maillietauthor=H.+Minoux&title=Tricyclic+series+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+part+I%3A+discovery+of+tricyclic+imidazo%5B4%2C5-c%5Dpyridines+as+potent+inhibitors+of+the+Hsp90+molecular+chaperone&doi=10.1021%2Fjm200784m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5-c]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone</span></div><div class="casAuthors">Vallee, Francois; Carrez, Chantal; Pilorge, Fabienne; Dupuy, Alain; Parent, Annick; Bertin, Luc; Thompson, Fabienne; Ferrari, Paul; Fassy, Florence; Lamberton, Annabelle; Thomas, Anne; Arrebola, Rosalia; Guerif, Stephane; Rohaut, Alexandre; Certal, Victor; Ruxer, Jean-Marie; Gouyon, Thierry; Delorme, Cecile; Jouanen, Alain; Dumas, Jacques; Grepin, Claudine; Combeau, Cecile; Goulaouic, Helene; Dereu, Norbert; Mikol, Vincent; Mailliet, Patrick; Minoux, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7206-7219</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel class of heat shock protein 90 (Hsp90) inhibitors was developed after a low throughput screen (LTS) of a focused library contg. approx. 21K compds. selected by virtual screening.  The initial [1-{3-H-imidazo[4-5-c]pyridin-2-yl}-3,4-dihydro-2H-pyrido[2,1-a]isoindole-6-one] (1) compd. showed moderate activity (IC50 = 7.6 μM on Hsp82, the yeast homolog of Hsp90).  A high-resoln. X-ray structure shows that compd. 1 binds into an "induced" hydrophobic pocket, 10-15 Å away from the ATP/resorcinol binding site.  Iterative cycles of structure-based drug design (SBDD) and chem. synthesis led to the design and prepn. of analogs with improved affinity.  These optimized mols. make productive interactions within the ATP binding site as reported by other Hsp90 inhibitors.  This resulted in compd. 8 (I), which is a highly potent inhibitor in biochem. and cellular assays (Kd = 0.35 nM on Hsp90; IC50 = 30 nM on SKBr3 mammary carcinoma cells) and in an in vivo leukemia model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkJP_-jKMFXLVg90H21EOLACvtfcHk0lilb4H7Qq-EcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OnsbnE&md5=59dcceed7dc283fcc4c116c3616865f8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm200784m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200784m%26sid%3Dliteratum%253Aachs%26aulast%3DVallee%26aufirst%3DF.%26aulast%3DCarrez%26aufirst%3DC.%26aulast%3DPilorge%26aufirst%3DF.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DParent%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DF.%26aulast%3DFerrari%26aufirst%3DP.%26aulast%3DFassy%26aufirst%3DF.%26aulast%3DLamberton%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DArrebola%26aufirst%3DR.%26aulast%3DGuerif%26aufirst%3DS.%26aulast%3DRohaut%26aufirst%3DA.%26aulast%3DCertal%26aufirst%3DV.%26aulast%3DRuxer%26aufirst%3DJ.%2BM.%26aulast%3DGouyon%26aufirst%3DT.%26aulast%3DDelorme%26aufirst%3DC.%26aulast%3DJouanen%26aufirst%3DA.%26aulast%3DDumas%26aufirst%3DJ.%26aulast%3DGrepin%26aufirst%3DC.%26aulast%3DCombeau%26aufirst%3DC.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DDereu%26aufirst%3DN.%26aulast%3DMikol%26aufirst%3DV.%26aulast%3DMailliet%26aufirst%3DP.%26aulast%3DMinoux%26aufirst%3DH.%26atitle%3DTricyclic%2520series%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520part%2520I%253A%2520discovery%2520of%2520tricyclic%2520imidazo%255B4%252C5-c%255Dpyridines%2520as%2520potent%2520inhibitors%2520of%2520the%2520Hsp90%2520molecular%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7206%26epage%3D7219%26doi%3D10.1021%2Fjm200784m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amaral, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokh, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegener, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggenweiler, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirrenberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frech, M.</span></span> <span> </span><span class="NLM_article-title">Protein conformational flexibility modulates kinetics and thermodynamics of drug binding</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2276</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02258-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1038%2Fs41467-017-02258-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=29273709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A280%3ADC%252BC1Mzksleqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2276&author=M.+Amaralauthor=D.+B.+Kokhauthor=J.+Bomkeauthor=A.+Wegenerauthor=H.+P.+Buchstallerauthor=H.+M.+Eggenweilerauthor=P.+Matiasauthor=C.+Sirrenbergauthor=R.+C.+Wadeauthor=M.+Frech&title=Protein+conformational+flexibility+modulates+kinetics+and+thermodynamics+of+drug+binding&doi=10.1038%2Fs41467-017-02258-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Protein conformational flexibility modulates kinetics and thermodynamics of drug binding</span></div><div class="casAuthors">Amaral M; Matias P; Amaral M; Wegener A; Frech M; Amaral M; Kokh D B; Wade R C; Bomke J; Buchstaller H P; Eggenweiler H M; Matias P; Sirrenberg C; Wade R C; Wade R C</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2276</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based drug design has often been restricted by the rather static picture of protein-ligand complexes presented by crystal structures, despite the widely accepted importance of protein flexibility in biomolecular recognition.  Here we report a detailed experimental and computational study of the drug target, human heat shock protein 90, to explore the contribution of protein dynamics to the binding thermodynamics and kinetics of drug-like compounds.  We observe that their binding properties depend on whether the protein has a loop or a helical conformation in the binding site of the ligand-bound state.  Compounds bound to the helical conformation display slow association and dissociation rates, high-affinity and high cellular efficacy, and predominantly entropically driven binding.  An important entropic contribution comes from the greater flexibility of the helical relative to the loop conformation in the ligand-bound state.  This unusual mechanism suggests increasing target flexibility in the bound state by ligand design as a new strategy for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLPI8jjKBQEQvupmecNw_lfW6udTcc2eYCDwDT-8UyDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mzksleqsg%253D%253D&md5=2ccf76a6569363af27b6f27cb1be5b7a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02258-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02258-w%26sid%3Dliteratum%253Aachs%26aulast%3DAmaral%26aufirst%3DM.%26aulast%3DKokh%26aufirst%3DD.%2BB.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DWegener%26aufirst%3DA.%26aulast%3DBuchstaller%26aufirst%3DH.%2BP.%26aulast%3DEggenweiler%26aufirst%3DH.%2BM.%26aulast%3DMatias%26aufirst%3DP.%26aulast%3DSirrenberg%26aufirst%3DC.%26aulast%3DWade%26aufirst%3DR.%2BC.%26aulast%3DFrech%26aufirst%3DM.%26atitle%3DProtein%2520conformational%2520flexibility%2520modulates%2520kinetics%2520and%2520thermodynamics%2520of%2520drug%2520binding%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D2276%26doi%3D10.1038%2Fs41467-017-02258-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBean, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dushin, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boschelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, J. I.</span></span> <span> </span><span class="NLM_article-title">Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3627</span>– <span class="NLM_lpage">3631</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bmcl.2011.04.102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=21605975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntFKhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3627-3631&author=C.+W.+Zapfauthor=J.+D.+Bloomauthor=J.+L.+McBeanauthor=R.+G.+Dushinauthor=J.+M.+Golasauthor=H.+Liuauthor=J.+Lucasauthor=F.+Boschelliauthor=E.+Voganauthor=J.+I.+Levin&title=Discovery+of+a+macrocyclic+o-aminobenzamide+Hsp90+inhibitor+with+heterocyclic+tether+that+shows+extended+biomarker+activity+and+in+vivo+efficacy+in+a+mouse+xenograft+model&doi=10.1016%2Fj.bmcl.2011.04.102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a macrocyclic o-aminobenzamide Hsp90 inhibitor with heterocyclic tether that shows extended biomarker activity and in vivo efficacy in a mouse xenograft model</span></div><div class="casAuthors">Zapf, Christoph W.; Bloom, Jonathan D.; McBean, Jamie L.; Dushin, Russell G.; Golas, Jennifer M.; Liu, Hao; Lucas, Judy; Boschelli, Frank; Vogan, Erik; Levin, Jeremy I.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3627-3631</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel series of macrocyclic ortho-aminobenzamide Hsp90 inhibitors is reported.  In continuation of our research, heterocycle-contg. tethers were explored with the intent to further improve potency and minimize hERG liabilities.  This effort culminated in the discovery of compd. 10, which efficiently suppressed proliferation of HCT116 and U87 cells.  This compd. showed prolonged Hsp90-inhibitory activity at least 24 h post-administration consistent with elevated and prolonged exposure in the tumor.  When studied in a xenograft model, the compd. demonstrated significant suppression of tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRrrpG_p0G7Vg90H21EOLACvtfcHk0ljMHNZLUhG7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntFKhs70%253D&md5=4afc55549e0cd2aa83ce0a89af81fae5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.102%26sid%3Dliteratum%253Aachs%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DBloom%26aufirst%3DJ.%2BD.%26aulast%3DMcBean%26aufirst%3DJ.%2BL.%26aulast%3DDushin%26aufirst%3DR.%2BG.%26aulast%3DGolas%26aufirst%3DJ.%2BM.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DBoschelli%26aufirst%3DF.%26aulast%3DVogan%26aufirst%3DE.%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26atitle%3DDiscovery%2520of%2520a%2520macrocyclic%2520o-aminobenzamide%2520Hsp90%2520inhibitor%2520with%2520heterocyclic%2520tether%2520that%2520shows%2520extended%2520biomarker%2520activity%2520and%2520in%2520vivo%2520efficacy%2520in%2520a%2520mouse%2520xenograft%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3627%26epage%3D3631%26doi%3D10.1016%2Fj.bmcl.2011.04.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">238</span>, <span class="refDoi"> DOI: 10.3892/or.2014.3552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.3892%2For.2014.3552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=25334086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC2MXksVyisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=230-238&author=X.+Wangauthor=S.+Wangauthor=Y.+Liuauthor=D.+Huangauthor=K.+Zhengauthor=Y.+Zhangauthor=X.+Wangauthor=Q.+Liuauthor=D.+Yangauthor=Y.+Wang&title=Comparative+effects+of+SNX-7081+and+SNX-2112+on+cell+cycle%2C+apoptosis+and+Hsp90+client+proteins+in+human+cancer+cells&doi=10.3892%2For.2014.3552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells</span></div><div class="casAuthors">Wang, Xiao; Wang, Shaoxiang; Liu, Yuting; Huang, Dane; Zheng, Kai; Zhang, Yi; Wang, Xiaoyan; Liu, Qiuying; Yang, Depo; Wang, Yifei</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-238</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">SNX-2112, a novel 2-aminobenzamide inhibitor of Hsp90, previously showed a broad spectrum of anticancer activity.  However, subsequent development has been discontinued due to ocular toxicity as identified in a phase I study.  SNX-7081, another closely related Hsp90 inhibitor with a side chain of indole instead of indazole, has recently attracted attention.  The aim of the present study was to investigate the anticancer effects of SNX-7081 in eleven cell lines, as well as the mechanisms involved, with SNX-2112 serving as a ref.  The cytotoxic effects were detd. using an MTT assay and apoptosis was measured using flow cytometry.  The results showed that SNX-7081 exerted better inhibitory effects than SNX-2112 in six eighths of the human cancer cell lines, with an av. IC50 of 1 μM.  The two inhibitors exerted low cytotoxicity in L-02, HDF and MRC5 normal human cells (IC50 >50 μM), and arrested cancer cells at the G2/M phase in a similar manner to normal cells.  Compared with SNX-2112, SNX-7081 exhibited more potent effects on cell apoptosis in four sixths of the human cancer cell lines, and was more active in the downregulation of Hsp90 client proteins.  In addn., SNX-7081 exhibited a stronger binding affinity to Hsp90 than SNX-2112 in mol. docking expts.  Considering the superior effects against Hsp90 affinity, cell growth, apoptosis, and Hsp90 client proteins in a majority of human cancer cells, the novel SNX-7081 may be a promising alternative to SNX-2112, which merits further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodmOB3wdORxbVg90H21EOLACvtfcHk0ljMHNZLUhG7jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXksVyisr4%253D&md5=7b22276e7bea0d14e5afac658851e374</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3892%2For.2014.3552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2014.3552%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DComparative%2520effects%2520of%2520SNX-7081%2520and%2520SNX-2112%2520on%2520cell%2520cycle%252C%2520apoptosis%2520and%2520Hsp90%2520client%2520proteins%2520in%2520human%2520cancer%2520cells%26jtitle%3DOncol.%2520Rep.%26date%3D2015%26volume%3D33%26spage%3D230%26epage%3D238%26doi%3D10.3892%2For.2014.3552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banipal, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banipal, P. K.</span></span> <span> </span><span class="NLM_article-title">Binding studies of caffeine and theophylline to bovine serum albumin: Calorimetric and spectroscopic approach</span>. <i>J. Mol. Liq.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">1048</span>– <span class="NLM_lpage">1055</span>, <span class="refDoi"> DOI: 10.1016/j.molliq.2016.09.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.molliq.2016.09.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFenu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2016&pages=1048-1055&author=T.+S.+Banipalauthor=N.+Kaurauthor=P.+K.+Banipal&title=Binding+studies+of+caffeine+and+theophylline+to+bovine+serum+albumin%3A+Calorimetric+and+spectroscopic+approach&doi=10.1016%2Fj.molliq.2016.09.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Binding studies of caffeine and theophylline to bovine serum albumin: Calorimetric and spectroscopic approach</span></div><div class="casAuthors">Banipal, Tarlok S.; Kaur, Navalpreet; Banipal, Parampaul K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Liquids</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1048-1055</span>CODEN:
                <span class="NLM_cas:coden">JMLIDT</span>;
        ISSN:<span class="NLM_cas:issn">0167-7322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Binding studies of pharmacol. active drugs-caffeine and theophylline to bovine serum albumin (BSA) in phosphate buffer soln., pH = 7.4 have been investigated using spectroscopic (UV-visible, fluorescence and NMR) and calorimetric (isothermal titrn. calorimetry) techniques.  The derived parameters obtained from all the techniques suggest that the magnitude of binding affinity of BSA-drug follows the order: theophylline > caffeine, which may be attributed to greater acidity of former at physiol. pH.  UV-visible and fluorescence spectroscopy suggests 1:1 stoichiometry of drug-protein interactions, while calorimetric results support two binding sites.  Apart from the tryptophan binding site, a low affinity site also exists which is assessed from the calorimetric measurements.  The neg. enthalpy and pos. entropy, both favors the binding process, and the feasibility of binding is also supported by neg. value of Gibbs free energy.  The pos. heat capacity, consistent with the pos. entropy, may be attributed to the exposure of hydrophobic protein surfaces.  The obsd. pos. changes in chem. shifts, Δ δ may be due to the deshielding of drug protons owing to hydrophilic-ionic/hydrogen bonding interactions with BSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFd7k6XHNNGLVg90H21EOLACvtfcHk0licpEzI0GKNVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFenu73N&md5=afa5be62581ed77786799020786d09ee</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.molliq.2016.09.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molliq.2016.09.034%26sid%3Dliteratum%253Aachs%26aulast%3DBanipal%26aufirst%3DT.%2BS.%26aulast%3DKaur%26aufirst%3DN.%26aulast%3DBanipal%26aufirst%3DP.%2BK.%26atitle%3DBinding%2520studies%2520of%2520caffeine%2520and%2520theophylline%2520to%2520bovine%2520serum%2520albumin%253A%2520Calorimetric%2520and%2520spectroscopic%2520approach%26jtitle%3DJ.%2520Mol.%2520Liq.%26date%3D2016%26volume%3D223%26spage%3D1048%26epage%3D1055%26doi%3D10.1016%2Fj.molliq.2016.09.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kandeel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh-Hashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitade, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase</span>. <i>J. Therm. Anal. Calorim.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">2089</span>– <span class="NLM_lpage">2097</span>, <span class="refDoi"> DOI: 10.1007/s10973-013-3319-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1007%2Fs10973-013-3319-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyjtL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2014&pages=2089-2097&author=M.+Kandeelauthor=Y.+Noguchiauthor=K.+Oh-Hashiauthor=H.-S.+Kimauthor=Y.+Kitade&title=Molecular+dynamics+and+energetic+perceptions+of+substrate+recognition+by+thymidylate+kinase&doi=10.1007%2Fs10973-013-3319-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics and energetic perceptions of substrate recognition by thymidylate kinase</span></div><div class="casAuthors">Kandeel, Mahmoud; Noguchi, Yoshihiro; Oh-Hashi, Kentaro; Kim, Hye-Sook; Kitade, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thermal Analysis and Calorimetry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2089-2097</span>CODEN:
                <span class="NLM_cas:coden">JTACF7</span>;
        ISSN:<span class="NLM_cas:issn">1388-6150</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Plasmodium deoxyguanylate pathways are an attractive area of investigation for future metabolic and drug discovery studies due to their unusual substrate specificities.  We investigated the energetic contribution to thymidylate kinase substrate binding, and the forces underlying ligand recognition.  The binding const. varied from 8 × 104 M-1 at 290 K to 6 × 104 M-1 at 310 K for dGMP, and from 16 × 104 M-1 at 290 K to 4 × 104 M-1 at 310 K for TMP.  ΔCp was estd. as -1.75 kJ mol-1 K-1 for TMP and +2 kJ mol-1 K-1 for dGMP.  In comparison with TMP, the binding of dGMP to PfTMK produced less favorable enthalpy change, pos. or favorable entropic contribution at lower temp., pos. heat capacity change, neg. ΔS°HE·, pos. ΔSother, higher total solvent-exposed surface area and more or less rigid body binding.  These changes indicate unfavorable conditions for proper binding and lower conformational changes, and suboptimal structural reordering during dGMP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG1u76B8BqnLVg90H21EOLACvtfcHk0licpEzI0GKNVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyjtL%252FI&md5=eeb7c2d75d27b1c873f92819d92624b3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs10973-013-3319-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10973-013-3319-5%26sid%3Dliteratum%253Aachs%26aulast%3DKandeel%26aufirst%3DM.%26aulast%3DNoguchi%26aufirst%3DY.%26aulast%3DOh-Hashi%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DH.-S.%26aulast%3DKitade%26aufirst%3DY.%26atitle%3DMolecular%2520dynamics%2520and%2520energetic%2520perceptions%2520of%2520substrate%2520recognition%2520by%2520thymidylate%2520kinase%26jtitle%3DJ.%2520Therm.%2520Anal.%2520Calorim.%26date%3D2014%26volume%3D115%26spage%3D2089%26epage%3D2097%26doi%3D10.1007%2Fs10973-013-3319-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duerfeldt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maynard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eletto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostrovsky, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinogle, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argon, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicchitta, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, B. S.</span></span> <span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">9796</span>– <span class="NLM_lpage">9804</span>, <span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0li_j1X22w4cjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bussenius, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazey, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anand, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcalas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baik, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowles, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhr, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costanzo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFina, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubenko, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuer, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lougheed, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manalo, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoll, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Womble, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5396</span>– <span class="NLM_lpage">5404</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.bmcl.2012.07.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22877636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5396-5404&author=J.+Busseniusauthor=C.+M.+Blazeyauthor=N.+Aayauthor=N.+K.+Anandauthor=A.+Arcalasauthor=T.+Baikauthor=O.+J.+Bowlesauthor=C.+A.+Buhrauthor=S.+Costanzoauthor=J.+K.+Curtisauthor=S.+C.+DeFinaauthor=L.+Dubenkoauthor=T.+S.+Heuerauthor=P.+Huangauthor=C.+Jaegerauthor=A.+Joshiauthor=A.+R.+Kennedyauthor=A.+I.+Kimauthor=K.+Laraauthor=J.+Leeauthor=J.+Liauthor=J.+C.+Lougheedauthor=S.+Maauthor=S.+Malekauthor=J.+C.+Manaloauthor=J.+F.+Martiniauthor=G.+McGrathauthor=M.+Nicollauthor=J.+M.+Nussauthor=M.+Packauthor=C.+J.+Petoauthor=T.+H.+Tsangauthor=L.+Wangauthor=S.+W.+Wombleauthor=M.+Yakesauthor=W.+Zhangauthor=K.+D.+Rice&title=Discovery+of+XL888%3A+a+novel+tropane-derived+small+molecule+inhibitor+of+HSP90&doi=10.1016%2Fj.bmcl.2012.07.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90</span></div><div class="casAuthors">Bussenius, Joerg; Blazey, Charles M.; Aay, Naing; Anand, Neel K.; Arcalas, Arlyn; Baik, TaeGon; Bowles, Owen J.; Buhr, Chris A.; Costanzo, Simona; Curtis, Jeffrey K.; DeFina, Steven C.; Dubenko, Larisa; Heuer, Timothy S.; Huang, Ping; Jaeger, Christopher; Joshi, Anagha; Kennedy, Abigail R.; Kim, Angie I.; Lara, Katherine; Lee, Jae; Li, Jonathan; Lougheed, Julie C.; Ma, Sunghoon; Malek, Shiva; Manalo, Jean-Claire L.; Martini, Jean-Francois; McGrath, Garth; Nicoll, Monique; Nuss, John M.; Pack, Michael; Peto, Csaba J.; Tsang, Tsze H.; Wang, Longcheng; Womble, Scott W.; Yakes, Michael; Zhang, Wentao; Rice, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5396-5404</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With structural guidance, tropane-derived HTS hits were modified to optimize for HSP90 inhibition and a desirable in vivo profile.  Through an iterative SAR development process 12i [I; X = cyclopropyl, R1 = Me, R2 = (R)-sec-Bu, XL888] was discovered and shown to reduce HSP90 client protein content in PD studies.  Furthermore, efficacy expts. performed in a NCI-N87 mouse xenograft model demonstrated tumor regression in some dosing regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYT__qJeDg0rVg90H21EOLACvtfcHk0li_j1X22w4cjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGht7%252FL&md5=d62d69690c1f80ae0489a6a1350f2abe</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.052%26sid%3Dliteratum%253Aachs%26aulast%3DBussenius%26aufirst%3DJ.%26aulast%3DBlazey%26aufirst%3DC.%2BM.%26aulast%3DAay%26aufirst%3DN.%26aulast%3DAnand%26aufirst%3DN.%2BK.%26aulast%3DArcalas%26aufirst%3DA.%26aulast%3DBaik%26aufirst%3DT.%26aulast%3DBowles%26aufirst%3DO.%2BJ.%26aulast%3DBuhr%26aufirst%3DC.%2BA.%26aulast%3DCostanzo%26aufirst%3DS.%26aulast%3DCurtis%26aufirst%3DJ.%2BK.%26aulast%3DDeFina%26aufirst%3DS.%2BC.%26aulast%3DDubenko%26aufirst%3DL.%26aulast%3DHeuer%26aufirst%3DT.%2BS.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DJaeger%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DA.%2BR.%26aulast%3DKim%26aufirst%3DA.%2BI.%26aulast%3DLara%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLougheed%26aufirst%3DJ.%2BC.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMalek%26aufirst%3DS.%26aulast%3DManalo%26aufirst%3DJ.%2BC.%26aulast%3DMartini%26aufirst%3DJ.%2BF.%26aulast%3DMcGrath%26aufirst%3DG.%26aulast%3DNicoll%26aufirst%3DM.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DPack%26aufirst%3DM.%26aulast%3DPeto%26aufirst%3DC.%2BJ.%26aulast%3DTsang%26aufirst%3DT.%2BH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWomble%26aufirst%3DS.%2BW.%26aulast%3DYakes%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DRice%26aufirst%3DK.%2BD.%26atitle%3DDiscovery%2520of%2520XL888%253A%2520a%2520novel%2520tropane-derived%2520small%2520molecule%2520inhibitor%2520of%2520HSP90%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5396%26epage%3D5404%26doi%3D10.1016%2Fj.bmcl.2012.07.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawasaki, T.</span></span> <span> </span><span class="NLM_article-title">Simple screening method for autoantigen proteins using the N-terminal biotinylated protein library produced by wheat cell-free synthesis</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4264</span>– <span class="NLM_lpage">4273</span>, <span class="refDoi"> DOI: 10.1021/pr9010553</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr9010553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFegs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=4264-4273&issue=8&author=K.+Matsuokaauthor=H.+Komoriauthor=M.+Noseauthor=Y.+Endoauthor=T.+Sawasaki&title=Simple+screening+method+for+autoantigen+proteins+using+the+N-terminal+biotinylated+protein+library+produced+by+wheat+cell-free+synthesis&doi=10.1021%2Fpr9010553"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Simple Screening Method for Autoantigen Proteins Using the N-Terminal Biotinylated Protein Library Produced by Wheat Cell-Free Synthesis</span></div><div class="casAuthors">Matsuoka, Kazuhiro; Komori, Hiroaki; Nose, Masato; Endo, Yaeta; Sawasaki, Tatsuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4264-4273</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autoimmune diseases are a heterogeneous group of diseases characterized by immune reactions against either a major or a limited no. of the bodies own autoantigens, causing inflammation and damage to tissues and organs.  Thus, identification of autoantigens is an important first step to understanding autoimmune diseases.  Here the authors demonstrate a simple screening method for identification of autoantigens reacting with patient serum antibodies by combination of an N-terminal biotinylated protein library (BPL), produced using a wheat cell-free protein prodn. system, and a com. available luminescence system.  Optimization studies using well-characterized autoantigens showed specific interactions between N-terminal biotinylated proteins and antibody that were sensitively detected under homogeneous reaction conditions.  In this optimized assay, 1 μL of the translation mixt. expressing the biotinylated proteins produced significant luminescence signal by addn. of dild. serum between 1:500 and 1:10,000 in 25 μL of reaction vol.  For the BPL construction, 214 mouse genes, consisting of 103 well-known autoantigens and 111 genes in the mouse autoimmune susceptibility loci, and the sera of MRL/lpr mouse were used as an autoimmune model.  By this screening method, 25 well-known autoantigens and 71 proteins in the loci were identified as autoantigen proteins specifically reacting with sera antibodies.  Cross-referencing with the Gene Ontol. Database, 26 and 38 of autoantigen proteins were predicted to have nuclear localization and identified as membrane and/or extracellular proteins.  The immune reaction of six randomly selected proteins was confirmed by immunopptn. and/or immunoblot analyses.  Interestingly, three autoantigen proteins were recognized by immunopptn. but not by immunoblot anal.  These results suggest that the BPL-based method could provide a simple system for screening of autoantigen proteins and would help with identification of autoantigen proteins reacting with antibodies that recognize folded proteins, rather than denatured or unfolded forms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_25Ve-t_ZWbVg90H21EOLACvtfcHk0li91wwA8RS8eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFegs7Y%253D&md5=db5b2991c71891e8e210ed2ffc2dc89f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fpr9010553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr9010553%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DKomori%26aufirst%3DH.%26aulast%3DNose%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DSawasaki%26aufirst%3DT.%26atitle%3DSimple%2520screening%2520method%2520for%2520autoantigen%2520proteins%2520using%2520the%2520N-terminal%2520biotinylated%2520protein%2520library%2520produced%2520by%2520wheat%2520cell-free%2520synthesis%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2010%26volume%3D9%26issue%3D8%26spage%3D4264%26epage%3D4273%26doi%3D10.1021%2Fpr9010553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makoto, K.</span>; <span class="NLM_string-name">Satoshi, Y.</span>; <span class="NLM_string-name">Shuichi, O.</span></span> <span> </span><span class="NLM_article-title">Novel bicyclic compound or salt there of</span>. <span class="NLM_patent">WO2012093708A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=K.+Makoto&author=Y.+Satoshi&author=O.+Shuichi&title=Novel+bicyclic+compound+or+salt+there+of"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMakoto%26aufirst%3DK.%26atitle%3DNovel%2520bicyclic%2520compound%2520or%2520salt%2520there%2520of%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makoto, K.</span>; <span class="NLM_string-name">Shuichi, O.</span>; <span class="NLM_string-name">Chihoko, Y.</span>; <span class="NLM_string-name">Satoshi, Y.</span>; <span class="NLM_string-name">Hiromi, O.</span>; <span class="NLM_string-name">Takao, U.</span>; <span class="NLM_string-name">Yuichi, K.</span></span>, <span class="NLM_patent">WO2011004610A1</span>. <span> </span><span class="NLM_article-title">Azabicyclo compound and salt thereof</span>. <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Makoto&author=O.+Shuichi&author=Y.+Chihoko&author=Y.+Satoshi&author=O.+Hiromi&author=U.+Takao&author=K.+Yuichi&title=Azabicyclo+compound+and+salt+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMakoto%26aufirst%3DK.%26atitle%3DAzabicyclo%2520compound%2520and%2520salt%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howes, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Northfield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surgenor, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wayne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drysdale, M. J.</span></span> <span> </span><span class="NLM_article-title">A fluorescence polarization assay for inhibitors of Hsp90</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2005.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1016%2Fj.ab.2005.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=16460658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVeht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2006&pages=202-213&author=R.+Howesauthor=X.+Barrilauthor=B.+W.+Dymockauthor=K.+Grantauthor=C.+J.+Northfieldauthor=A.+G.+Robertsonauthor=A.+Surgenorauthor=J.+Wayneauthor=L.+Wrightauthor=K.+Jamesauthor=T.+Matthewsauthor=K.+M.+Cheungauthor=E.+McDonaldauthor=P.+Workmanauthor=M.+J.+Drysdale&title=A+fluorescence+polarization+assay+for+inhibitors+of+Hsp90&doi=10.1016%2Fj.ab.2005.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A fluorescence polarization assay for inhibitors of Hsp90</span></div><div class="casAuthors">Howes, R.; Barril, X.; Dymock, B. W.; Grant, K.; Northfield, C. J.; Robertson, A. G. S.; Surgenor, A.; Wayne, J.; Wright, L.; James, K.; Matthews, T.; Cheung, K.-M.; McDonald, E.; Workman, P.; Drysdale, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-213</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Hsp90 encodes a ubiquitous mol. chaperone protein conserved among species which acts on multiple substrates, many of which are important cell-signaling proteins.  Inhibition of Hsp90 function has been promoted as a mechanism to degrade client proteins involved in tumorigenesis and disease progression.  Several assays to monitor inhibition of Hsp90 function currently exist but are limited in their use for a drug discovery campaign.  Using data from the crystal structure of an initial hit compd., we have synthesized a fluorescent probe to be used in a fluorescence polarization assay to monitor binding of compds. to the ATP-binding site of Hsp90.  This assay is very robust (Z' > 0.9) and can detect affinity of compds. with IC50s to 40 nM.  We have used this assay in conjunction with cocrystal structures of small mols. to drive a structure-based design program aimed at the discovery and optimization of a novel class of potent Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoag8hYDpa7BrVg90H21EOLACvtfcHk0li91wwA8RS8eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVeht74%253D&md5=59b8bce204a19c6618f9bce225eeb7df</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2005.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2005.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26aulast%3DGrant%26aufirst%3DK.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWayne%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DL.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26atitle%3DA%2520fluorescence%2520polarization%2520assay%2520for%2520inhibitors%2520of%2520Hsp90%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D350%26spage%3D202%26epage%3D213%26doi%3D10.1016%2Fj.ab.2005.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lea, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span> <span> </span><span class="NLM_article-title">Fluorescence polarization assays in small molecule screening</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1517/17460441.2011.537322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=10.1517%2F17460441.2011.537322" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=22328899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SrtbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=17-32&author=W.+A.+Leaauthor=A.+Simeonov&title=Fluorescence+polarization+assays+in+small+molecule+screening&doi=10.1517%2F17460441.2011.537322"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescence polarization assays in small molecule screening</span></div><div class="casAuthors">Lea, Wendy A.; Simeonov, Anton</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-32</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Fluorescence polarization (FP) is a homogeneous method that allows rapid and quant. anal. of diverse mol. interactions and enzyme activities.  This technique has been widely utilized in clin. and biomedical settings, including the diagnosis of certain diseases and monitoring therapeutic drug levels in body fluids.  Recent developments in the field have been symbolized by the facile adoption of FP in high-throughput screening and small mol. drug discovery of an increasing range of target classes.  Areas covered in this review: The article provides a brief overview of the theor. foundation of FP, followed by updates on recent advancements in its application for various drug target classes, including GPCRs, enzymes and protein-protein interactions.  The strengths and weaknesses of this method, practical considerations in assay design, novel applications and future directions are also discussed.  What the reader will gain: The reader is informed of the most recent advancements and future directions of FP application to small mol. screening.  Take home message: In addn. to its continued utilization in high-throughput screening, FP has expanded into new disease and target areas and has been marked by increased use of labeled small mol. ligands for receptor-binding studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqudLso-a4wR7Vg90H21EOLACvtfcHk0ljEFQ4zo0oLLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SrtbvP&md5=6f102f40b56fd7a13c4fb59b64a3f883</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.537322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.537322%26sid%3Dliteratum%253Aachs%26aulast%3DLea%26aufirst%3DW.%2BA.%26aulast%3DSimeonov%26aufirst%3DA.%26atitle%3DFluorescence%2520polarization%2520assays%2520in%2520small%2520molecule%2520screening%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D17%26epage%3D32%26doi%3D10.1517%2F17460441.2011.537322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span> <i>Molecular Operating
Environment</i>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">Montreal,
Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Molecular+Operating%0AEnvironment%3B+Chemical+Computing+Group+Inc.%3A+Montreal%2C%0ACanada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%250AEnvironment%26pub%3DChemical%2520Computing%2520Group%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, S. J.</span>; <span class="NLM_string-name">Thornton, J. M.</span></span> <i>NACCESS</i>; <span class="NLM_publisher-name">Department of Biochemistry and Molecular Biology, University College</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">1993</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=S.+J.+Hubbard&author=J.+M.+Thornton&title=NACCESS"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DHubbard%26aufirst%3DS.%2BJ.%26jtitle%3DNACCESS%26pub%3DDepartment%2520of%2520Biochemistry%2520and%2520Molecular%2520Biology%252C%2520University%2520College%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZR3','PDB','5ZR3'); return false;">PDB: 5ZR3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WQ9','PDB','3WQ9'); return false;">PDB: 3WQ9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3QDD','PDB','3QDD'); return false;">PDB: 3QDD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R92" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3R92','PDB','3R92'); return false;">PDB: 3R92</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI','PDB','2VCI'); return false;">PDB: 2VCI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YET" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YET','PDB','1YET'); return false;">PDB: 1YET</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e1026-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01715">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62574"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01715?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01715</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Scheme for the synthesis of compounds (TAS-116, THS-510, THS-975, and THS-762), the data of SPR, competitive binding assay, ITC, molecular model of complexes (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_001.pdf">jm0c01715_si_001.pdf (850.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01715/suppl_file/jm0c01715_si_002.csv">jm0c01715_si_002.csv (0.47 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01715&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01715%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01715" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b0bec9e0622a8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
